
<html lang="en"     class="pb-page"  data-request-id="1cc585b4-e3a4-4299-abe9-969a7b839bd4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm301190s;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Covalent Inhibitors of Interleukin-2 Inducible T Cell Kinase (Itk) with Nanomolar Potency in a Whole-Blood Assay" /></meta><meta name="dc.Creator" content="Christoph W.  Zapf" /></meta><meta name="dc.Creator" content="Brian S.  Gerstenberger" /></meta><meta name="dc.Creator" content="Li  Xing" /></meta><meta name="dc.Creator" content="David C.  Limburg" /></meta><meta name="dc.Creator" content="David R.  Anderson" /></meta><meta name="dc.Creator" content="Nicole  Caspers" /></meta><meta name="dc.Creator" content="Seungil  Han" /></meta><meta name="dc.Creator" content="Ann  Aulabaugh" /></meta><meta name="dc.Creator" content="Ravi  Kurumbail" /></meta><meta name="dc.Creator" content="Subarna  Shakya" /></meta><meta name="dc.Creator" content="Xin  Li" /></meta><meta name="dc.Creator" content="Vikki  Spaulding" /></meta><meta name="dc.Creator" content="Robert M.  Czerwinski" /></meta><meta name="dc.Creator" content="Nilufer  Seth" /></meta><meta name="dc.Creator" content="Quintus G.  Medley" /></meta><meta name="dc.Description" content="We wish to report a strategy that targets interleukin-2inducible T cell kinase (Itk) with covalent inhibitors. Thus far, covalent inhibition of Itk has not been disclosed in the literature. Structu..." /></meta><meta name="Description" content="We wish to report a strategy that targets interleukin-2inducible T cell kinase (Itk) with covalent inhibitors. Thus far, covalent inhibition of Itk has not been disclosed in the literature. Structu..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 12, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm301190s" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm301190s" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm301190s" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm301190s" /></link>
        
    
    

<title>Covalent Inhibitors of Interleukin-2 Inducible T Cell Kinase (Itk) with Nanomolar Potency in a Whole-Blood Assay | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm301190s" /></meta><meta property="og:title" content="Covalent Inhibitors of Interleukin-2 Inducible T Cell Kinase (Itk) with Nanomolar Potency in a Whole-Blood Assay" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0020.jpeg" /></meta><meta property="og:description" content="We wish to report a strategy that targets interleukin-2inducible T cell kinase (Itk) with covalent inhibitors. Thus far, covalent inhibition of Itk has not been disclosed in the literature. Structure-based drug design was utilized to achieve low nanomolar potency of the disclosed series even at high ATP concentrations. Kinetic measurements confirmed an irreversible binding mode with off-rate half-lives exceeding 24 h and moderate on-rates. The analogues are highly potent in a cellular IP1 assay as well as in a human whole-blood (hWB) assay. Despite a half-life of approximately 2 h in resting primary T cells, the covalent inhibition of Itk resulted in functional silencing of the TCR pathway for more than 24 h. This prolonged effect indicates that covalent inhibition is a viable strategy to target the inactivation of Itk." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm301190s"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm301190s">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm301190s&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm301190s&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm301190s&amp;href=/doi/10.1021/jm301190s" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 10047-10063</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301188x" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301201z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Covalent Inhibitors of Interleukin-2 Inducible T Cell Kinase (Itk) with Nanomolar Potency in a Whole-Blood Assay</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christoph+W.++Zapf">Christoph W. Zapf</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+S.++Gerstenberger">Brian S. Gerstenberger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Xing">Li Xing</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+C.++Limburg">David C. Limburg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+R.++Anderson">David R. Anderson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicole++Caspers">Nicole Caspers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seungil++Han">Seungil Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ann++Aulabaugh">Ann Aulabaugh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ravi++Kurumbail">Ravi Kurumbail</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Subarna++Shakya">Subarna Shakya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Li">Xin Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vikki++Spaulding">Vikki Spaulding</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+M.++Czerwinski">Robert M. Czerwinski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nilufer++Seth">Nilufer Seth</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Quintus+G.++Medley">Quintus G. Medley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">BioTherapeutics Chemistry, Pfizer Worldwide Medicinal Chemistry, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">BioTherapeutics Chemistry, Pfizer Worldwide Medicinal Chemistry, Eastern Point Road, Groton, Connecticut 06340, United States </span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Structure Biology and Biophysics, Pfizer Worldwide Medicinal Chemistry, Eastern Point Road, Groton, Connecticut 06340, United States </span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Inflammation and Autoimmunity, Pfizer Research, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: +1 617 665 5602. Fax: +1 617 665 5682. E-mail: <a href="/cdn-cgi/l/email-protection#a0c3c8d2c9d3d4cfd0c88edac1d0c6e0d0c6c9dac5d28ec3cfcd"><span class="__cf_email__" data-cfemail="610209130812150e11094f1b001107211107081b04134f020e0c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm301190s&amp;href=/doi/10.1021%2Fjm301190s" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 10047–10063</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 25, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 August 2012</li><li><span class="item_label"><b>Published</b> online</span>12 November 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm301190s" title="DOI URL">https://doi.org/10.1021/jm301190s</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10047%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristoph%2BW.%2BZapf%252C%2BBrian%2BS.%2BGerstenberger%252C%2BLi%2BXing%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D22%26contentID%3Djm301190s%26title%3DCovalent%2BInhibitors%2Bof%2BInterleukin-2%2BInducible%2BT%2BCell%2BKinase%2B%2528Itk%2529%2Bwith%2BNanomolar%2BPotency%2Bin%2Ba%2BWhole-Blood%2BAssay%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10063%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm301190s"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4312</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">50</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm301190s" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Covalent Inhibitors of Interleukin-2 Inducible T Cell Kinase (Itk) with Nanomolar Potency in a Whole-Blood Assay&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christoph&quot;,&quot;last_name&quot;:&quot;W. Zapf&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;S. Gerstenberger&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Xing&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;C. Limburg&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;R. Anderson&quot;},{&quot;first_name&quot;:&quot;Nicole&quot;,&quot;last_name&quot;:&quot;Caspers&quot;},{&quot;first_name&quot;:&quot;Seungil&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Ann&quot;,&quot;last_name&quot;:&quot;Aulabaugh&quot;},{&quot;first_name&quot;:&quot;Ravi&quot;,&quot;last_name&quot;:&quot;Kurumbail&quot;},{&quot;first_name&quot;:&quot;Subarna&quot;,&quot;last_name&quot;:&quot;Shakya&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Vikki&quot;,&quot;last_name&quot;:&quot;Spaulding&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;M. Czerwinski&quot;},{&quot;first_name&quot;:&quot;Nilufer&quot;,&quot;last_name&quot;:&quot;Seth&quot;},{&quot;first_name&quot;:&quot;Quintus&quot;,&quot;last_name&quot;:&quot;G. Medley&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;10047-10063&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm301190s&quot;},&quot;abstract&quot;:&quot;We wish to report a strategy that targets interleukin-2inducible T cell kinase (Itk) with covalent inhibitors. Thus far, covalent inhibition of Itk has not been disclosed in the literature. Structure-based drug design was utilized to achieve low nanomolar potency of the disclosed series even at high ATP concentrations. Kinetic measurements confirmed an irreversible binding mode with off-rate half-lives exceeding 24 h and moderate on-rates. The analogues are highly potent in a cellular IP1 assay as well as in a human whole-blood (hWB) assay. Despite a half-life of approximately 2 h in resting primary T cells, the covalent inhibition of Itk resulted in functional silencing of the TCR pathway for more than 24 h. This prolonged effect indicates that covalent inhibition is a viable strategy to target the inactivation of Itk.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301190s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301190s" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301190s&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301190s" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301190s&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301190s" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm301190s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301190s&amp;href=/doi/10.1021/jm301190s" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm301190s" /></input><a href="/doi/pdf/10.1021/jm301190s" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm301190s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm301190s%26sid%3Dliteratum%253Aachs%26pmid%3D23098091%26genre%3Darticle%26aulast%3DZapf%26date%3D2012%26atitle%3DCovalent%2BInhibitors%2Bof%2BInterleukin-2%2BInducible%2BT%2BCell%2BKinase%2B%2528Itk%2529%2Bwith%2BNanomolar%2BPotency%2Bin%2Ba%2BWhole-Blood%2BAssay%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D22%26spage%3D10047%26epage%3D10063%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292593" title="Liquid chromatography-mass spectrometry">Liquid chromatography-mass spectrometry</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jmcmar.2012.55.issue-22/production/jmcmar.2012.55.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We wish to report a strategy that targets interleukin-2inducible T cell kinase (Itk) with covalent inhibitors. Thus far, covalent inhibition of Itk has not been disclosed in the literature. Structure-based drug design was utilized to achieve low nanomolar potency of the disclosed series even at high ATP concentrations. Kinetic measurements confirmed an irreversible binding mode with off-rate half-lives exceeding 24 h and moderate on-rates. The analogues are highly potent in a cellular IP1 assay as well as in a human whole-blood (hWB) assay. Despite a half-life of approximately 2 h in resting primary T cells, the covalent inhibition of Itk resulted in functional silencing of the TCR pathway for more than 24 h. This prolonged effect indicates that covalent inhibition is a viable strategy to target the inactivation of Itk.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18756" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18756" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The nonreceptor tyrosine kinase Itk (interleukin-2 inducible T-cell kinase) is a member of the TEC-kinase family which encompasses Itk, Rlk, Btk, Bmx, and Tec. It is expressed mainly in immune cells such as T cells, mast cells, NK cells, and NKT cells. Recent work suggests that Itk may be a negative regulator in mast cells as responses of mast cells lacking Itk to FcεR1 signaling are not attenuated and can be increased relative to WT mast cells.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In contrast, Itk positively regulates T cell receptor (TCR) signaling and plays a role in numerous T cell responses.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Itk is activated downstream of the T cell receptor and activates PLCγ1 by phosphorylation. This leads to the production of IP3 and DAG and triggers the release of intracellular calcium and activation of PKCϕ, respectively. These actions induce T cell proliferation and drive transcription of cytokines through NFATc.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> For an excellent and more comprehensive schematic representation of the TCR pathway please refer to the recent literature.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Itk is strongly upregulated upon activation of naive T cells, and both respond to and drive the expression of IL-2. It is the sole TEC kinase expressed in Th2 T cells and has been shown to play a key role in Th2 cytokine production <i>in vivo</i>.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> Itk has also been implicated in the production of IL-17A in Th17 cells.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> An effect on T cell integrins has been shown to involve Itk and can alter binding to APC’s and the extracellular matrix.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> In addition to its role in the TCR pathway, Itk has been shown to be involved in the response of T cells to several chemokines, and Itk knockout T cells have reduced chemotaxis to SDF-α1.<a onclick="showRef(event, 'ref5 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref5 ref9 ref10">(5, 9, 10)</a> Itk KO mice also have reduced T cell recruitment to the lungs in OVA-asthma models, suggesting a role for Itk in T cell trafficking. Additionally, the use of RNA interference studies, kinase-inactive Itk mutants, and Itk small molecule inhibitors demonstrated that efficient uptake of HIV by CD4 + T cells and viral replication requires Itk kinase activity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Several potent ATP-competitive small-molecule Itk inhibitors have been reported in the literature to date (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). BMS disclosed some of the earliest potent and selective small molecule Itk inhibitors<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> focusing on aminothiazoles such as compound <b>1</b>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a>Subsequently, Boehringer Ingelheim disclosed several papers<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18">(14-18)</a> culminating in the discovery of highly optimized benzimidazoles such as analogue <b>2</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Very recently, Vertex published their own SAR efforts around the potent pyridone template (<b>3</b>)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and a detailed understanding of the hydration state of the Itk active site.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Mannkind and GSK also disclosed several potent Itk inhibitors represented by aryl ketone <b>4</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and aminobenzothiazole <b>5</b>,<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> respectively.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Known Itk inhibitors from the literature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite these advances, to the best of our knowledge no Itk inhibitors have been advanced to clinical trials. It should be pointed out that literature reported inhibition values were generally determined in the presence of ATP concentrations corresponding to the <i>K</i><sub>m</sub> of the enzyme (∼5 μM). When tested in a cellular environment with an ATP concentration of 1–2 mM, ATP-competitive inhibitors were found to be 30–50-fold less potent as predicted by Cheng-Prusoff.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> To overcome this problem of biochemical efficiency, other modes of inhibition need to be applied.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p">Non-ATP-competitive kinase inhibition is an approach that is getting increased attention because this strategy allows improved selectivity.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> A recently disclosed allosteric site on Itk<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> drove a discovery program targeting small molecule allosteric inhibitors of Itk.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">A recent analysis of the marketed drugs highlights that more than half of them undergo a chemical reaction in the enzyme’s active site or are structurally related to the natural substrate.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In spite of the pharmaceutical industry’s tendency to shy away from deliberately targeting covalent inhibitors, this class of compounds is experiencing renewed interest presumably due to some of the inherent mechanistic advantages.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Much effort has been brought forth to understand the relationship between the reactivity of an electrophile and its potential toxicological profile in order to predict and derisk off-target reactivity.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> More than half of the 39 FDA approved covalent drugs are utilized either as antibiotics or anticancer medicines. However, one cannot ignore the fact that in 2010 two of the top five selling drugs in the US were known to be covalent inhibitors (Nexium and Plavix) and did not belong to either drug class.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">Pfizer recently disclosed a series of inhibitors targeting Bruton’s tyrosine kinase (Btk) in a covalent fashion.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The known covalent Btk inhibitor PCI32765,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> which was advanced to clinical trials for the treatment of chronic lymphocytic leukemia and B cell lymphoma has also been reported to be a potent inhibitor of Itk.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">Encouraged by these recent successful clinical applications of covalent inhibitors and with our institutional knowledge of advancing covalent inhibitors to clinical trials,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> we initiated a program to target low dose<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> covalent inhibitors of Itk to overcome the biochemical efficiency hurdle inherent to the kinase. At the outset of this approach, concerns were considered with respect to selectivity over other cysteine containing kinases. Analysis of the ATP binding site of 434 kinases revealed that 10 other kinases such as Btk, Egfr, Rlk Jak3, etc. contain a cysteine corresponding to Cys442 in Itk, the cysteine to be targeted for covalent modification.</div><div class="NLM_p last">The microenvironment of Cys442 in Itk was perceived as an additional hurdle to discovering covalent Itk inhibitors. The p<i>K</i><sub>a</sub> of a cysteine sulfhydryl group can potentially be influenced in a substantial manner depending on the surrounding amino acids, leading to a wide range of reactivity. When comparing the cysteine-containing kinases, different p<i>K</i><sub>a</sub>-modifying amino acids can be found at the i+3 position with respect to the cysteine. The majority of the cysteine-containing kinases in question either contain an Asp or an Asn in this position. Compared to the kinases displaying an Asn, the former amino acids lead to an increase in p<i>K</i><sub>a</sub> and concomitant reduction in nucleophilicity. Itk is characterized by the presence of Asp445, which leads to an increase in the p<i>K</i><sub>a</sub> of the cysteine to about 8.5, whereas Btk contains an Asn in the corresponding position resulting in a p<i>K</i><sub>a</sub> of about 7.7 for the respective cysteine. The expected reduction in nucleophilicity of Cys442 was perceived as an additional obstacle to discover a covalent inhibitor for Itk.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Itk Half-Life Determination</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01484" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01484" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To implement a successful covalent strategy for the inhibition of Itk, it was important to understand the stability of the inhibitor–Itk complex and the resynthesis rate or half-life of the kinase. To determine the half-life of Itk, human CD4<sup>+</sup> T cells were used to perform a traditional pulse–chase experiment utilizing <sup>35</sup>S Met/Cys.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> It was determined that Itk has a half-life of approximately one hour in resting primary CD4+ T cells (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) indicating that the protein is rapidly turned over in cells. We next tested if treatment of CD4<sup>+</sup> T cells with covalent Itk inhibitors would affect Itk turnover. Cells were <sup>35</sup>S Met/Cys labeled and treated with a covalent inhibitor for 45 min. The cells were then washed to remove unbound inhibitor, and protein turnover was measured over time. It was demonstrated that treatment of cells with a covalent inhibitor stabilizes Itk leading to an increased half-life of 22 h.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pulse-chase experiment in the presence and absence of a covalent Itk inhibitor to determine the functional half-life of Itk in primary cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine the pharmacodynamic effect of covalent Itk inhibition, T cells were stimulated at various times following covalent Itk inhibition, and the phosphorylation of PLCγ1 was measured. Cells were treated with an Itk inhibitor for one hour after which the excess inhibitor was removed by extensive washing, and the cells were cultured further. At different time points, cells were removed and activated through the TCR with anti-CD3/CD28 beads. The extent of phospho-PLCγ1 was determined by SDS gel and Western blotting. Inhibition of the generation of phospho-PLCγ1 lasted for up to 24 h following covalent Itk inhibition (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, data normalized to the absence of the inhibitor). This prolonged pharmacodynamic effect following covalent Itk inhibition correlates well with the increased Itk half-life following the covalent inhibition that we observed. Phosphorylation has been linked to the regulation of protein turnover, and the cbl family of ubiquitin ligases are generally targeted to client proteins through a phosphorylation site.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> It is possible that Itk autophosphorylation results in the formation of or regulates the formation of a ubiquitin–ligase binding site. Kinase activity has been linked to protein turnover in several signaling pathways including recent data showing that downstream Syk-dependent BCR signaling is required for BCR ubiquitination.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Mice carrying a cbl-b E3 ubiquitin ligase-defective mutation have hyperactive TCR signaling and spontaneous autoimmunity showing that cbl family ubiquitin ligases play an important role in negative signaling in T cells.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Determination of the inhibition of phospho-PLCγ1 over time in the presence of 10 μM covalent Itk inhibitors. The measured phospho-PLCγ1 inhibition in the presence of an inhibitor was normalized to the control (absence of inhibitor).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27861" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27861" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Syntheses of covalent pyrazolopyrimidines <b>10</b>–<b>27</b> commenced from reagent <b>6</b><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and commercially available <b>7</b> via a Mitsunobu reaction to yield chiral iodopyrazolopyrimidine <b>8</b> in 70% yield (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). This core could be elaborated by either applying parallel medicinal chemistry or singleton chemical synthesis. Suzuki couplings of iodide <b>8</b> to a variety of aryl and heteroaryl boronic acids provide piperidine <b>9</b> in moderate to good yield (60–70%). Subsequent Boc deprotection using 4 N HCl in dioxane cleanly provided the piperidine HCl salt in nearly quantitative yield. This salt could be used directly to install the acrylamide in <b>10</b>–<b>27</b> via amide coupling utilizing acrylic acid or via acryloyl chloride.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Aryl and Heteroaryl-Substituted Pyrazolopyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIAD, PPh<sub>3</sub>, THF; (b) boronic acid, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 120 °C; (c) 4 N HCl, 1,4-dioxane; (d) EDCI, HOBT, TEA, acrylic acid, THF or acryloyl chloride, TEA, DCM.</p></p></figure><div class="NLM_p">Synthesis of amide substituted pyrazolopyrimidines <b>30</b>–<b>51</b> used key intermediate <b>28</b> that was accessed via Suzuki coupling of iodide <b>8</b> followed by hydrolysis to provide acid <b>28</b> in 98% yield (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Direct access to benzoic acid <b>28</b> via Suzuki coupling with 3-boronobenzoic acid also provided the desired intermediate but was found to be problematic during scale up. Amide couplings using standard HATU conditions provided amides <b>29</b> in good to excellent yield (62–96%). Boc deprotection of <b>29</b> using 4 N HCl in dioxane again cleanly provided the piperidine HCl salt. As before, this salt could be used directly in the next step to install a variety of electrophiles via amide coupling conditions from the carboxylic acids or by utilizing acryloyl chloride to provide <b>30</b>–<b>51</b> in poor to moderate yield (8–61%). Intermediate <b>29</b> also reacted cleanly with cyanogen bromide to provide <b>64</b> (vide infra) in 55% yield.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Amide Substituted Pyrazolopyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-(methoxycarbonyl)phenylboronic acid, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 1,4 dioxane, 120 °C; (b) NaOH, MeOH, H<sub>2</sub>O; (c) HATU, TEA, HNR<sub>1</sub>R<sub>2</sub>, THF; (d) 4 N HCl, 1,4-dioxane; (e) HATU, TEA, R<sub>3</sub>CO<sub>2</sub>H, THF or R<sub>3</sub>C(O)Cl, TEA, DCM or BrCN, Cs<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64028" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64028" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In an effort to explore novel chemical space, the corporate compound repository was surveyed for potentially covalent kinase inhibitors. Pyrazolopyrimidine <b>52</b> with an electrophilic acrylamide (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A) was found to be a potent Itk inhibitor in the enzyme assay in the presence of a physiological level of ATP (IC<sub>50</sub> = 73 nM). The compound was also tested in the IP1 assay in which Jurkat cells are treated with the inhibitor before anti-CD3 is added as a stimulus and the inhibition of PLCγ phosphorylation, the immediate downstream target of Itk, is measured. Compared to the enzyme assay, amide <b>52</b> was found to display a substantial drop in potency in the cell assay (IC<sub>50</sub> = 2.21 μM). However, this <i>m</i>-amide analogue provided an intriguing starting point for further SAR exploration. An X-ray crystal structure of amide <b>52</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B) revealed the compound’s binding mode, which presumably allows the phenyl ring attached to the heterocyclic core to interact with the gatekeeper Phe435 through π-stacking. The crystal structure also confirmed that compound <b>52</b> engages Cys442 in a covalent bond between the β-carbon of the acrylamide and the cysteine sulfhydryl (C–S distance 2.0 Å). An additional hydrogen bond was detected between the carbonyl of the acrylamide and NH of the cysteine backbone (2.8 Å). The aminopyrimidine core interacts with Met438 and Glu436 at the hinge through two hydrogen bonds (3.1 and 2.8 Å). The π-stacking interaction of the phenyl ring attached to the pyrazolopyrimidine with gatekeeper Phe435 presumably positions the diarylamide group to form two hydrogen bonds with Lys391 (3.2 Å) and Asp500 (2.8 Å).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Itk potency of amide <b>52</b>. (B) X-ray crystal structures of <b>52</b> in the ATP binding site of Itk (a portion of the P-loop was omitted for clarity purposes).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The crystal structure of <b>52</b> was compared to that of pyridone <b>3</b>,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> which was recently disclosed by Vertex. The amino-pyrazine heterocycle in pyridone <b>3</b>, which was shown to interact with Lys391 and Glu406 via hydrogen bonds, overlaps reasonably well with the central phenyl ring in <b>52</b>. It was hypothesized that installation of a suitable heterocycle in place of the diaryl amide side chain in <b>52</b> could retain or improve potency while significantly reducing molecular weight. Furthermore, molecular modeling suggested that an aryl or heteroaryl side chain attached to the pyrazolo-pyrimidine heterocycle could potentially interact productively with the gatekeeper Phe435 by a π-stacking interaction.</div><div class="NLM_p">The library of pyrazolopyrimidines <b>10</b>–<b>27</b> was prepared with the stereochemistry suggested by the crystal structure of acrylamide <b>52</b>. It was found that the π-stacking hypothesiswas supported by the potencies of analogues <b>10</b>–<b>15</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), which correlate with the electronic nature of the phenyl rings. The electron-rich methoxy analogues <b>10</b> and <b>11</b> were more potent than the electron-deficient trifluoromethyl analogues <b>12</b> and <b>13</b>. The potency of the trifluoromethoxy analogues <b>14</b> and <b>15</b> were as expected. The <i>m</i>-substituted analogues in this set appeared to be slightly but consistently more potent than the corresponding <i>p</i>-substituted derivatives. Attempts to increase the electron density of the phenyl ring by addition of another alkoxy substituent did not lead to an improvement in potency (<b>16</b> and <b>17</b>) possibly due to steric interference. In contrast, benzyl alcohol derivative <b>18</b> did lead to a slight potency improvement as compared to the methoxy analogues.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition Constants of Aryl and Heteroaryl Substituted Pyrazolopyrimidines at Cellular ATP Concentration</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0011.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">Incorporation of a range of heterocyclic substituents attempting to engage Lys391 with or without an additional interaction to Glu406 did not provide the expected gain in potency as can be seen from analogues <b>19</b>–<b>24</b>. Likewise, attempting to form hydrogen bonds to sulfoxide <b>25</b> or sulfones <b>26</b> and <b>27</b> failed to improve the activity of the compounds. These aryl and heteroaryl-substituted pyrazolopyrimidines displayed an unsatisfying level potency in the presence of a high ATP concentration. This finding led to the conclusion that the biaryl motif was an essential part of the pharmacophore.</div><div class="NLM_p">Amide <b>52</b> was active in the enzyme assay, but its potency in the IP1 cell assay had to be improved. A library of amides was prepared for this purpose and to seek a replacement of the metabolically unfavorable <i>tert</i>-butyl group (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). A broad range of substituted anilines, benzylamines, phenethylamines, and alkylamines was explored varying the substitution pattern and electronic nature of the arene, while retaining the electrophilic acrylamide. Replacement of the <i>tert</i>-butyl group by a CF<sub>3</sub>-group provided analogues <b>30</b> and <b>31</b>, which are still potent but also showed a significant loss in activity compared to <b>52</b>. The corresponding methoxy-analogues <b>32</b> and <b>33</b> were equipotent suggesting that the electronic nature of the distal arene does not influence the binding affinity. Other fluorophenyl derivatives <b>34</b>–<b>37</b> with varying substitution patterns did not provide an improvement in potency. Incorporation of a heteroatom to improve physical properties led to a potency loss for pyridines <b>38</b> and <b>39</b>. A significant potency improvement compared to that of amide <b>52</b> was achieved with the <i>p</i>-isopropylphenyl analogues <b>40</b> and <b>41</b> (PF-06465469).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition Constants of Amides at the Meta Position of a Phenyl Substituted Pyrazolopyrimidine at Cellular ATP Concentration</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0013.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p">To probe the spatial tolerability of the pocket, the homologous benzyl and phenethylamines were tested. Similar to the <i>p</i>-isopropylphenyl analogues, the hydrophobic <i>tert</i>-butyl benzylamine derived amide <b>42</b> was found to be a highly potent covalent Itk inhibitor. While the CF<sub>3</sub>-derived benzylamine analogue <b>43</b> shows the same level of potency compared to those of aniline-derived amides <b>30</b> and <b>31</b>, the related benyzlamides <b>44</b>–<b>47</b> and the phenethylamide <b>48</b> are substantially less potent. Alkylamine-derivedamides such as <b>49</b>–<b>51</b> were either only weakly active or inactive. The series of compounds shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> strongly suggests that an alkyl-substituted phenyl ring at the distal position of the covalent inhibitors is optimal for potency.</div><div class="NLM_p">An additional feature of the crystal structure shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B is the stereochemistry of the piperidine ring. The presumed eutomer in this series is the (<i>R</i>)-enantiomer as shown. To confirm this finding, the (<i>R</i>)- and (<i>S</i>)-enantiomers <b>40</b> and <b>53</b> were prepared independently from chiral starting materials (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A), and the expected increase in potency was noted for the (<i>R</i>)-enantiomer in the three assays. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B illustrates the X-ray crystal structure of the two enantiomers. While both compounds form a covalent bond with the cysteine sulfhydryl, the (<i>R</i>)-enantiomer <b>40</b> is characterized by a hydrogen bond from the acrylamide carbonyl to the backbone protein, which cannot be detected in the structure of (<i>S</i>)-enantiomer. This additional interaction provides improved potency for inhibitor <b>40</b>, which translates convincingly through the three assays.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Comparison of the potencies of the enantiomeric pair <b>40</b> and <b>53</b> highlights the critical influence of the stereogenic center. (B) Overlay of the two enantiomers bound to the ATP-binding site of Itk.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As highlighted in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B, it was postulated that the amide bond between the aryl groups of analogue <b>52</b> forms a hydrogen bond with Lys391 and Asp500. To understand the contribution of engaging Asp500 in this interaction, methylated analogue <b>54</b> was prepared (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). When tested in the inhibition assay, a significant difference in potency was observed between the methylated and unmethylated analogue. Whereas the parent amide <b>40</b> is very potent in the enzyme assay at high ATP concentration (IC<sub>50</sub> = 10 nM), the corresponding N-methylated analogue <b>54</b> is essentially inactive, thus underscoring the critical nature of the engagement of this hydrogen bond.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Comparison of Amide <b>40</b> and <b>54</b> Demonstrates the Importance of the Amide’s Hydrogen Bond Donor Function</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0014.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd #</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">Itk IC<sub>50</sub> [μM] (1 mM ATP)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div></div><div class="NLM_p">Enantiomer <b>40</b> was subsequently utilized as a reference in a survey to explore the range of potential electrophiles that could be considered in subsequent covalent inhibitor designs. Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>highlights the analogues that were prepared for this comparison. While it appeared initially that any substitution around the acrylamide would be prohibitive (<b>55</b>–<b>57</b>), hydroxycrotonamide <b>58</b> and <i>N</i>-methylcrotonamide <b>59</b> clearly showed that the actual SAR is more complex. Further expansion of the electrophilic moiety initially led to an inactive piperazine analogue <b>60</b>. However, activity was restored upon extension of the polar functionality providing the elaborated analogue <b>61</b>. By increasing theelectron density around the electrophile, the methyl substituents in<b>55</b>–<b>57</b> presumably lower the electrophilicity of the olefin. In comparison, the hydroxymethyl and <i>N</i>-methyl aminomethyl groups are less deactivating compared to crotonamide <b>55</b>. For the piperazine analogue <b>61</b>, it was theorized that it is sufficiently basic to deprotonate the sulfhydryl group of Cys442, thus renderingit more reactive. While potent in the enzyme assay, analogue <b>61</b>, however, did not show any potency in the cell-based assay. Propargylamides <b>62</b> and <b>63</b> behaved similarly compared to the acrylamides in that the unsubstituted warhead was highly potent, while the methylated analogue was found to be inactive. Exploring cyanamide <b>64</b> as a structurally different class of electrophile led to a complete loss of activity.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Comparing Various Covalent Warheads by Potencies and Calculated Electrophilicity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0016.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0017.gif" alt="" id="fx7" /></img><div></div></div><div class="NLM_p">The compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> were utilized to investigate whether the Itk activity of newly designed analogues could be predicted by computational methods. It was found that calculated electrophilicity, which is a measure of the reactivity of the different electrophiles, can be employed to generally predict the compounds’ Itk inhibitory potency. The less reactive electrophiles, as calculated by lower electrophilicity values (e.g., <8 kcal/mol),<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a>produce compounds devoid of activity against Itk (IC<sub>50</sub> > 100 uM).Conversely, attachment of a stronger electrophilic group tothe pyrazolopyrimidine template yields analogues (such as <b>40</b>and <b>62</b>) with potent Itk inhibition (IC<sub>50</sub> = 10 nM). While the variations for this set of analogues are focused on the reactive group that forms a covalent adduct with Cys442, the Itk activities overall appear to be primarily driven by the intrinsic chemical reactivity of the electrophile. The underlying assumption for this analysis is that the geometrical requirement for covalent bond formation is consistently met. The significance of this assumption is potentially reflected in the lack of activity of piperazine <b>60</b>, which based on its electrophilicity calculations should be the most potent Itk inhibitor in the present series.</div><div class="NLM_p">In order to better understand the contribution of the electrophile to the potency of the covalent inhibitors and to expand the SAR information around the lipophilic back-pocket, additional acrylamides and their corresponding reversible acetamides were prepared. Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> highlights benzylamine- and aniline-based analogues. None of the reversible acetamides show potency in the presence of high ATP concentration, while only the acetamides incorporating <i>p</i>-isopropylphenyl (<b>±-69</b>) and <i>tert</i>-butylphenyl (<b>±-70</b> and <b>71</b>) show micromolar potency at low ATP concentrations. The incorporation of the electrophile leads to a substantial increase in potency independent from the ATP assay concentration.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Demonstrating the Critical Nature of the Covalent Warhead for Itk Inhibition</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0018.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0019.gif" alt="" id="fx9" /></img><div></div></div><div class="NLM_p">An interesting observation can be made comparing covalent benzyl amides <b>65</b> and <b>42</b>. At physiological ATP concentrations, the presence of the lipophilic <i>p</i>-<i>tert</i>-butyl group leads to an increase in potency of essentially 3 orders of magnitude. Theoretical considerations suggest that this increase in potency cannot derivefrom merely a hydrophobic interaction but must involve a much stronger hydrogen bond network.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> As was shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B, amide <b>52</b> engages Lys391 and Asp500 in two hydrogen bonds. Presumably, the sufficiently large lipophilic substituents at the terminal phenyl ring in <b>40</b>, <b>52</b>, <b>42</b>, and <b>41</b> act as anchors to position the aryl amide suitably to form the hydrogen bonds. The lack of this substituent (<b>65</b>) or a substituent of insufficient size (<b>67</b>) results in excessive flexibility of the distal phenyl ring and disruption of the hydrogen bonds with concomitant loss in potency.</div><div class="NLM_p">The most potent amides <b>40</b>, <b>41</b>, <b>±-52</b>, and <b>42</b> were profiled in the cell-based IP1 assay as well as a whole-blood assay. In the IP1 assay, primary cells are treated with the inhibitor before anti-CD3 is added as a stimulus, and the inhibition of PLCγ phosphorylation, the immediate downstream target of Itk, is measured. Similarly, the whole-blood assay encompasses treatment with the inhibitor and stimulation with anti-CD3; however, the read-out is the detection of IL-2 production. As can be seen in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, the potencies of compounds <b>40</b> and <b>41</b> translate well from the enzyme to cell and hWB assay, while amide<b>s ±-52</b>, <b>42</b>, and <b>61</b> show a significant loss in potency across the assays. The most potent compound <b>41</b> (PF-06465469)<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> in the enzyme assay is also the most potent compound in the IP1 and hWB assay.</div><div class="NLM_p">A very interesting trend was observed among the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> with respect to selectivity over Btk. Compounds <b>40</b> and <b>41</b> were virtually equipotent at both kinases in the presence of ATP concentrations corresponding to their respective <i>K</i><sub>m</sub> values. However, inhibitors <b>42</b> and <b>61</b> show selectivities, which trend toward the desired direction. The data implies that sufficient BTK selectivity could possibly be accomplished by suitable structural modifications at the distal phenyl ring as well as around the electrophilic warhead. The learnings from this SAR information are of significance for the future design of Itk inhibitors with improved selectivity.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Cell Potencies and Kinetic Binding Data for Advanced Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd #</th><th class="colsep0 rowsep0" align="center">Itk IC<sub>50</sub> [μM] (5 μM ATP, <i>K</i><sub>m</sub>)</th><th class="colsep0 rowsep0" align="center">IP1 IC<sub>50</sub> [μM]</th><th class="colsep0 rowsep0" align="center">hWB IC<sub>50</sub> [μM]</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> [1000/(M·s)]</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> [h]</th><th class="colsep0 rowsep0" align="center">Btk IC<sub>50</sub> [μM] (50 μM ATP, <i>K</i><sub>m</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0.005</td><td class="colsep0 rowsep0" align="left">0.160</td><td class="colsep0 rowsep0" align="left">0.073</td><td class="colsep0 rowsep0" align="left">29.4</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">0.002</td><td class="colsep0 rowsep0" align="left">0.031</td><td class="colsep0 rowsep0" align="left">0.048</td><td class="colsep0 rowsep0" align="left">16.1</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">0.002</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">±-52</td><td class="colsep0 rowsep0" align="left">0.014</td><td class="colsep0 rowsep0" align="left">2.21</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">0.015</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">0.005</td><td class="colsep0 rowsep0" align="left">0.516</td><td class="colsep0 rowsep0" align="left">6.731</td><td class="colsep0 rowsep0" align="left">18.6</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">0.012</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">0.060</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">1.050</td></tr></tbody></table></div></div><div class="NLM_p">In the context of covalent enzyme inactivation, time-dependent inhibition profiles of the inhibitors represent a critical means of characterization. Kinetic measurement of the binding event is an important technique of distinguishing covalent inhibitors.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> While amide <b>41</b> is the most potent inhibitor in the hWB assay, its on-rate (<i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub>) is about half compared to the second most potent analogue <b>40</b>. Analogue <b>42</b>, which shows only micromolar potency in the WB assay, is characterized by essentially the same on-rate as compound <b>41</b> (PF-06465469).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The three evaluated pyrazolopyrimidines display enzyme off-rates well beyond 24 h and thus can be characterized as truly irreversible inhibitors.</div><div class="NLM_p">An analysis of IP1 cell potency vs enzyme potency determined in the presence of 1 mM ATP reveals that a correlation exists between the two assays (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). The moderate to low RRCK cell-permeability data for <b>40</b>–<b>42</b> shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> may explain this series’ left shift between the two assays.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Reasonable correlation is observed (within approximately 20-fold) for potency data obtained from the cell-based IP1 and 1 mM ATP enzyme assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> also highlights some calculated as well as physical and ADME properties of the most potent inhibitors reported in this series. The compounds reported here have reasonable topological polar surface area. The elevated clogP value is reflective of a moderate solubility and very high microsomal clearance, which leads to very short half-lives in the microsomal assay. The compounds in this series are moderately permeable and reasonably potent in the cell toxicity assay (THLE). The inhibitors are moderately potent in the dofetilide displacement assay, which gauges the compound’s potency at the hERG ion channel. Together with the potencies reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, compounds <b>40</b> and <b>41</b> (PF-06465469)<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> show a promising level of ligand efficiency (LE) and lipophilic ligand efficiency (LipE).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Calculated, Physical, and ADMET Properties for Advanced Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd #</th><th class="colsep0 rowsep0" align="center">TPSA</th><th class="colsep0 rowsep0" align="center">clogP</th><th class="colsep0 rowsep0" align="center">sol. [μM] pH 6.5</th><th class="colsep0 rowsep0" align="center">CLint HLM [μL/(min·mg)]</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> HLM [min]</th><th class="colsep0 rowsep0" align="center">RRCK AB [10<sup>–6</sup>cm·s<sup>–1</sup>]</th><th class="colsep0 rowsep0" align="center">THLE IC<sub>50</sub> [μM]</th><th class="colsep0 rowsep0" align="center">DOF IC<sub>50</sub> [μM]</th><th class="colsep0 rowsep0" align="center">LE</th><th class="colsep0 rowsep0" align="center">LipE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">119</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left">>320</td><td class="colsep0 rowsep0" align="left"><3</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">4.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">119</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">10.6</td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><0.1</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">0.31</td><td class="colsep0 rowsep0" align="left">4.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">119</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">>227</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">32.3</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">3.48</td></tr></tbody></table></div></div><div class="NLM_p">To better depict the overall progress of the covalent Itk inhibitors with respect to LipE, a correlation of pIC<sub>50</sub> and clogP was plotted with LipE lines entered as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>. While a large portion of the compounds are in a very low LipE space (≤3), a good number of potent inhibitors show a LipE in the 4–5 range. However, in order to reach an acceptable LipE ≥ 6, a significant reduction of the series’ clogP range would have to be accomplished without compromising enzyme and whole-blood potency. A reduction of clogP would most likely also lead to an improvement of the series’ HLM clearance properties.</div><div class="NLM_p">In conclusion, we have discovered novel and potent covalent inhibitors of Itk. The extremely low <i>K</i><sub>m</sub> of ATP for Itk (5 μM) represents a significant hurdle for inhibiting Itk in a cellular environment. To drive this program effectively, the present covalent compounds were all assessed in the presence of a physiologically relevant ATP concentration (1 mM). The disclosed electrophilic acrylamides display a wide range of potencies under the assay conditions. However, the corresponding acetamide analogues of several of the most potent acrylamides are essentially inactive in the presence of 1 mM ATP suggesting that the electrophilic nature of the compounds plays a dominant role in the inhibition event.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. A pIC<sub>50</sub> vs clogP plot reveals that among the acrylamides (cyan) several of them are potent and show LipE values in the 4–5 range; the noncovalent acetamides (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) are included as well (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Crucial to the covalent inhibition strategy of this project is the half-life at which Itk is regenerated within cells. A traditional pulse–chase experiment yielded a value of about 2 h. A more informative experiment in which inhibition of the generation of phospho-PLCγ1 was measured following covalent Itk inhibition, however, showed that the inhibitory effect can last for up to 24 h. This finding was critical to validating the strategy of a covalent inhibition approach to Itk.</div><div class="NLM_p last">Structural information was utilized to guide the design of a library in which the distal phenyl ring of the biaryl amide motif was varied to optimize physical properties without compromising potency. This effort has provided potent covalent analogues featuring a biaryl amide bond crucial for Itk potency. The SAR information, however, strongly suggests a highly lipophilic pocket into which this aromatic group binds. The acrylamide analogue <b>41</b> (PF-06465469)<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> with the 3-methyl-4-isopropylphenyl benzamide substituent was the most potent inhibitor in the enzyme assay in the presence of 1 mM ATP. When tested in the IP1 and hWB cell-based assays, this compound was found to be highly potent with IC<sub>50</sub>s of 31 and 48 nM, respectively. Kinetic measurements to determine the inhibitor’s enzyme on- and off-rates yielded results that indicated that the acrylamide has a decent on-rate and is irreversibly bound to the enzyme. X-ray crystal structures of related analogues feature the covalent interaction of the acrylamide with Cys442. The crystallographic analysis further revealed significant ligand–protein hydrogen bond interactions of the acrylamide carbonyl and the pyrazolopyrimidine scaffold as well as the N–H and carbonyl of the diarylamide. Itk’s high sequence homology with Btk (70% for the binding site) as well as the reduced nucleophilicity of Cys442 resulting from its elevated p<i>K</i><sub>a</sub> have defined selectivity as a major parameter for the advancement of the current series. However, the SAR information obtained from the presented analogues together with crystal structure information will prove to be critical to devise strategies for improving this series’ selectivity profile as well as physical properties.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">General Synthetic Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry Methods and Compound Characterization</h3><div class="NLM_p">Proton (<sup>1</sup>H NMR) and carbon (<sup>13</sup>C NMR) magnetic resonance spectra where obtained in DMSO-<i>d</i><sub>6</sub> at 400 and 100 MHz, respectively, unless otherwise noted. The following abbreviations were utilized to describe peak patterns when appropriate: br = broad, s = singlet, d = doublet, and m = multiplet. High-resolution mass measurements were obtained on an Agilent ToF mass spectrometer. Accurate Mass Spectrometry analyses were conducted on an Agilent 6220 TOF mass spectrometer (Agilent Technologies, Wilmington, DE) in positive or negative electrospray mode. The system was calibrated to greater than 1 ppm accuracy across the mass range prior to analyses according to manufacturer’s specifications. The samples were separated using UHPLC on an Agilent 1200 (Agilent Technologies, Wilmington, DE) system prior to mass spectrometric analysis. The resulting spectra were automatically lockmass corrected, and the target mass ions and any confirming adducts (Na<sup>+</sup>, NH<sub>4</sub><sup>+</sup>) were extracted and combined as a chromatogram. The mass accuracy was calculated for all observed isotopes against the theoretical mass ions derived from the chemical formula using MassHunter software (Agilent Technologies, Wilmington, DE). All air and moisture sensitive reactions were carried out under an atmosphere of dry nitrogen using heat-dried glassware and standard syringe techniques. Tetrahydrofuran (THF) and acetonitrile were purchased from EMD anhydrous and were used without further drying. All final compounds were isolated following flash chromatography, which was performed using an Analogix Intelliflash 280 with Sepra Si 50 silica gel utilizing ethyl acetate/heptane mixtures as solvent unless otherwise indicated. All compounds submitted for biological testing and reported in this article were obtained in ≥95% purity unless otherwise noted. Certain compounds from the examples described were purified on reversed-phase using automated preparative high performance liquid chromatography (HPLC) on a Gilson GX281, Shimadzu CL-2010C, or Agilent 1200 system. Samples were submitted dissolved in 1 mL of DMSO. Depending on the nature of the compounds and the results of a preanalysis, the purification was performed under a variety of conditions at ambient temperature. HPLC was carried out on an Agella Venusil ASB C18 column (21.2 × 150 mm, 5 μm). A flow rate of 0.5–150 mL/min was used with mobile phase A, water + 0.1% modifier (v/v), and B, acetonitrile + 0.1% modifier (v/v). The modifier was formic acid, trifluoroacetate, ammonia acetate, or hydrochloric acid. A Shimadzu MS2010EV MS2525 binary LC or Waters 2545 BGM pump supplied a mobile phase with a composition of 5% B for 1 min then ran from 5% to 98% B over 6 min followed by a 2 min hold at 98% B. Detection was achieved using a Shimadzu SPD-20AV or Waters 2998 PDA wavelength absorbance detector set at 220 or 200 nm followed in series by a Shimadzu MS2010EV or Waters 3100 mass spectrometer.</div><div class="NLM_p">Quality control (QC) analysis was performed using a LC-MS method. Acidic runs were carried out on a Shimadzu XB-C18 (2.1 × 30 mm, 5 μm), X-Bridge (50 × 4.6 mm, 5 μm), Gemini NX C18 (50 × 4.6, 3 μm), or Gemini NX C18 (50 × 4.6, 5 μm). A flow rate of 1.0–1.2 mL/min was used with mobile phase A, water + 0.1% modifier (v/v), and B, acetonitrile + 0.1% modifier (v/v). For acidic runs, the modifier was trifluoroacetic acid. A Shimadzu 20AB pump ran a gradient elution from 0% to 98% B over 2 min followed by a 1 min hold at 95% B. Detection was achieved using a Shimadzu 10A detector set at 220 or 260 nm followed in series by a Shimadzu MS2010EV or Applied Biosystem API 2000 mass spectrometer in parallel.</div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (<i>R</i>)-<i>tert</i>-Butyl 3-(4-Amino-3-iodo-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidine-1-carboxylate (<b>8</b>)</h4><div class="NLM_p last">To a mixture of 3-Iodo-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-amine <b>6</b> (1.27 g, 4.87 mmol, 1.0 equiv) in THF (150 mL) was added triphenyl phosphine (1.95 g, 7.30 mmol, 1.5 equiv), diisopropyldiazene-1,2-dicarboxylate (1.54 mL, 7.30 mmol, 1.5 equiv), and (<i>S</i>)-<i>tert</i>-butyl 3-hydroxypiperidine-1-carboxylate <b>7</b> (1.96 g, 9.73 mmol, 2.0 equiv) at room temperature. The reaction was stirred for 16 h and was judged complete by LC-MS. The reaction was concentrated to a residue and purified via column chromatography (0% ethyl acetate in dichloromethane to 80%) to provide the desired material as a white solid (1.33 g, 83%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 1.45 (s, 9 H), 1.55–1.77 (m, 1 H), 1.80–1.96 (m, 1 H), 2.08–2.29 (m, 1 H), 2.74–2.94 (m, 1 H), 3.6–3.49 (m, 1 H), 4.12 (q, <i>J</i> = 7.0 Hz, 2 H), 4.64–4.86 (m, 1 H), 6.45 (br. s., 2 H), 8.31 (s, 1 H). LC-MS: 98%, <i>m</i>/<i>z</i> = 445.1 [M + H]; Chiral HPLC (ChiralPak AS-H, 4.6 × 100 mm, 5 μm, heptane/ethanol) = 98% e.e.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (<i>R</i>)-1-(3-(4-Amino-3-(4-methoxyphenyl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (<b>10</b>)</h4><div class="NLM_p"><b>Step 1:</b> In a sealed tube containing <b>8</b> (1.0 g, 2.255 mmol, 1.0 equiv), 4-methoxyphenyl boronic acid (0.48 g, 3.158 mmol, 1.4 equiv) and potassium carbonate (0.62 g, 4.511 mmol, 2.0 equiv) in 1,4-dioxane (50 mL) was purged under argon for 15 min. PdCl<sub>2</sub>(dppf)<sub>2</sub> (92 mg, 0.112 mmol, 0.05 equiv) was added and again purged under argon for 10 min. The reaction mixture was heated to 120 °C for 12 h. TLC showed the completion of the reaction. The reaction mixture was filtered through a Celite bed, and the filtrate was concentrated and purified by column chromatography (60% ethyl acetate in petroleum ether) to provide <b>9a</b> as a white solid (0.60 g, 62%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.4 (s, 9H), 1.6 (m, 2H), 2.1 (m, 2H), 3.0 (m, 2H), 3.9 (s, 3H), 4.0 (m, 2H), 4.7 (m, 1H), 6.8 (bs, 2H), 7.1 (d, 2H),7.6 (d, 2H), 8.2 (s, 1H). LC-MS: 76.4%, <i>m</i>/<i>z</i> = 425.0 [M + H].</div><div class="NLM_p">To stirred solution of <b>9a</b> (0.7 g, 1.65 mmol, 1.0 equiv) in 1,4 dioxane (10 mL) at 0 °C was added 4 N HCl in dioxane (15 mL). The reaction mixture was stirred at room temperature for 4 h. After complete conversion of the starting material, excess 1,4-dioxane was removed under vacuum and to the residue was added ethyl acetate and water. The water layer was basified with 2 N NaHCO<sub>3</sub> solution and extracted with ethyl acetate. The organic layer was then washed with water followed by brine. The organic layer was dried over sodium sulfate, filtered, and concentrated to provided the deprotected piperidine (0.45 g, 84%). <sup>1</sup>H NMR (300 MHz, DMSO): δ = 1.6 (m, 2H), 1.8 (m, 2H), 2.1 (m, 2H), 3.0 (m, 2H), 3.1 (d, 1H), 3.9 (s, 3H), 4.7 (m, 1H), 7.1 (d, 2H), 7.6 (m, 4H), 8.2 (s, 1H). LC-MS: 83.4%; <i>m</i>/<i>z</i> = 325.1 [M + H].</div><div class="NLM_p last"><b>Step 2:</b>To a stirred solution of acrylic acid (0.095 mL, 1.388, mmol, 1.0 equiv), EDCI (0.399 g, 2.0832 mmol, 1.5 equiv), HOBt (0.318 g, 2.0832 mmol, 1.5 equiv), and triethylamine (0.39 mL, 2.776 mmol, 2.0 equiv) in THF (40 mL) at 0 °C was added the deprotected piperidine (0.45 g, 1.388 mmol, 1.0 equiv). Reaction mixture was stirred at room temperature for 24 h. After complete consumption of the starting material, the reaction was diluted with ethyl acetate and water. The organic layer was dried over sodium sulfate and evaporated to get crude <b>10</b> (0.5 g crude). The crude compound was purified by prep TLC to provide <b>10</b>. <sup>1</sup>H NMR (300 MHz, DMSO): δ = 1.6 (m, 2H), 1.9 (m, 1H), 2.1 (m, 1H), 3.1 (m, 2H), 3.9 (s, 3H), 4.2 (m, 2H), 4.6 (m, 1H), 4.7 (m, 1H), 5.7 (dd, 1H), 6.1 (t, 1H), 6.7 to 6.9 (m, 2H), 7.1 (d, 2H),7.6 (d, 2H), 8.2 (s, 1H). LC-MS: 88.8%, <i>m</i>/<i>z</i> = 378.9 [M + H]; HRMS [M + H] for C<sub>20</sub>H<sub>23</sub>N<sub>6</sub>O<sub>2</sub>, calcd, 379.1877; found, 379.1880.</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (<i>R</i>)-1-(3-(4-Amino-3-(3-methoxyphenyl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (<b>11</b>)</h4><div class="NLM_p"><b>Step 1:</b> By following a procedure similar to that for <b>9a</b>, <b>8</b> (1.0 g, 2.255 mmol, 1.0 equiv) was converted into <b>9b</b> (0.6 g, 62%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.4 (s, 9H), 1.6 (m, 2H), 2.1 (m, 2H), 3.0 (m, 2H), 3.9 (s, 3H), 4.0 (m, 2H), 4.7 (m, 1H), 7.0 (d, 1H), 7.15 (s, 1H), 7.2 (d, 1H), 7.5 (t, 1H), 7.6 (bs, 2H), 8.3 (s, 1H). LC-MS: 74.4%, <i>m</i>/<i>z</i> = 425.0 [M + H].</div><div class="NLM_p"><b>Step 2:</b>Compound <b>9b</b> (0.7 g, 1.6509 mmol, 1.0 equiv) was deprotected by following a procedure similar to that for for the deprotection of <b>9a</b>, providing the free piperidine (0.45 g, 84%). <sup>1</sup>H NMR (300 MHz, DMSO): δ = 1.6 (m, 2H), 1.8 (m, 2H), 2.1 (m, 2H), 3.0 (m, 2H), 3.1 (d, 1H), 3.9 (s, 3H), 4.7 (m, 1H), 7.1 (d, 1H), 7.2 (s, 1H), 7.25 (d, 1H), 7.4 to7.6 (m, 3H), 8.3 (s, 1H). LC-MS: 86.2%, <i>m</i>/<i>z</i> = 325.1 [M + H].</div><div class="NLM_p"><b>Step 3:</b> By following a procedure similar to that for target <b>10</b>, the deprotected piperidine (0.12 g, 0.3703 mmol, 1.0 equiv) was converted into <b>11</b> (15 mg, 10%). LC-MS (95.74%, M + H). <sup>1</sup>H NMR (300 MHz, DMSO): δ = 1.6 (m, 1H), 1.9 (m, 1H), 2.1 (m, 1H), 2.3 (m, 1H), 3.0 (m, 1H), 3.2 (m, 1H), 3.9 (s, 3H), 4.1 (m, 1H), 4.2 (m, 1H), 4.5 (m, 1H), 4.7 (m, 1H), 5.6 to 5.7 (m, 1H), 6.1 (m, 1H), 6.7 to 6.9 (m, 2H), 7.1 (d, 1H), 7.2 (s, 1H), 7.25 (d, 1H), 7.5 (t, 1H), 8.3 (s, 1H); HRMS [M + H] for C<sub>20</sub>H<sub>23</sub>N<sub>6</sub>O<sub>2</sub>, calcd, 379.1877; found, 379.1881.</div><div id="sec3_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> Suzuki Library</h5><div class="NLM_p"><b>Step 1:</b> To a solution of template (125 μmol, 1.0 equiv) in anhydrous 1,4-dioxane (625 μL) was added a solution of boronic acid monomer (125 μmol, 1.0 equiv) in anhydrous 1,4-dioxane (625 μL). The solution was degassed thoroughly. To the solution was added PdCl<sub>2</sub>(dppf) (6 mg, 7.5 μmol, 0.6 equiv) followed by anhydrous K<sub>2</sub>CO<sub>3</sub> (52 mg, 375 μmol, 3 equiv). The reaction was stirred under argon at 90 °C for 16 h and monitored by LC-MS. The reaction mixture was filtered through a Celite bed and washed with 1,4-dioxane, and solvent was evaporated in a thermo explorer (2 h, 5 Torr, and 45 °C). The residue was dissolved in ethyl acetate (5 mL) and washed with water (1 × 3 mL) and brine (1 × 3 mL). The organic layer was dried over anhydrous sodium sulfate and evaporated under reduced pressure.</div><div class="NLM_p"><b>Step 2:</b> The residue from the previous step was dissolved in 1,4-dioxane (500 μL), transferred to reaction vials, and cooled to 0 °C. To the reaction was added 1,4-dioaxne-HCl (500 μL), and the reaction was stirred for 16 h at 25 °C. The solvent was evaporated under reduced pressure and azeotroped with toluene to provide a residue that was used in step 3 without further purification.</div><div class="NLM_p"><b>Step 3:</b> To a solution of acrylic acid (250 mg, 3.5 mmol) in DCM (20 mL) was added thionyl chloride (5.2 mmol, 0.38 mL, 1.5 equiv). The reaction was heated at 40 °C for 4 h. Half of the total volume of DCM was evaporated. The residue from the previous step was dissolved in DCM (1 mL), and TEA (70 μL, 5.0 equiv) was added to the reaction vial. To the reaction was added acryloyl chloride solution (300 μL) at 0 °C. Reaction vials were stirred at 0 °C for 10–15 min after which it was quenched with ice, and the solvent was evaporated. All the compounds were dissolved in 100% DMSO. Ten microliters from each well was transferred to a daughter plate and diluted with 200 μL of DMSO. LC-MS of crude compounds were done, and these were further purified on Waters Autopurification System (Column: Luna Phenyl Hexyl (21 × 150 mm, 10 μm), with mobile phase A, 10 mM ammonium acetate in water, and B, acetonitrile. <i>T</i> = 0; flow = 20; A = 90%; B = 10%; <i>T</i> = 3; flow = 20; A = 75%; B = 25%; <i>T</i> = 18; flow = 20; A = 35%; B = 65%.) Prep fractions were collected in bar coded test tubes and evaporated in a Thermo explorer (40 °C, 15 Torr, 16 h). Each of the compounds were then dissolved in ethanol (1.6 mL) and transferred to pretared 2 drum glass vials. Finally they were dried in Genevac first for 1 h (at 40 °C, 10 mbar) and then for 12 h (at 40 °C, 0 mbar). Weights were taken using Mettler Balance. These compounds were then dissolved in a calculated amount of DMSO to prepare a 30 mM solution. Eight microliters was removed for final QC analysis (diluted with 150 μL of DMSO) on an analytical LC/MS. QC reports were generated to check the identity and purity of each compound.</div><div class="NLM_p"><b>12:</b> LC-MS 100%, min 1.67, <i>m</i>/<i>z</i> = 417.18 [M + H]; HRMS [M + H] for C<sub>20</sub>H<sub>20</sub>F<sub>3</sub>N<sub>6</sub>O, calcd, 417.1645; found, 417.1650.</div><div class="NLM_p"><b>13:</b> LC-MS 88.4%, min 1.69, <i>m</i>/<i>z</i> = 417.21 [M + H]; HRMS [M + H] for C<sub>20</sub>H<sub>20</sub>F<sub>3</sub>N<sub>6</sub>O, calcd, 417.1645; found, 417.1650.</div><div class="NLM_p"><b>14:</b> LC-MS 95.10%, min 1.68, <i>m</i>/<i>z</i> = 433.16 [M + H]; HRMS [M + H] for C<sub>20</sub>H<sub>20</sub>F<sub>3</sub>N<sub>6</sub>O<sub>2</sub>, calcd, 433.1594; found, 433.1599.</div><div class="NLM_p"><b>15:</b> LC-MS 100%, min 1.72, <i>m</i>/<i>z</i> = 433.21 [M + H].</div><div class="NLM_p"><b>16:</b> LC-MS 96.1%, min 1.49, <i>m</i>/<i>z</i> = 409.28 [M + H]; HRMS [M + H] for C<sub>21</sub>H<sub>25</sub>N<sub>6</sub>O<sub>3</sub>, calcd, 409.1983; found, 409.1987.</div><div class="NLM_p"><b>17:</b> LC-MS 95.8%, min 1.53, <i>m</i>/<i>z</i> = 407.21 [M + H]; HRMS [M + H] for C<sub>21</sub>H<sub>23</sub>N<sub>6</sub>O<sub>3</sub>, calcd, 407.1826; found, 407.1829.</div><div class="NLM_p"><b>18:</b> LC-MS 100%, min 1.38, <i>m</i>/<i>z</i> = 379.35 [M + H]; HRMS [M + H] for C<sub>20</sub>H<sub>23</sub>N<sub>6</sub>O<sub>2</sub>, calcd, 379.1877; found, 379.1883.</div><div class="NLM_p"><b>19:</b> LC-MS 100%, min 1.50, <i>m</i>/<i>z</i> = 380.23 [M + H]; HRMS [M + H] for C<sub>19</sub>H<sub>22</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 380.1829; found, 380.1835.</div><div class="NLM_p"><b>29:</b> LC-MS 100%, 1.24 min, <i>m</i>/<i>z</i> = 379.19 [M + H]; HRMS [M + H] for C<sub>19</sub>H<sub>23</sub>N<sub>8</sub>O, calcd, 379.1989; found, 379.1990.</div><div class="NLM_p"><b>21:</b> LC-MS 100%, 1.37 min, <i>m</i>/<i>z</i> = 351.21 [M + H]; HRMS [M + H] for C<sub>17</sub>H<sub>19</sub>N<sub>8</sub>O, calcd, 351.1676; found, 351.1675.</div><div class="NLM_p"><b>22:</b> LC-MS 81.4%, min 1.58, <i>m</i>/<i>z</i> = 400.23 [M + H]; HRMS [M + H] for C<sub>22</sub>H<sub>22</sub>N<sub>7</sub>O, calcd, 400.1880; found, 400.1886.</div><div class="NLM_p"><b>23:</b> LC-MS 100%, min 1.46, <i>m</i>/<i>z</i> = 400.19 [M + H]; HRMS [M + H] for C<sub>22</sub>H<sub>22</sub>N<sub>7</sub>O, calcd, 400.1880; found, 400.1885.</div><div class="NLM_p"><b>24:</b> LC-MS 100%, min 1.50, <i>m</i>/<i>z</i> = 400.28 [M + H]; HRMS [M + H] for C<sub>22</sub>H<sub>22</sub>N<sub>7</sub>O, calcd, 400.1880; found, 400.1884.</div><div class="NLM_p"><b>25:</b> LC-MS 100%, min 1.41, <i>m</i>/<i>z</i> = 411.21 [M + H].</div><div class="NLM_p"><b>26:</b> LC-MS 100%, min 1.44, <i>m</i>/<i>z</i> = 425.25 [M + H].</div><div class="NLM_p last"><b>27:</b> LC-MS100%, min 1.43, <i>m</i>/<i>z</i> = 427.23 [M + H]; HRMS [M + H] for C<sub>20</sub>H<sub>23</sub>N<sub>6</sub>O<sub>3</sub>S, calcd, 427.1547; found, 427.1551.</div></div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (<i>R</i>)-3-(1-(1-Acryloylpiperidin-3-yl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)benzamide (<b>40</b>)</h4><div class="NLM_p"><b>Step 1:</b>Diimidazol-1-yl-methanone (649 mg, 4 mmol) was added to the suspension of 3-[4-amino-3-(3-carboxyphenyl)pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl]piperidine-1-carboxylic acid <i>tert</i>-butyl ester (877 mg, 2 mmol) in dichloromethane (8 mL), and the mixture was stirred for 30 min. Then 4-isopropylphenylamine (595 mg, 4.4 mmol) was added, and the mixture was stirred for 30 min. The solvent was removed under reduced pressure, and the mixture was purified by column chromatography (2% methanol in dichloromethane) to afford 3-{4-amino-3-[3-(4-isopropylphenylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidine-1-carboxylic acid <i>tert</i>-butyl ester (840 mg, 76%) as a white solid.</div><div class="NLM_p"><b>Step 2</b>: To a solution of 3-{4-amino-3-[3-(4-isopropylphenylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidine-1-carboxylic acid <i>tert</i>-butyl ester (778 mg, 1.4 mmol, 1.0 equiv) in dioxane (4.2 mL) was added 4 N HCl in dioxane (2.1 mL, 8.4 mmol, 6.0 equiv). The reaction mixture was refluxed for 30 min, and the solvent was removed under reduced pressure to afford 3-{4-amino-3-[3-(4-isopropylphenylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidinium chloride (689 mg, 100%) as an off-white solid.</div><div class="NLM_p"><b>Step 3:</b> Triethylamine (152 mg, 1.5 mmol) followed by acroyl chloride (50 mg, 550 μmol) was added to the suspension of 3-{4-amino-3-[3-(4-isopropylphenylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidinium chloride (246 mg, 500 μmol) in dichloromethane (1.5 mL) at 0 °C while stirring. The cooling bath was removed, and the mixture was stirred for 30 min. The mixture was then directly purified by column chromatography (0% methanol in dichloromethane to 7%) to afford <b>40</b> (136 mg, 53%) as a colorless glass. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.22 (d, <i>J</i> = 6.63 Hz, 6 H), 1.54–1.70 (m, 2 H), 1.90–2.40 (m, 3 H), 2.82–2.94 (m, 1 H), 3.01–3.75 (m 2 H), 4.01–4.30 (m, 1 H), 4.54–4.87 (m, 1 H), 5.56–6.40 (m, 1 H), 6.68–6.95 (m, 1 H), 7.25 (d, <i>J</i> = 8.59 Hz, 2 H), 7.63–7.77 (m, 3 H), 7.88 (d, <i>J</i> = 7.41 Hz, 1 H), 8.07 (d, <i>J</i> = 7.81 Hz, 1 H), 8.25 (br. s., 1 H), 8.30 (s, 1 H) 10.29 (br. s., 1 H); LC-MS: 99%, <i>m</i>/<i>z</i> = 510.3 [M + H].</div><div class="NLM_p last">Chiralcel OJ-H RT = 5.20 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.22 (d, <i>J</i> = 6.63 Hz, 6 H), 1.54–1.70 (m, 2 H), 1.90–2.40 (m, 3 H), 2.82–2.94 (m, 1 H), 3.01–3.75 (m 2 H), 4.01–4.30 (m, 1 H), 4.54–4.87 (m, 1 H), 5.56–6.40 (m, 1 H), 6.68–6.95 (m, 1 H), 7.25 (d, <i>J</i> = 8.59 Hz, 2 H), 7.63–7.77 (m, 3 H), 7.88 (d, <i>J</i> = 7.41 Hz, 1 H), 8.07 (d, <i>J</i> = 7.81 Hz, 1 H), 8.25 (br. s., 1 H), 8.30 (s, 1 H) 10.29 (br. s., 1 H). LC-MS: 100%, <i>m</i>/<i>z</i> = 510.0 [M + H]; HRMS [M + H] for C<sub>29</sub>H<sub>32</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 510.2612; found, 510.2614.</div></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>R</i>)-3-(1-(1-Acryloylpiperidin-3-yl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-<i>tert</i>-butylbenzyl)benzamide (<b>42</b>)</h4><div class="NLM_p"><b>Step 1</b>: To a stirred solution of compound <b>28</b> (150 mg, 0.342 mmol) in DMF (3 mL) was added DIPEA (132.4 mg, 1.03 mmol), HATU (143 mg, 0.376 mmol), and (4-(<i>tert</i>-butyl) benzylamine (56 mg, 0.342 mmol) at 0 °C. The reaction mixture was stirred at room temperature for 16 h. It was quenched with ice water and extracted with ethyl acetate (3 × 50 mL). The organic layer was washed with water (2 × 20 mL) followed by brine (1 × 20 mL), dried over sodium sulfate, and was evaporated to dryness. The crude mass was purified by column chromatography (20% ethyl acetate in hexane) to afford compound <b>29c</b> (140 mg, 70%) as a brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.26 (s, 9 H), 1.34 (s, 9 H), 2.65–2.46 (m, 1 H), 1.91 (br s, 1 H), 2.10- 2.06 (m, 1 H), 2.28–2.24 (m, 1 H), 3.04 (br s, 1 H), 3.91 (br s, 1 H), 4.46 (d, 2 H), 4.69 (br s, 1 H), 7.25 (d, 2 H), 7.34 (d, 2 H), 7.63 (t, 1 H), 7.79 (d, 1 H), 7.98 (d, 1 H), 8.18 (s, 1 H), 8.27 (s, 1 H), 9.10–9.09 (m, 1 H); LC-MS: <i>m</i>/<i>z</i> = 584.2 [M + H].</div><div class="NLM_p"><b>Step 2:</b>To a stirred solution of compound <b>29c</b> (140 mg, 0.216 mmol) in dioxane (1 mL) was added 4 N HCl in dioxane (7 mL) at 0 °C, and it was stirred at room temperature for 3 h. Then excess dioxane was evaporated. The reaction residue was triturated with <i>n</i>-pentane. The solid was collected by filtration and was dried to afford the deprotected piperidine. This off-white solid (115 mg, 86%) was directly used for the next step as the HCl salt. LC-MS: <i>m</i>/<i>z</i> = 484.6 [M + H].</div><div class="NLM_p last"><b>Step 3</b>: To a stirred solution of the deprotected piperidine (115 mg, 0.207 mmol) in DMF (2 mL) was added the BOP reagent (91.5 mg, 0.207 mmol) followed by DIPEA (0.089 mL, 0.518 mmol) and acrylic acid (15 mg, 0.189 mmol). The reaction mixture was stirred at room temperature for 15 min. It was quenched with ice water and filtered. The residue was dissolved in ethyl acetate, dried over sodium sulfate, and was concentrated to dryness. The crude material was purified by prep-HPLC to afford the desired material <b>42</b> as a white solid (43 mg, 39%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C): δ = 1.30 (s, 9H), 1.68–1.62 (m, 1H), 1.99–1.96 (m, 1H), 2.30 (m, 1H), 2.36 (m, 1H), 3.20–3.14 (m, 1H), 3.55 (m, 1H), 4.12–4.08 (m, 1H), 4.42–4.39 (m, 1H), 4.50 (d, 2H), 4.79–4.74 (m, 1H), 5.66–5.60 (m, 1H), 6.07–6.03 (m, 1H), 6.07–6.03 (m, 1H), 6.53 (s, 2H), 6.74–6.67 (m, 1H), 7.37–7.28 (m, 4H), 7.63 (t, 1H), 7.81 (d, 1H), 7.99 (d, 1H), 8.18 (s, 1H), 8.28 (s, 1H), 8.74 (s, 1H). HPLC purity: 96.12%; HRMS [M + H] for C<sub>30</sub>H<sub>34</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 524.2768; found, 524.2769.</div></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 3-(1-(1-Acryloylpiperidin-3-yl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-cyclohexylbenzamide (<b>49</b>)</h4><div class="NLM_p"><b>Step 1:</b>Diimidazol-1-yl-methanone (649 mg, 4 mmol, 2.0 equiv) was added to the suspension of 3-[4-amino-3-(3-carboxyphenyl)pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl]piperidine-1-carboxylic acid <i>tert</i>-butyl ester (877 mg, 2 mmol, 1.0 equiv) in dichloromethane (8 mL), and the mixture was stirred for 30 min. Subsequently, cyclohexylamine (436 mg, 4.4 mmol, 2.2 equiv) was added, and the mixture was stirred for 30 min. Then, the solvent was removed under reduced pressure, and the residue was separated by column chromatography (2% methanol in dichloromethane) to afford 3-{4-amino-3-[3-(cyclohexylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidine-1-carboxylic acid <i>tert</i>-butyl ester (921 mg, 89%) as a white solid.</div><div class="NLM_p"><b>Step 2:</b> To a solution of 3-{4-amino-3-[3-(3-<i>tert</i>-butylphenylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidine-1-carboxylic acid <i>tert</i>-butyl ester (912 mg, 1.6 mmol, 1.0 equiv) in dioxane (4.8 mL) was added 4 N HCl in dioxane (2.4 mL, 9.6 mmol, 6.0 equiv). The reaction mixture was refluxed for 30 min, and the solvent was removed under reduced pressure to afford 3-{4-amino-3-[3-(3-<i>tert</i>-butylphenylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidinium chloride (729 mg, 100%) as a white solid.</div><div class="NLM_p last"><b>Step 3:</b> Triethylamine (152 mg, 1.5 mmol) followed by acetyl chloride (43 mg, 550 μmol) was added to the suspension of 3-{4-amino-3-[3-(3-<i>tert</i>-butylphenylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidinium chloride (228 mg, 500 μmol) in dichloromethane (1.5 mL) at 0 °C while stirring. The cooling bath was removed, and the mixture was stirred for 30 min. The mixture was then directly purified by column chromatography (0% methanol in dichloromethane to 7%) to afford compound <b>49</b> (100 mg, 42%) as a colorless glass. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.04–1.41 (m, 4 H), 1.46–2.38 (m, 8 H), 2.93–3.27 (m, 1 H), 3.11–3.26 (m, 1 H), 3.64–3.89 (m, 2 H), 3.99–4.28 (m, 2 H), 4.50–4.81 (m, 2 H), 5.56–5.74 (m, 1 H), 6.05–6.20 (m, 1 H), 6.65–6.94 (m, 1 H), 7.61 (d, <i>J</i> = 8.05 Hz, 1 H), 7.76 (br. s., 1 H), 7.93 (d, <i>J</i> = 8.05 Hz, 1 H), 8.10 (br. s., 1 H), 8.26 (br. s., 1 H), 8.31 (d, <i>J</i> = 8.05 Hz, 1 H). LC-MS: 100%, <i>m</i>/<i>z</i> = 474.3 [M + H]; HRMS [M + H] for C<sub>26</sub>H<sub>32</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 474.2612; found, 474.2615.</div></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 3-(1-(1-Acryloylpiperidin-3-yl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(3-<i>tert</i>-butylphenyl)benzamide (<b>52</b>)</h4><div class="NLM_p"><b>Step 1:</b>Diimidazol-1-yl-methanone (649 mg, 4 mmol) was added to the suspension of 3-[4-amino-3-(3-carboxyphenyl)pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl]piperidine-1-carboxylic acid <i>tert</i>-butyl ester (877 mg, 2 mmol) in dichloromethane (8 mL), and the mixture was stirred for 30 min. Then, 3-<i>tert</i>-butylphenylamine (657 mg, 4.4 mmol) was added, and the mixture was stirred for 30 min. Then, the solvent was removed under reduced pressure, and the residue was separated by column chromatography (2% methanol in dichloromethane) to afford 3-{4-amino-3-[3-(3-<i>tert</i>-butylphenylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidine-1-carboxylic acid <i>tert</i>-butyl ester (1.09 g, 96%) as a white solid.</div><div class="NLM_p"><b>Step 2:</b> To a solution of 3-{4-amino-3-[3-(3-<i>tert</i>-butylphenylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidine-1-carboxylic acid <i>tert</i>-butyl ester (912 mg, 1.6 mmol, 1.0 equiv) in dioxane (4.8 mL) was added 4 N HCl in dioxane (2.4 mL, 9.6 mmol, 6.0 equiv). The reaction mixture was refluxed for 30 min, and the solvent was removed under reduced pressure to afford 3-{4-amino-3-[3-(3-<i>tert</i>-butylphenylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidinium chloride (810 mg, 100%) as a colorless glass.</div><div class="NLM_p last"><b>Step 3:</b> Triethylamine (152 mg, 1.5 mmol) followed by acroyl chloride (50 mg, 550 μmol, 1.1 equiv) was added to the suspension of 3-{4-amino-3-[3-(3-<i>tert</i>-butylphenylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidinium chloride (253 mg, 500 μmol, 1.0 equiv) in dichloromethane (1.5 mL) at 0 °C while stirring. The cooling bath was removed, and the mixture was stirred for 30 min. The mixture was then directly purified by column chromatography (0% methanol in dichloromethane to 7%) to afford <b>52</b> (187 mg, 71%) as a colorless glass. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.13–1.42 (m, 9 H), 1.49–1.72 (m, 1 H), 1.80–2.41 (m, 3 H), 3.00–3.77 (m, 2 H), 3.95–4.29 (m, 1 H), 4.53–4.84 (m, 1 H), 5.47–6.34 (m, 1 H), 5.94–6.27 (m, 1 H), 6.60–6.95 (m, 1 H), 7.15 (d, <i>J</i> = 8.05 Hz, 2 H), 7.28 (t, <i>J</i> = 8.05 Hz, 1 H), 7.65–7.74 (m, 2 H), 7.80 (br. s., 1 H), 7.87 (d, <i>J</i> = 6.59 Hz, 1 H), 8.06 (d, <i>J</i> = 8.05 Hz, 1 H), 8.23–8.30 (m, 2 H), 10.28 (s, 1 H); HPLC = 100%; HRMS [M + H] for C<sub>30</sub>H<sub>32</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 524.2774; found, 524.2891.</div></div><div id="sec3_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>S</i>)-3-(1-(1-Acryloylpiperidin-3-yl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)benzamide (<b>53</b>)</h4><div class="NLM_p last">Chiralcel OJ-H RT = 4.49 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.22 (d, <i>J</i> =6.63 Hz, 6 H), 1.54–1.70 (m, 2 H), 1.90–2.40 (m, 3 H), 2.82–2.94 (m, 1 H), 3.01–3.75 (m 2 H), 4.01–4.30 (m, 1 H), 4.54–4.87 (m, 1 H), 5.56–6.40 (m, 1 H), 6.68–6.95 (m, 1 H), 7.25 (d, <i>J</i> = 8.59 Hz, 2 H), 7.63–7.77 (m, 3 H), 7.88 (d, <i>J</i> = 7.41 Hz, 1 H), 8.07 (d, <i>J</i> = 7.81 Hz, 1 H), 8.25 (br. s., 1 H), 8.30 (s, 1 H) 10.29 (br. s., 1 H). LC-MS: 100%, <i>m</i>/<i>z</i> = 510.0 [M + H]; HRMS [M + H] for C<sub>29</sub>H<sub>32</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 510.2612; found, 510.2611.</div></div><div id="sec3_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>R</i>)-3-(1-(1-Acryloylpiperidin-3-yl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)-<i>N</i>-methylbenzamide (<b>54</b>)</h4><div class="NLM_p"><b>Step 1</b>: To a stirred solution of compound <b>28</b> (200 mg, 0.457 mmol, 1.0 equiv) in THF was added triethylamine (162 mg, 1.6 mmol, 3.5 equiv), 4-isopropyl-<i>N</i>-methylaniline (68 mg, 0.457 mmol, 1.0 equiv), and propylphosphonic anhydride (435 mg, 1.37 mmol, 3.0 equiv) at 0 °C. The reaction mixture was stirred at room temperature for 16 h. It was quenched with ice water and extracted with ethyl acetate (3 × 50 mL). The organic layer was washed with water (1 × 30 mL), brine (1 × 30 mL), dried over sodium sulfate, and was evaporated to dryness. The crude mass was purified by column chromatography (20% ethyl acetate in hexane) to afford the desired material <b>29b</b> as a brown solid (150 mg, 58%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 1.15 (d, 6H). 1.43 (s, 9H), 1.69 (d, 1H), 1.87 (s, 1H), 2.22–2.16 (m, 2H), 2.86–2.80 (m, 2H), 3.49 (s, 3H), 4.12–4.10 (m, 1H), 4.81 (s, 1H), 5.23 (s, 2H), 6.99 (d, 2H), 7.08 (d, 2H), 7.30 (s, 2H), 7.60 (s, 1H), 7.71 (s, 1H), 8.35 (s, 1H); LC-MS: <i>m</i>/<i>z</i> = 568.2 [M + H].</div><div class="NLM_p"><b>Step 2</b>: To a stirred solution of <b>29b</b> (100 mg, 0.216 mmol, 1.0 equiv) in dioxane (1 mL) was added 4 N HCl in dioxane (7 mL) at 0 °C, and it was stirred at room temperature for 3 h. Then, the excess dioxane was evaporated. The reaction residue was triturated with <i>n</i>-pentane. The solid was collected by filtration and dried to afford the deprotected piperidine. The white solid (130 mg, 91%) was directly used for the next step as HCl salt. LC-MS: <i>m</i>/<i>z</i> = 470.0 [M + H].</div><div class="NLM_p last"><b>Step 3</b>: To a stirred solution of the deprotected piperidine (130 mg, 0.25 mmol, 1.0 equiv) in DMF (2 mL) was added BOP reagent (110.6 mg, 0.25 mmol, 1.0 equiv) followed by DIPEA (0.108 mL, 0.625 mmol, 2.5 equiv) and acrylic acid (19.9 mg, 0.276 mmol, 1.1 equiv). The reaction was stirred at room temperature for 10 min. Then, it was quenched with ice water and filtered. The residue was dissolved in ethyl acetate, dried over sodium sulfate, and was concentrated to dryness. The crude product was purified by prep-HPLC to afford final compound <b>54</b> as a white solid (30 mg, 24%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C): δ = 1.12 (d, 6 H), 1.48–1.28 (m, 1 H), 1.68–1.62 (m, 1 H), 1.99–1.95 (m, 1 H), 2.33–2.15 (m, 1 H), 2.82 (q, 1 H), 3.17 (t, 1 H), 3.40 (s, 3 H), 3.50 (br s, 1 H), 4.11–4.08 (m, 1 H), 4.35 (br s, 1 H), 4.75–4.70 (m, 1 H), 5.63–5.61 (m, 1 H), 6.08–6.04 (m, 2 H), 6.40 (s, 2 H), 6.74–6.67 (m, 1 H), 7.14 (s, 4 H), 7.41–7.38 (m, 2 H), 7.59 (s, 2 H), 8.26 (s, 1 H). HPLC purity: 94.79%; HRMS [M + H] for C<sub>30</sub>H<sub>34</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 524.2768; found, 524.2767.</div></div><div id="sec3_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>R</i>,<i>E</i>)-3-(4-Amino-1-(1-but-2-enoylpiperidin-3-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)benzamide (<b>55</b>)</h4><div class="NLM_p last">By following a procedure similar to that for target <b>57</b>, the free piperidine prepared for the synthesis of <b>40</b> (75 mg, 0.16 mmol, 1.0 equiv) was converted into <b>55</b> (7 mg, 8%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.20 (d, <i>J</i> = 6.59 Hz, 6 H), 1.50–2.00 (m, 5 H), 2.13 (d, <i>J</i> = 8.79 Hz, 1 H), 2.22–2.36 (m, 1 H), 2.87 (dt, <i>J</i> = 13.73, 6.97 Hz, 1 H), 3.13–3.25 (m, 1 H), 4.01–4.41 (m, 2 H), 4.46–4.85 (m, 2 H), 6.25–6.83 (m, 2 H), 7.23 (d, <i>J</i> = 8.79 Hz, 2 H), 7.61–7.76 (m, 3 H), 7.86 (d, <i>J</i> = 7.47 Hz, 1 H), 8.05 (d, <i>J</i> = 7.91 Hz, 1 H), 8.23 (br. s., 1 H), 8.29 (br. s., 1 H), 10.27 (s, 1 H). LC-MS: 100%, <i>m</i>/<i>z</i> = 524.3 [M + H]; HRMS [M + H] for C<sub>30</sub>H<sub>34</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 524.2768; found, 524.2769.</div></div><div id="sec3_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>R</i>)-3-(4-Amino-1-(1-methacryloylpiperidin-3-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)benzamide (<b>56</b>)</h4><div class="NLM_p last">By following a procedure similar to that for target <b>57</b>, the free piperidine prepared for the synthesis of <b>40</b> (75 mg, 0.16 mmol, 1.0 equiv) was converted into <b>56</b> (11 mg, 13%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.20 (d, <i>J</i> = 7.02 Hz, 6 H), 1.58–1.65 (m, 2 H), 1.85 (br. s., 3 H), 1.94 (d, <i>J</i> = 13.59 Hz, 2 H), 2.12–2.20 (m, 2 H), 2.31 (d, <i>J</i> = 8.77 Hz, 1 H), 2.87 (dt, <i>J</i> = 13.70, 6.96 Hz, 1 H), 4.73–4.82 (m, 1 H), 4.96–5.20 (m, 2 H), 7.22 (d, <i>J</i> = 8.33 Hz, 1 H), 7.65–7.72 (m, 3 H), 7.86 (d, <i>J</i> = 7.45 Hz, 1 H), 8.05 (d, <i>J</i> = 7.89 Hz, 1 H), 8.23 (s, 1 H), 8.28 (s, 1 H), 10.22 (s, 3 H). LC-MS: 100%, <i>m</i>/<i>z</i> = 524.3 [M + H]; HRMS [M + H] for C<sub>30</sub>H<sub>34</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 524.2768; found, 524.2770.</div></div><div id="sec3_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>R</i>)-3-(4-Amino-1-(1-(3-methylbut-2-enoyl)piperidin-3-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)benzamide (<b>57</b>)</h4><div class="NLM_p last">To a cooled solution of the free piperidine prepared for the synthesis of <b>40</b> (75 mg, 0.16 mmol, 1.0 equiv) in dichloromethane (4 mL) at 0 °C was added triethylamine (0.115 mL, 0.825 mmol, 5.0 equiv). The reaction was stirred for 5 min resulting in a homogeneous solution. To the reaction was added a solution of 3-methylcrotonoylchloride (0.018 mL, 0.165 mmol, 1.0 equiv) in dichloromethane (1 mL). The reaction was stirred for 30 min. The reaction was judged complete by LC-MS and quenched with water and extracted with ethyl acetate. The organic layer was then concentrated and dissolved in DMSO. The crude product solution in DMSO was purified via prep-HPLC to provide the desired material (54 mg, 61%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.20 (d, <i>J</i> = 7.02 Hz, 6 H), 1.52–1.98 (m, 4 H), 2.10–2.35 (m, 1 H), 2.87 (dt, <i>J</i> = 13.59, 6.80 Hz, 1 H), 2.92–3.30 (m, 1 H), 3.58 (m, 6 H), 3.69–4.21 (m, 2 H), 4.48–4.77 (m, 1 H), 5.77–5.98 (m, 1 H), 7.22 (d, <i>J</i> = 8.77 Hz, 2 H), 7.67–7.72 (m, 3 H), 7.86 (d, <i>J</i> = 7.45 Hz, 1 H), 8.06 (d, <i>J</i> = 7.89 Hz, 1 H), 8.23 (br. s., 1 H), 8.32 (s, 1 H), 10.23 (s, 1 H). LC-MS: 100%, <i>m</i>/<i>z</i> =538.3 [M + H]; HRMS [M + H] for C<sub>31</sub>H<sub>36</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 538.2925; found, 538.2927.</div></div><div id="sec3_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>R</i>,<i>E</i>)-3-(4-Amino-1-(1-(4-hydroxybut-2-enoyl)piperidin-3-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)benzamide (<b>58</b>)</h4><div class="NLM_p last">By following a procedure similar to that for <b>62</b>, the free piperidine prepared for the synthesis of <b>40</b> (82 mg, 0.18 mmol, 1.0 equiv) was converted into <b>58</b> (46 mg, 48%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 0.65–0.81 (m, 6 H), 1.15 (br. s., 1 H), 1.48 (br. s., 1 H), 1.69 (d, <i>J</i> = 9.21 Hz, 1 H), 1.83 (d, <i>J</i> = 10.52 Hz, 1 H), 2.42 (dt, <i>J</i> = 14.03, 7.02 Hz, 1 H), 2.77 (br. s., 1 H), 3.21 (s, 2 H), 3.57–3.78 (m, 2 H), 4.07–4.37 (m, 1 H), 5.95–6.30 (m, 2 H), 6.77 (d, <i>J</i> = 8.33 Hz, 2 H), 7.14–7.30 (m, 3 H), 7.41 (d, <i>J</i> = 7.89 Hz, 1 H), 7.61 (d, <i>J</i> = 7.89 Hz, 1 H), 7.77 (s, 1 H), 7.88 (s, 1 H) 9.77 (s, 1 H). LC-MS: 100%, <i>m</i>/<i>z</i> = 540.3 [M + H]; HRMS [M + H] for C<sub>30</sub>H<sub>34</sub>N<sub>7</sub>O<sub>3</sub>, calcd, 540.2718; found, 540.2717.</div></div><div id="sec3_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>R</i>,<i>E</i>)-3-(4-Amino-1-(1-(4-(methylamino)but-2-enoyl)piperidin-3-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)benzamide (<b>59</b>)</h4><div class="NLM_p last">To a solution of the bromocrotonamide obtained in the synthesis of <b>61</b> (100 mg, 0.166 mmol, 1.0 equiv) in THF (10 mL) was added triethylamine (0.069 mL, 0.498 mmol, 3.0 equiv), methyl amine (0.830 mmol, 5.0 equiv), and potassium iodide (27.7 mg, 0.166 mmol, 1.0 equiv). The reaction was stirred at room temperature overnight in a sealed vial. The LC-MS of the reaction mixture showed completion of the reaction. The reaction was concentrated to dryness and diluted with DMSO, which was subjected to HPLC purification to provide the desired material <b>59</b> as a solid (2.9 mg, 3%). LC-MS: 99%, <i>m</i>/<i>z</i> = 553.2 [M + H];</div></div><div id="sec3_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>R</i>,<i>E</i>)-3-(4-Amino-1-(1-(4-(piperazin-1-yl)but-2-enoyl)piperidin-3-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)benzamide (<b>60</b>)</h4><div class="NLM_p last">To a solution of the Boc-protected piperazine intermediate (prepared analogously to <b>59</b>) (75 mg, 0.11, 1.0 equiv) in dichloromethane (0.5 mL) was added 4 N HCl in dioxane (0.265 mL, 1.06 mmol, 10.0 equiv), and the reaction was stirred overnight. LC-MS indicated the reaction was completed. The reaction was concentrated to a residue and diluted with DMSO and subjected to HPLC purification to provide the desired material as a solid (50 mg, 78%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.12–1.31 (m, 6 H) 1.59 (br. s., 2 H) 1.95 (br. s., 2 H) 2.09–2.35 (m, 6 H) 2.59–2.76 (m, 4 H) 2.83–3.17 (m, 4 H) 4.00–4.17 (m, 1 H) 4.50–4.83 (m, 1 H) 6.41–6.68 (m, 1 H) 7.23 (d, <i>J</i> = 8.33 Hz, 2 H) 7.58–7.76 (m, 3 H) 7.86 (d, <i>J</i> = 7.02 Hz, 1 H) 8.05 (d, <i>J</i> = 7.89 Hz, 1 H) 8.20–8.31 (m, 2 H) 10.23 (s, 1 H). LC-MS: 91%, <i>m</i>/<i>z</i> = 609.3 [M + H]; HRMS [M + Na] for C<sub>34</sub>H<sub>41</sub>N<sub>9</sub>NaO<sub>2</sub>, calcd, 630.3275; found, 630.3275.</div></div><div id="sec3_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>R</i>,<i>E</i>)-3-(4-Amino-1-(1-(4-(4-(2-aminoethyl)piperazin-1-yl)but-2-enoyl)piperidin-3-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)benzamide (<b>61</b>)</h4><div class="NLM_p"><b>Step 1:</b> To a cooled solution of the free piperidine prepared for the synthesis of <b>40</b> (500 mg, 1.10 mmol, 1.0 equiv) in dichloromethane (10 mL) at 0 °C was added triethylamine (0.305 mL, 2.20 mmol, 2.0 equiv). The reaction was stirred for 5 min resulting in a homogeneous solution. To the reaction was added (<i>E</i>)-4-bromobut-2-enoyl chloride (201 mg, 1.1 mmol, 1.0 equiv). The reaction was stirred for 1 h. The reaction was judged complete by LC-MS and quenched with water and extracted with ethyl acetate. The organic layer was then concentrated and purified via silica gel chromatography (50% ethyl acetate in heptane to 100%) to provide the desired product as a solid (325 mg, 49%). LC-MS: 96%, <i>m</i>/<i>z</i> = 602.2/604.2 [M + H].</div><div class="NLM_p"><b>Step 2:</b> To a solution of the bromocrotonamide from the previous reaction (300 mg, 0.498 mmol, 1.0 equiv) in THF (10 mL) was added triethylamine (0.208 mL, 1.49 mmol, 3.0 equiv) followed by <i>tert</i>-butyl 2-(piperazin-1-yl)ethylcarbamate (114 mg, 0.498 mmol, 1.0 equiv). The reaction was stirred overnight at room temperature. The reaction was judged complete by LC-MS and was concentrated under vacuum. The residue was purified via C18 reverse phase chromatography (5% acetonitrile in water (0.01% formic acid) to 95%) to provide the desired product as a white solid (231 mg, 62%). LC-MS: 99%, <i>m</i>/<i>z</i> = 751.3 [M + H].</div><div class="NLM_p last"><b>Step 3:</b> A solution of the Boc-protected material from the previous reaction (220 mg, 0.293 mmol, 1.0 equiv) in methanol (5 mL) was cooled to 0 °C, and 4 N HCl in dioxane (0.733 mL, 2.93 mmol, 10.0 equiv) was added. The reaction was stirred for 2 h at 0 °C and then at room temperature overnight. The reaction was judged complete by LC-MS, and the reaction was concentrated to the desired material as the HCl salt (200 mg, 99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.22 (d, <i>J</i> = 7.02 Hz, 6 H), 1.54–2.37 (m, 6 H), 2.89 (dt, <i>J</i> = 13.76, 6.98 Hz, 1 H), 2.94–3.54 (m, 12 H), 3.71–3.98 (m, 2 H), 4.05–4.34 (m, 1 H), 4.57–4.94 (m, 2 H), 6.59–7.13 (m, 2 H), 7.25 (d, <i>J</i> = 8.59 Hz, 2 H), 7.69–7.79 (m, 3 H), 7.89 (d, <i>J</i> = 7.81 Hz, 1 H), 8.15–8.18 (m, 3 H), 8.26 (s, 1 H), 8.56–8.63 (m, 1 H), 10.29–10.42 (m, 1 H). LC-MS: 99%, <i>m</i>/<i>z</i> = 651.3 [M + H]; HRMS [M + H] for C<sub>36</sub>H<sub>47</sub>N<sub>10</sub>O<sub>2</sub>, calcd, 651.3878; found, 651.3874.</div></div><div id="sec3_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>R</i>)-3-(4-Amino-1-(1-propioloylpiperidin-3-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)benzamide (<b>62</b>)</h4><div class="NLM_p last">A solution of the free piperidine prepared for the synthesis of <b>40</b> (75 mg, 0.16 mmol, 1.0 equiv) and propargylic acid (17.3 mg, 0.247 mmol, 1.5 equiv) in DMF (0.8 mL) was cooled to 0 °C. To the solution was added DIPEA (0.086 mL, 0.495 mmol, 3.0 equiv) followed by BOP (109 mg, 0.247 mmol, 1.5 equiv). The reaction was stirred for 1 h, then allowed to warm to room temperature. The reaction was continued for 2 h at which point LC-MS indicated that the reaction was complete. The reaction was quenched with water and extracted with ethyl acetate. The organic layer was then concentrated and dissolved in DMSO. The crude product solution in DMSO was purified via prep-HPLC to provide the desired material (44 mg, 53%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.20 (d, <i>J</i> = 6.58 Hz, 6 H), 1.47–1.78 (m, 1 H), 1.84–2.34 (m, 3 H), 2.87 (dt, <i>J</i> = 13.70, 6.96 Hz, 1 H),3.10–3.44 (m, 1 H), 3.27–3.46 (m, 1 H), 3.88 (dd, <i>J</i> = 13.15, 9.21 Hz, 1 H), 4.03–4.26 (m, 1 H), 4.30–4.49 (m, 1 H), 4.38–4.50 (m, 1 H), 4.69–5.00 (m, 1 H), 7.22 (d, <i>J</i> = 8.33 Hz, 2 H), 7.63–7.73 (m, 3 H), 7.88 (dd, <i>J</i> = 6.36, 1.53 Hz, 1 H), 8.07 (d, <i>J</i> = 7.89 Hz, 1 H), 8.24 (s, 1 H), 8.30–8.40 (m, 1 H), 10.22 (d, <i>J</i> = 8.33 Hz, 1 H). LC-MS: 94%, <i>m</i>/<i>z</i> = 508.1 [M + H]; HRMS [M + H] for C<sub>29</sub>H<sub>30</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 508.2455; found, 508.2454.</div></div><div id="sec3_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>R</i>)-3-(1-(1-Acryloylpiperidin-3-yl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)benzamide (<b>63</b>)</h4><div class="NLM_p last">By following a procedure similar to that for <b>62</b>, the free piperidine prepared for the synthesis of <b>40</b> (75 mg, 0.16 mmol, 1.0 equiv) was converted into <b>63</b> (45 mg, 53%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.15–1.25 (m, 6 H), 1.52–1.70 (m, 1 H), 1.87–2.04 (m, 3 H), 1.94–2.02 (m, 1 H), 2.17 (br. s., 1 H), 2.25–2.34 (m, 1 H), 2.87 (dt, <i>J</i> = 13.92, 6.85 Hz, 1 H), 3.33 (dd, <i>J</i> = 12.28, 10.52 Hz, 1 H), 3.85 (dd, <i>J</i> = 12.94, 8.99 Hz, 1 H), 4.01–4.24 (m, 1 H), 4.33–4.46 (m, 1 H), 4.68–4.88 (m, 1 H), 7.23 (d, <i>J</i> = 7.89 Hz, 2 H), 7.66–7.74 (m, 3 H), 7.87 (d, <i>J</i> = 7.45 Hz, 1 H), 8.07 (dd, <i>J</i> = 7.67, 1.10 Hz, 1 H), 8.24 (d, <i>J</i> = 1.75 Hz, 1 H), 8.35 (d, <i>J</i> = 9.65 Hz, 1 H), 10.22 (d, <i>J</i> = 3.51 Hz, 1 H). LC-MS: 100%, <i>m</i>/<i>z</i> = 522.2 [M + H]; HRMS [M + H] for C<sub>30</sub>H<sub>32</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 522.2612; found, 522.2616.</div></div><div id="sec3_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>R</i>)-3-(4-Amino-1-(1-cyanopiperidin-3-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)benzamide (<b>64</b>)</h4><div class="NLM_p last">A solution of the free piperidine prepared for the synthesis of <b>40</b> (50 mg, 0.11 mmol, 1.0 equiv) and cesium carbonate (143 mg, 0.440 mmol, 4.0 equiv) in DMF (2 mL) was cooled to 0 °C. To the solution was added cyanogen bromide (0.073 mL, 0.220 mmol, 2.0 equiv), and the reaction was stirred for 30 min, then allowed to warm to room temperature. The reaction was continued for 30 min at which point LC-MS indicated the reaction was complete. The reaction was quenched with water and extracted with ethyl acetate. The organic layer was then concentrated and dissolved in DMSO. The crude product solution in DMSO was purified via prep-HPLC to provide the desired material (29 mg, 55%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.20 (d, <i>J</i> = 7.02 Hz, 6 H) 1.83 (br. s., 1 H) 1.91 (d, <i>J</i> = 3.51 Hz, 1 H) 2.13 (d, <i>J</i> = 3.51 Hz, 1 H) 2.20 (d, <i>J</i> = 3.07 Hz, 1 H) 2.84–2.92 (m, 1 H) 3.18 (dd, <i>J</i> = 11.62, 9.87 Hz, 1 H) 3.40 (d, <i>J</i> = 12.72 Hz, 1 H) 3.56 (dd, <i>J</i> = 12.50, 10.30 Hz, 1 H) 3.65 (dd, <i>J</i> = 12.28, 4.39 Hz, 1 H) 4.86–4.95 (m, 1 H) 7.22 (d, <i>J</i> = 8.77 Hz, 2 H) 7.63–7.72 (m, 3 H) 7.87 (d, <i>J</i> = 7.89 Hz, 1 H) 8.06 (d, <i>J</i> = 7.89 Hz, 1 H) 8.19–8.26 (m, 1 H) 8.30 (s, 1 H) 10.22 (s, 1 H). LC-MS: 97%, <i>m</i>/<i>z</i> = 481.2 [M + H]; HRMS [M + H] for C<sub>27</sub>H<sub>29</sub>N<sub>9</sub>O, calcd, 481.2459; found, 481.2460.</div></div><div id="sec3_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>R</i>)-3-(1-(1-Acryloylpiperidin-3-yl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-benzamide (<b>65</b>)</h4><div class="NLM_p"><b>Step 1:</b> To a stirred solution of compound <b>28</b> (150 mg, 0.342 mmol, 1.0 equiv) in DMF (3 mL) was added DIPEA (132.4 mg, 1.026 mmol, 3.0 equiv), HATU (143 mg, 0.376 mmol, 1.1 equiv), and benzylamine (36.6 mg, 0.342 mmol, 1.0 equiv) at 0 °C. The reaction mixture was stirred at room temperature for 4 h. The reaction mixture was quenched with ice water and was extracted with ethyl acetate (3 × 50 mL). The organic layer was washed with water (2 × 20 mL) followed by brine (1 × 20 mL), dried over sodium sulfate, and was evaporated to dryness. The crude material was purified by column chromatography (30% ethyl acetate in hexane) to afford compound <b>29a</b> as an off-white solid (125 mg, 69%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.42 (s, 9 H), 1.69–1.66 (m, 2 H), 2.29–2.26 (m, 2 H), 3.60–3.20 (m, 2 H), 4.08 (m, 1 H), 4.40–4.10 (m, 1 H), 4.66 (d, 2 H), 4.82 (m, 1 H), 7.36–7.31 (m, 5 H), 7.60 (t, 1 H), 7.82 (t, 1 H), 7.87 (d, 1 H), 8.11 (s, 1 H), 8.34 (s, 1 H). LC-MS: <i>m</i>/<i>z</i> = 528.4 [M + H].</div><div class="NLM_p"><b>Step 2:</b> To a stirred solution of compound <b>29a</b> (100 mg, 0.216 mmol, 1.0 equiv) in dioxane (1 mL) was added 4 N HCl in dioxane (7 mL) at 0 °C, and it was stirred at room temperature for 3 h. Then, the solvent was evaporated, and the residue was triturated with <i>n</i>-pentane. The solid was collected by filtration and was dried under vacuum to afford the deprotected piperidine. This off-white solid (100 mg, 84%) was directly used for the next step as HCl salt. LC-MS (M + H): 428.6.</div><div class="NLM_p last"><b>Step 3:</b> To a stirred solution of the deprotected piperidine (100 mg, 0.216 mmol, 1.0 equiv) in DMF (2 mL) was added BOP reagent (95.4 mg, 0.216 mmol, 1.0 equiv) followed by DIPEA (0.093 mL, 0.54 mmol, 2.5 equiv) and acrylic acid (17.1 mg, 0.237 mmol, 1.1 equiv) at 0 °C. The reaction mixture was stirred at room temperature for 15 min. The reaction was quenched with ice water and filtered. The residue was dissolved in ethyl acetate, dried over sodium sulfate, and was concentrated. The crude mass was purified by prep-HPLC to afford final compound <b>65</b> as a white solid (19 mg, 21%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.68–1.62 (m, 1 H), 1.99–1.95 (m, 1 H), 2.38–2.18 (m, 1 H), 3.20–3.14 (m, 1 H), 3.55 (s, 1 H), 4.12–4.08 (m, 1 H) 4.42–4.39 (m, 1 H), 4.50 (d, 2 H), 4.79–4.74 (m, 1 H), 5.66–5.60 (m, 1 H), 6.08–6.03 (m, 1 H), 6.53 (s, 2 H), 6.74–6.67 (m, 1H), 7.38–7.22 (m, 5 H), 7.63 (t, 1 H), 7.81 (d, 1 H), 8.0 (d, 1 H), 8.19 (s, 1 H), 8.28 (s, 1 H), 8.79 (s, 1 H). HPLC purity: 97.09%; HRMS [M + H] for C<sub>27</sub>H<sub>28</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 482.2299; found, 482.2302.</div></div><div id="sec3_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>R</i>)-3-(1-(1-Acetylpiperidin-3-yl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-benzylbenzamide (<b>66</b>)</h4><div class="NLM_p last">To a stirred solution of the deprotected piperidineprepared for the synthesis of compound <b>65</b> (200 mg, 0.562 mmol) in dichloromethane (10 mL) was added triethylamine (0.313 mL, 2.248 mmol) and acetyl chloride (0.036 mL, 0.505 mmol) at 0 °C. The reaction mixture was allowed to stir at the same temperature for 2 h. The reaction mixture was diluted with dichloromethane (5 mL), and the organic layer was washed with water (2 × 10 mL) followed by brine (1 × 10 mL), dried over sodium sulfate, and was evaporated to dryness. The crude mass was purified by column chromatography (3% methanol in dichloromethane) to afford the desired material <b>66</b> as a white solid (120 mg, 45%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.58 (m, 1 H), 1.67 (m, 1 H), 1.97 (s, 3 H), 2.07 (m, 1 H), 2.23 (m, 1 H), 2.79–3.17 (m, 2 H), 3.60–3.85 (m, 1 H), 3.98–4.23 (m, 1 H), 4.51 (m, 2 H), 4.62–4.80 (m, 1 H), 7.26 (m, 1 H), 7.34 (d, 4 H), 7.64 (t, 1 H), 7.81 (d, 1 H), 8.00 (d, 1 H), 8.19 (s, 1 H), 8.28 (d, 1 H), 9.15 (m, 1 H); HPLC purity = 96.13%; HRMS [M + H] for C<sub>26</sub>H<sub>28</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 470.2299; found, 470.2302.</div></div><div id="sec3_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>R</i>)-3-(1-(1-Acetylpiperidin-3-yl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-methylbenzyl)benzamide (<b>68</b>)</h4><div class="NLM_p"><b>Step 1:</b> To a stirred solution of <b>28</b> (300 mg, 0.684 mmol) in dichloromethane (10 mL) was added 4-methylbenzyl amine (0.104 mL, 0.820 mmol)and DIPEA (0.226 mL, 1.368 mmol) followed by the addition of PyBOP (534 mg, 1.026 mmol). The reaction mixture was allowed to stir at room temperature for 18 h. The reaction mixture was diluted with dichloromethane (15 mL). The organic layer was washed with water (2 × 10 mL) followed by brine (1 × 10 mL), dried over sodium sulfate, and was evaporated to dryness. The residue was purified by column chromatography (100% ethyl acetate) to afford compound 30 as a white solid (349 mg, 94%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.34 (s, 9H), 1.57 (m, 1H), 1.85 (m, 1H), 2.18 (m, 1H), 2.31 (s, 3H), 3.13 (m, 1H), 3.30 (m, 1H), 3.62 (m, 1H), 3.85 (m, 1H), 4.46 (d, 2H), 4.69 (m, 1H), 7.13 (d, 2H), 7.22 (d, 2H), 7.63 (m, 1H), 7.79 (d, 1H), 7.98 (d, 1H), 8.17 (s, 1H), 8.27 (s, 1H), 9.09 (m, 1H); LC-MS <i>m</i>/<i>z</i> = 542.2 [M + H].</div><div class="NLM_p"><b>Step 2:</b> To a stirred solution of compound <b>29</b> (349 mg, 0.644 mmol) in dioxane (2 mL) was added 4 N HCl in dioxane (10 mL) at 0 °C. The reaction mixture was allowed to stir at room temperature for 1 h. The reaction mixture was evaporated to dryness and was triturated with diethyl ether to afford the HCl salt of the deprotected piperidine as a white solid (280 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.95 (s, 2 H), 2.17 (m, 2 H), 2.49 (s, 3 H), 3.11 (m, 1 H), 3.30 (m, 1 H), 3.44 (m, 1 H), 3.60 (m, 1 H), 4.46 (d, 2 H), 5.22 (m, 1 H), 7.13 (d, 2 H), 7.22 (d, 2 H), 7.66 (t, 1 H), 7.82 (d, 1 H), 8.06 (d, 1 H), 8.22 (s, 1 H), 8.52 (s, 1 H), 9.18–9.38 (m, 3 H); LC-MS <i>m</i>/<i>z</i> = 442.2 [M + H].</div><div class="NLM_p last"><b>Step 3:</b> To a stirred solution of the deprotected piperidine (280 mg, 0.634 mmol) in dichloromethane (10 mL) was added triethylamine (0.354 mL, 2.539 mmol) and acetyl chloride (0.04 mL, 0.571 mmol) at 0 °C, and the reaction mixture was allowed to stir at the same temperature for 2 h. The reaction mixture was diluted with dichloromethane (5 mL), and the organic layer was washed with water (2 × 10 mL) followed by brine (1 × 10 mL), dried over sodium sulfate, and was evaporated to dryness. The crude mass was purified by column chromatography (3% methanol in dichloromethane) to afford compound <b>68</b> as a white solid (120 mg, 45%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.52 (m, 1 H), 1.66 (m, 1 H), 1.97 (s, 3 H), 2.11 (m, 1 H), 2.27 (m, 4 H), 2.79–3.17 (m, 2 H), 3.60–3.80 (m, 1 H), 3.99–4.23 (m, 1 H), 4.51–4.54 (dd, 2 H), 4.75–4.80 (m, 1 H), 7.13 (d, 2 H), 7.22 (d, 2 H), 7.63 (t, 1 H), 7.80 (d, 1 H), 7.98 (d, 1 H), 8.18 (s, 1 H), 8.28 (d, 1 H), 9.11 (m, 1 H); HPLC purity = 97.65%; HRMS [M + H] for C<sub>27</sub>H<sub>30</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 484.2455; found, 484.2458.</div></div><div id="sec3_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-(1-(1-Acetylpiperidin-3-yl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-isopropylphenyl)benzamide (<b>69</b>)</h4><div class="NLM_p last">Triethylamine (152 mg, 1.5 mmol) followed by acetyl chloride (43 mg, 550 μmol) was added to the suspension of 3-{4-amino-3-[3-(4-isopropylphenylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidinium chloride (246 mg, 500 μmol) in dichloromethane (1.5 mL) at 0 °C while stirring. The cooling bath was removed, and the mixture was stirred for 30 min. The mixture was then directly purified by column chromatography (0% methanol in dichloromethane to 7%) to afford <b>69</b> (183 mg, 73%) as a colorless glass. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 0.96–1.34 (m, 6 H), 1.40–1.92 (m, 2 H), 1.96–2.08 (m, 3 H), 2.07–2.39 (m, 2 H), 2.69–3.21 (m, 3 H), 3.56–4.58 (m, 2 H), 4.58–4.85 (m, 1 H) 7.22 (d, <i>J</i> = 8.79 Hz, 2 H) 7.57–7.73 (m, 3 H) 7.86 (d, <i>J</i> = 8.05 Hz, 1 H) 8.04 (d, <i>J</i> = 8.05 Hz, 1 H) 8.22 (d, <i>J</i> = 1.46 Hz, 1 H) 8.25–8.34 (m, 1 H) 10.27 (s, 1 H). LC-MS: 99%, <i>m</i>/<i>z</i> = 498.3; HRMS [M + H] for C<sub>28</sub>H<sub>32</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 498.2612; found, 498.2617.</div></div><div id="sec3_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-(1-(1-Acetylpiperidin-3-yl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(3-<i>tert</i>-butylphenyl)benzamide (<b>70</b>)</h4><div class="NLM_p last">Triethylamine (152 mg, 1.5 mmol, 3.0 equiv) followed by acetyl chloride (43 mg, 550 μmol, 1.1 equiv) was added to the suspension of 3-{4-amino-3-[3-(3-<i>tert</i>-butylphenylcarbamoyl)phenyl]pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl}piperidinium chloride (253 mg, 500 μmol, 1.0 equiv) in dichloromethane (1.5 mL) at 0 °C while stirring. The cooling bath was removed, and the mixture was stirred for 30 min. The mixture was then directly purified by column chromatography (0% methanol in dichloromethane to 7%) to afford <b>71</b> (220 mg, 86%) as a colorless glass. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.23–1.38 (m, 9 H), 7.15 (d, <i>J</i> = 7.32 Hz, 1 H), 7.29 (t, <i>J</i> = 8.05 Hz, 1 H), 7.61–7.76 (m, 1 H) 7.80 (br. s., 2 H), 7.88 (d, <i>J</i> = 8.05 Hz, 1 H), 8.07 (d, <i>J</i> = 7.32 Hz, 1 H), 8.21–8.39 (m, 1 H), 10.28 (s, 2 H). LC-MS: 99%, <i>m</i>/<i>z</i> = 512.3; HRMS [M + H] for C<sub>29</sub>H<sub>34</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 512.2768; found, 512.2768.</div></div><div id="sec3_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>R</i>)-3-(1-(1-Acetylpiperidin-3-yl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-<i>N</i>-(4-<i>tert</i>-butylbenzyl)benzamide (<b>71</b>)</h4><div class="NLM_p"><b>Step 1:</b> To a stirred solution of acid compound <b>28</b> (300 mg, 0.684 mmol) in dichloromethane (10 mL) was added <i>tert</i>-butylbenzylamine (0.144 mL, 0.820 mmol) and DIPEA (0.226 mL, 1.368 mmol), followed by the addition of PyBOP (534 mg, 1.026 mmol), and the reaction mixture was allowed to stir at room temperature for 18 h. The reaction mixture was diluted with dichloromethane (15 mL). The organic layer was washed with water (2 × 10 mL) followed by brine (1 × 10 mL), dried over sodium sulfate, and was evaporated to dryness. The crude mass was purified by column chromatography (100% ethyl acetate) to afford compound 30 as an off-white solid (368 mg, 92%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.26–1.34 (m, 18 H), 1.56 (m, 1 H), 1.89 (m, 1 H), 2.09 (m, 1 H), 2.22 (m, 1 H), 2.96 (m, 1 H), 3.30- 3.40 (m, 2 H), 3.86 (m, 1 H), 4.46 (d, 2 H), 4.69 (m, 1 H), 7.27 (d, 2 H), 7.35 (d, 2 H), 7.63 (t, 1 H), 7.80 (d, 1 H), 7.98 (d, 1 H), 8.18 (s, 1 H), 8.27 (s, 1 H), 9.09 (m, 1 H); LC-MS <i>m</i>/<i>z</i> = 584.4 [M + H].</div><div class="NLM_p"><b>Step 2:</b>To a stirred solution of compound <b>29</b> (368 mg, 0.630 mmol) in dioxane (2 mL) was added 4 N HCl in dioxane (10 mL) at 0 °C. The reaction mixture was allowed to stir at room temperature for 1 h. The reaction mixture was evaporated to dryness and was triturated with diethyl ether to afford the deprotected piperidine as a white solid (300 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C): δ = 1.25 (s, 9 H), 1.98 (m, 2 H), 2.14 (m, 2 H), 3.01 (m, 2 H), 3.30 (m, 1 H), 3.50 (m, 1 H), 4.47 (d, 2 H), 5.23 (m, 1 H), 7.26 (d, 2 H), 7.35 (d, 2 H), 7.66 (t, 1 H), 7.82 (d, 1 H), 8.07 (d, 1 H), 8.23 (s, 1 H), 8.57 (s, 1 H), 9.20–9.45 (m, 3 H); LC-MS = 484.2 [M + H].</div><div class="NLM_p"><b>Step 3:</b> To a stirred solution of the deprotected piperidine (300 mg, 0.621 mmol) in dichloromethane (10 mL) was added triethylamine (0.346 mL, 2.484 mmol) and acetyl chloride (0.04 mL, 0.559 mmol) at 0 °C, and the reaction mixture was allowed to stir at the same temperature for 2 h. The reaction mixture was diluted with dichloromethane (5 mL), and the organic layer was washed with water (2 × 10 mL) followed by brine (1 × 10 mL), dried over sodium sulfate, and was evaporated to dryness. The crude mass was purified by column chromatography (3% methanol in dichloromethane) to afford <b>71</b> as a white solid (140 mg, 43%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.28 (s, 9H), 1.67 (m, 1H), 1.84 (m, 1H), 1.97 (s, 3H), 2.07 (m, 1H), 2.23 (m, 1H), 2.32 (m, 1H), 2.79–3.17 (m, 2H), 3.60–3.86 (m, 1H), 3.99–4.23 (m, 1H), 4.50–4.54 (m, 2H), 4.75–4.80 (m, 1H), 7.25 (d, 2H), 7.35 (d, 2H), 7.63 (t, 1H), 7.80 (d, 1H), 7.99 (d, 1H), 8.19 (s, 1H), 8.28 (d, 1H), 9.11 (m, 1H); HPLC purity = 99.02%; HRMS [M + H] for C<sub>30</sub>H<sub>36</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 526.2925; found, 526.2926.</div><div id="sec3_1_25_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> Amide Library</h5><div class="NLM_p"><b>Step 1:</b> A 0.2 M solution of acid template in anhydrous DMF was prepared (solution A), and a 0.2 M solution of amine monomers in anhydrous DMF was prepared (solution B). Solution A (625 μL (125 μmol)) was added to each reaction vial followed by 625 μL (1 equiv, 125 μmol) of solution B. HATU (125 μmol (1 equiv, 48 mg) was dispensed to each vial followed by DIPEA (125 μmol, 1.5 equiv, 22 μL). Reaction vials were shaken for 16 h at 60 °C and checked by LC-MS. Reaction mixtures were evaporated in a thermo explorer (2 h, 5 Torr, and 45 °C). Each residue was dissolved in ethyl acetate (5 mL) and washed with water (1 × 3 mL) and brine (1 × 3 mL). The organic part was dried over anhydrous sodium sulfate and evaporated under reduced pressure.</div><div class="NLM_p"><b>Step 2:</b> Each residue obtained after step 1 was dissolved in 500 μL of 1,4-dioxane, transferred to reaction vials, and cooled to 0 °C. 1,4-Dioxane-HCl (1 M, 500 μL) was added to each reaction vial and stirred at 25 °C for 16 h. The solvent was evaporated under reduced pressure and azeotroped with toluene. Residues obtained were used in step 3 without further purification.</div><div class="NLM_p"><b>Step 3:</b> To a solution of acrylic acid (250 mg, 3.5 mmol) in DCM (20 mL) was added thionyl chloride (1.5 equiv, 5.2 mmol, 0.38 mL). The reaction mixture was heated at 40 °C for 4 h, and half of the total volume of DCM was evaporated. The amine was dissolved in 1 mL of DCM, and 5 equiv of TEA (70 uL) was added to each reaction vial. The acryloyl chloride solution (1.5 equiv, 5.2 mmol, 0.38 mL) was slowly added to the solution of amine and TEA in DCM at 0 °C. Reaction vials were stirred at 0 °C for 10–15 min after which it was quenched with ice. The solvent was evaporated. DMSO (1.0 mL) was added to the crude products. Ten microliters of the DMSO solution was diluted to 200 μL with DMSO for QC analysis, and the remaining amount was submitted for prep-HPLC purification on Waters Autopurification System (column, Luna Phenyl Hexyl (21 × 150 mm, 10 μm); mobile phase, A, 10 mM ammonium acetate in water, and B, acetonitrile; <i>T</i> = 0; flow = 20; A = 90%; B = 10%; <i>T</i> = 3; flow = 20; A = 75%; B = 25%; <i>T</i> = 18; flow = 20; A = 35%; B = 65%.) Purified fractions were collected in bar coded test tubes and evaporated in a thermo explorer (40 °C, 15 Torr, 16 h). Each of the compounds were then dissolved in ethanol (1.6 mL) and transferred to 2 dram glass vials. Finally, they were dried in a Genevac first for 1 h (40 °C, 10 mbar) and then for 12 h (40 °C, 0 mbar). Weights were taken using a Mettler Balance. These compounds were then dissolved in calculated amounts of DMSO to prepare 30 mM solutions. Eight μL was removed for final QC analysis (diluted with 150 μL DMSO) on an analytical LC/MS. QC reports were generated to check the identity and purity of each compound.</div><div class="NLM_p"><b>30:</b> LC-MS 83.9%, 1.73 min, <i>m</i>/<i>z</i> = 536.35 [M + H].</div><div class="NLM_p"><b>31:</b> LC-MS 100%, 1.72 min, <i>m</i>/<i>z</i> = 536.30 [M + H].</div><div class="NLM_p"><b>32:</b> LC-MS 100%, 1.56 min, <i>m</i>/<i>z</i> = 498.27 [M + H]; HRMS [M + H] for C<sub>27</sub>H<sub>28</sub>N<sub>7</sub>O<sub>3</sub>, calcd, 498.2248; found, 498.2249.</div><div class="NLM_p"><b>33:</b> LC-MS 100%, 1.61 min, <i>m</i>/<i>z</i> = 498.33 [M + H]; HRMS [M + H] for C<sub>27</sub>H<sub>28</sub>N<sub>7</sub>O<sub>3</sub>, calcd, 498.2248; found, 498.2246.</div><div class="NLM_p"><b>34:</b> LC-MS 100%, 1.61 min, <i>m</i>/<i>z</i> = 486.31 [M + H]; HRMS [M + H] for C<sub>26</sub>H<sub>25</sub>FN<sub>7</sub>O<sub>2</sub>, calcd, 486.2048; found, 486.2051.</div><div class="NLM_p"><b>35:</b> LC-MS 97.7%, 1.66 min, <i>m</i>/<i>z</i> = 504.08 [M + H]; HRMS [M + H] for C<sub>26</sub>H<sub>24</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 504.1954; found, 504.1957.</div><div class="NLM_p"><b>37:</b> LC-MS 100%, 1.57 min, <i>m</i>/<i>z</i> = 504.22 [M + H]; HRMS [M + H] for C<sub>26</sub>H<sub>24</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 504.1954; found, 504.1956.</div><div class="NLM_p"><b>38:</b> LC-MS 94.1%, 1.58 min, <i>m</i>/<i>z</i> = 487.29 [M + H].</div><div class="NLM_p"><b>41</b> (PF-06465469):<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> LC-MS 95.1%, 1.79 min, <i>m</i>/<i>z</i> = 524.28 [M + H]; HRMS [M + H] for C<sub>30</sub>H<sub>34</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 524.2768; found, 524.2771.</div><div class="NLM_p"><b>43:</b> LC-MS 86.5%, 1.67 min, <i>m</i>/<i>z</i> = 550.21 [M + H].</div><div class="NLM_p"><b>44:</b> LC-MS 100%, 1.54 min, <i>m</i>/<i>z</i> =507.33 [M + H]; HRMS [M + H] for C<sub>28</sub>H<sub>27</sub>N<sub>8</sub>O<sub>2</sub>, calcd, 507.2251; found, 507.2255.</div><div class="NLM_p"><b>45:</b> LC-MS 100%, 1.56 min, <i>m</i>/<i>z</i> = 551.09 [M + H]; HRMS [M + H] for C<sub>27</sub>H<sub>26</sub>F<sub>3</sub>N<sub>8</sub>O<sub>2</sub>, calcd, 551.2125; found, 551.2128.</div><div class="NLM_p"><b>46:</b> LC-MS 93.6%, 1.56 min, <i>m</i>/<i>z</i> = 500.22 [M + H]; HRMS [M + H] for C<sub>27</sub>H<sub>27</sub>FN<sub>7</sub>O<sub>2</sub>, calcd, 500.2205; found, 500.2205.</div><div class="NLM_p"><b>47:</b> LC-MS 100%, 1.57 min, <i>m</i>/<i>z</i> = 512.24 [M + H]; HRMS [M + H] for C<sub>28</sub>H<sub>30</sub>N<sub>7</sub>O<sub>3</sub>, calcd, 512.2405; found, 512.2408.</div><div class="NLM_p"><b>48:</b> LC-MS 91.8%, 1.62 min, <i>m</i>/<i>z</i> = 514.29 [M + H].</div><div class="NLM_p"><b>50:</b> LC-MS 94.4%, 1.58 min, <i>m</i>/<i>z</i> = 462.27 [M + H]; HRMS [M + H] for C<sub>25</sub>H<sub>32</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 462.2612; found, 462.2616.</div><div class="NLM_p"><b>51:</b> LC-MS 97.0%, 1.50 min, <i>m</i>/<i>z</i> = 474.18 [M + H]; HRMS [M + H] for C<sub>22</sub>H<sub>23</sub>F<sub>3</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 474.1860; found, 474.1865.</div><div class="NLM_p last"><b>67:</b> LC-MS 96.5%, 1.63 min, <i>m</i>/<i>z</i> = 496.26 [M + H]; HRMS [M + H] for C<sub>28</sub>H<sub>30</sub>N<sub>7</sub>O<sub>2</sub>, calcd, 496.2455; found, 496.2458.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43"><a href="/doi/suppl/10.1021/jm301190s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Assay details, electrophilicity calculations, and <sup>1</sup>H NMR spectra. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301190s/suppl_file/jm301190s_si_001.pdf">jm301190s_si_001.pdf (4.98 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates of the Itk crystal structures have been deposited in the Protein Data Bank for compound <b>40</b> (4HCU), compound <b>52</b> (4HCT), and compound <b>53</b> (4HCV).</p><div class="testing" data-doi="10.1021/jm301190s" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christoph W. Zapf</span> - <span class="hlFld-Affiliation affiliation">BioTherapeutics Chemistry, Pfizer Worldwide Medicinal
Chemistry, 200 Cambridgepark Drive, Cambridge, Massachusetts
02140, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#47242f352e343328372f693d2637210737212e3d22356924282a"><span class="__cf_email__" data-cfemail="15767d677c66617a657d3b6f7465735565737c6f70673b767a78">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian S. Gerstenberger</span> - <span class="hlFld-Affiliation affiliation">BioTherapeutics
Chemistry, Pfizer Worldwide Medicinal Chemistry, Eastern Point Road, Groton, Connecticut 06340, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Xing</span> - <span class="hlFld-Affiliation affiliation">BioTherapeutics Chemistry, Pfizer Worldwide Medicinal
Chemistry, 200 Cambridgepark Drive, Cambridge, Massachusetts
02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David C. Limburg</span> - <span class="hlFld-Affiliation affiliation">BioTherapeutics
Chemistry, Pfizer Worldwide Medicinal Chemistry, Eastern Point Road, Groton, Connecticut 06340, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David R. Anderson</span> - <span class="hlFld-Affiliation affiliation">BioTherapeutics
Chemistry, Pfizer Worldwide Medicinal Chemistry, Eastern Point Road, Groton, Connecticut 06340, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicole Caspers</span> - <span class="hlFld-Affiliation affiliation">Structure Biology and Biophysics, Pfizer Worldwide Medicinal Chemistry, Eastern Point
Road, Groton, Connecticut 06340, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seungil Han</span> - <span class="hlFld-Affiliation affiliation">Structure Biology and Biophysics, Pfizer Worldwide Medicinal Chemistry, Eastern Point
Road, Groton, Connecticut 06340, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ann Aulabaugh</span> - <span class="hlFld-Affiliation affiliation">Structure Biology and Biophysics, Pfizer Worldwide Medicinal Chemistry, Eastern Point
Road, Groton, Connecticut 06340, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ravi Kurumbail</span> - <span class="hlFld-Affiliation affiliation">Structure Biology and Biophysics, Pfizer Worldwide Medicinal Chemistry, Eastern Point
Road, Groton, Connecticut 06340, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Subarna Shakya</span> - <span class="hlFld-Affiliation affiliation">Inflammation and Autoimmunity, Pfizer Research, 200 Cambridgepark Drive, Cambridge,
Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Li</span> - <span class="hlFld-Affiliation affiliation">Inflammation and Autoimmunity, Pfizer Research, 200 Cambridgepark Drive, Cambridge,
Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vikki Spaulding</span> - <span class="hlFld-Affiliation affiliation">Inflammation and Autoimmunity, Pfizer Research, 200 Cambridgepark Drive, Cambridge,
Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert M. Czerwinski</span> - <span class="hlFld-Affiliation affiliation">Inflammation and Autoimmunity, Pfizer Research, 200 Cambridgepark Drive, Cambridge,
Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nilufer Seth</span> - <span class="hlFld-Affiliation affiliation">Inflammation and Autoimmunity, Pfizer Research, 200 Cambridgepark Drive, Cambridge,
Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Quintus G. Medley</span> - <span class="hlFld-Affiliation affiliation">Inflammation and Autoimmunity, Pfizer Research, 200 Cambridgepark Drive, Cambridge,
Massachusetts 02140, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d572e4366-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73587" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73587" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Mark Schnute, Atli Thorarensen, Suvit Thaisrivongs, and Kyri Dunussi-Joannopoulos for stimulating discussions and support for the project.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i46" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i46"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i47" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i47"> Abbreviations Used</h2><tr><td class="NLM_term">Itk</td><td class="NLM_def"><p class="first last">interleukin-2 inducible T cell kinase</p></td></tr><tr><td class="NLM_term">IP1</td><td class="NLM_def"><p class="first last">inositol monophosphate</p></td></tr><tr><td class="NLM_term">hWB</td><td class="NLM_def"><p class="first last">human whole blood</p></td></tr><tr><td class="NLM_term">TCR</td><td class="NLM_def"><p class="first last">T cell receptor</p></td></tr><tr><td class="NLM_term">BTK</td><td class="NLM_def"><p class="first last">Bruton’s tyrosine kinase</p></td></tr><tr><td class="NLM_term">PLCγ1</td><td class="NLM_def"><p class="first last">phospholipase C, gamma 1</p></td></tr><tr><td class="NLM_term">IP3</td><td class="NLM_def"><p class="first last">inositol trisphosphate</p></td></tr><tr><td class="NLM_term">IL-2</td><td class="NLM_def"><p class="first last">interleukin 2</p></td></tr><tr><td class="NLM_term">APC</td><td class="NLM_def"><p class="first last">antigen-presenting cell</p></td></tr><tr><td class="NLM_term">KO</td><td class="NLM_def"><p class="first last">knockout</p></td></tr><tr><td class="NLM_term">OVA</td><td class="NLM_def"><p class="first last">ovalbumin</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">small interfering RNA</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">μM</td><td class="NLM_def"><p class="first last">micromolar</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-à-go-go-related gene</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01023" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01023" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Iyer, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">August, A.</span><span> </span><span class="NLM_article-title">The Tec family kinase, IL-2-inducible T cell kinase, differentially controls mast cell responses</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">7869</span><span class="NLM_x">–</span> <span class="NLM_lpage">7877</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=7869-7877&author=A.+S.+Iyerauthor=A.+August&title=The+Tec+family+kinase%2C+IL-2-inducible+T+cell+kinase%2C+differentially+controls+mast+cell+responses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIyer%26aufirst%3DA.%2BS.%26aulast%3DAugust%26aufirst%3DA.%26atitle%3DThe%2520Tec%2520family%2520kinase%252C%2520IL-2-inducible%2520T%2520cell%2520kinase%252C%2520differentially%2520controls%2520mast%2520cell%2520responses%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D7869%26epage%3D7877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Andreotti, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, L. J.</span><span> </span><span class="NLM_article-title">T-cell signaling regulated by the Tec family kinase, Itk</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a002287</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=a002287&author=A.+H.+Andreottiauthor=P.+L.+Schwartzbergauthor=R.+E.+Josephauthor=L.+J.+Berg&title=T-cell+signaling+regulated+by+the+Tec+family+kinase%2C+Itk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndreotti%26aufirst%3DA.%2BH.%26aulast%3DSchwartzberg%26aufirst%3DP.%2BL.%26aulast%3DJoseph%26aufirst%3DR.%2BE.%26aulast%3DBerg%26aufirst%3DL.%2BJ.%26atitle%3DT-cell%2520signaling%2520regulated%2520by%2520the%2520Tec%2520family%2520kinase%252C%2520Itk%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2010%26volume%3D2%26spage%3Da002287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Berg, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P. L.</span><span> </span><span class="NLM_article-title">Tec family kinases in T lymphocyte development and function</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1146%2Fannurev.immunol.22.012703.104743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=15771581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFOjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=549-600&author=L.+J.+Bergauthor=L.+D.+Finkelsteinauthor=J.+A.+Lucasauthor=P.+L.+Schwartzberg&title=Tec+family+kinases+in+T+lymphocyte+development+and+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tec family kinases in T lymphocyte development and function</span></div><div class="casAuthors">Berg, Leslie J.; Finkelstein, Lisa D.; Lucas, Julie A.; Schwartzberg, Pamela L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">549-600</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The Tec family tyrosine kinases are now recognized as important mediators of antigen receptor signaling in lymphocytes.  Three members of this family, Itk, Rlk, and Tec, are expressed in T cells and activated in response to T cell receptor (TCR) engagement.  Although initial studies demonstrated a role for these proteins in TCR-mediated activation of phospholipase C-γ, recent data indicate that Tec family kinases also regulate actin cytoskeletal reorganization and cellular adhesion following TCR stimulation.  In addn., Tec family kinases are activated downstream of G protein-coupled chemokine receptors, where they play parallel roles in the regulation of Rho GTPases, cell polarization, adhesion, and migration.  In all these systems, however, Tec family kinases are not essential signaling components, but instead function to modulate or amplify signaling pathways.  Although they quant. reduce proximal signaling, mutations that eliminate Tec family kinases in T cells nonetheless qual. alter T cell development and differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq80olBDulky7Vg90H21EOLACvtfcHk0ljMSowmPoOIfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFOjurc%253D&md5=bf2a0bd00c2bbea96c2683c5afbd56fa</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.22.012703.104743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.22.012703.104743%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DL.%2BJ.%26aulast%3DFinkelstein%26aufirst%3DL.%2BD.%26aulast%3DLucas%26aufirst%3DJ.%2BA.%26aulast%3DSchwartzberg%26aufirst%3DP.%2BL.%26atitle%3DTec%2520family%2520kinases%2520in%2520T%2520lymphocyte%2520development%2520and%2520function%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D23%26spage%3D549%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Burbach, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medeiros, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, Y.</span><span> </span><span class="NLM_article-title">T-cell receptor signaling to integrins</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">218</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1111%2Fj.1600-065X.2007.00527.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=17624944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSiu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=2007&pages=65-81&author=B.+J.+Burbachauthor=R.+B.+Medeirosauthor=K.+L.+Muellerauthor=Y.+Shimizu&title=T-cell+receptor+signaling+to+integrins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">T-cell receptor signaling to integrins</span></div><div class="casAuthors">Burbach, Brandon J.; Medeiros, Ricardo B.; Mueller, Kristen L.; Shimizu, Yoji</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65-81</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Integrin adhesion receptors are crit. for antigen recognition by T cells and for regulated recirculation and trafficking into and through various tissues in the body.  T-cell receptor (TCR) signaling induces rapid increases in integrin function that facilitate T-cell activation by promoting stable contact with antigen-presenting cells and extracellular proteins in the environment.  In this review, we outline the mol. mechanisms by which the TCR signals to integrins and present a model that highlights four key events:.  (i) initiation of proximal TCR signals nucleated by the linker for activated T cells (LAT) adapter protein and involving Itk, phospholipase C-γ1, Vav1, and Src homol. 2 domain-contg. leukocyte-specific phosphoprotein of 76 kDa;.  (ii) transmission of integrin activation signals from the LAT signalosome to integrins by protein kinase (PK) C and the adapter protein, adhesion and degranulation-promoting adapter protein;.  (iii) assembly of integrin-assocd. signaling complexes that include PKD, the guanosine triphosphatase Rap1 and its effectors, and talin; and.  (iv) reorganization of the actin cytoskeleton by WAVE2 and other actin-remodeling proteins.  These events coordinate changes in integrin conformation and clustering that result in enhanced integrin functional activity following TCR stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP7lwoCheD2bVg90H21EOLACvtfcHk0ljMSowmPoOIfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSiu7%252FK&md5=850a4b10b4c1ef6704a7df4cf3c044cc</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2007.00527.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2007.00527.x%26sid%3Dliteratum%253Aachs%26aulast%3DBurbach%26aufirst%3DB.%2BJ.%26aulast%3DMedeiros%26aufirst%3DR.%2BB.%26aulast%3DMueller%26aufirst%3DK.%2BL.%26aulast%3DShimizu%26aufirst%3DY.%26atitle%3DT-cell%2520receptor%2520signaling%2520to%2520integrins%26jtitle%3DImmunol.%2520Rev.%26date%3D2007%26volume%3D218%26spage%3D65%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sahu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">August, A.</span><span> </span><span class="NLM_article-title">Differential sensitivity to Itk kinase signals for T helper 2 cytokine production and chemokine-mediated migration</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">3833</span><span class="NLM_x">–</span> <span class="NLM_lpage">3838</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=3833-3838&author=N.+Sahuauthor=C.+Muellerauthor=A.+Fischerauthor=A.+August&title=Differential+sensitivity+to+Itk+kinase+signals+for+T+helper+2+cytokine+production+and+chemokine-mediated+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSahu%26aufirst%3DN.%26aulast%3DMueller%26aufirst%3DC.%26aulast%3DFischer%26aufirst%3DA.%26aulast%3DAugust%26aufirst%3DA.%26atitle%3DDifferential%2520sensitivity%2520to%2520Itk%2520kinase%2520signals%2520for%2520T%2520helper%25202%2520cytokine%2520production%2520and%2520chemokine-mediated%2520migration%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D3833%26epage%3D3838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kosaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felices, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, L. J.</span><span> </span><span class="NLM_article-title">Itk and Th2 responses: action but no reaction</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1016%2Fj.it.2006.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=16931156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Cntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=453-460&author=Y.+Kosakaauthor=M.+Felicesauthor=L.+J.+Berg&title=Itk+and+Th2+responses%3A+action+but+no+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Itk and Th2 responses: action but no reaction</span></div><div class="casAuthors">Kosaka, Yoko; Felices, Martin; Berg, Leslie J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Tec family tyrosine kinase, Itk, was initially characterized as a crucial component of T-cell receptor signaling pathways resulting in phospholipase C-γ1 activation and actin polymn.  In 1999, a seminal report by Fowell, Locksley and colleagues demonstrated that, in CD4+ T cells, Itk-dependent signals are differentially required for T-helper (Th)2 vs. Th1 differentiation and effector function.  These findings launched a series of in vitro and in vivo studies addressing the mol. defects of Itk-/- CD4+ T cells, and the impaired immune responses of intact Itk-deficient mice.  While demonstrating a bias against Th2 differentiation, overall these expts. have indicated that the most significant failing is an inability of Itk-/- CD4+ T cells to produce Th2 cytokines in a recall response, rather than an abs. defect in Th2 differentiation by T cells lacking Itk.  In this review, the authors discuss the pathways by which Itk might impact the differentiation of Th cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt4jE6pciDZLVg90H21EOLACvtfcHk0ljMSowmPoOIfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Cntro%253D&md5=12211f8e47c4ff4e1f0ddad9dbae76f7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2006.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2006.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DKosaka%26aufirst%3DY.%26aulast%3DFelices%26aufirst%3DM.%26aulast%3DBerg%26aufirst%3DL.%2BJ.%26atitle%3DItk%2520and%2520Th2%2520responses%253A%2520action%2520but%2520no%2520reaction%26jtitle%3DTrends%2520Immunol.%26date%3D2006%26volume%3D27%26spage%3D453%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Au-Yeung, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowell, D. J.</span><span> </span><span class="NLM_article-title">Cutting edge: Itk-dependent signals required for CD4+ T cells to exert, but not gain, Th2 effector function</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">3895</span><span class="NLM_x">–</span> <span class="NLM_lpage">3899</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=3895-3899&author=B.+B.+Au-Yeungauthor=S.+D.+Katzmanauthor=D.+J.+Fowell&title=Cutting+edge%3A+Itk-dependent+signals+required+for+CD4%2B+T+cells+to+exert%2C+but+not+gain%2C+Th2+effector+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAu-Yeung%26aufirst%3DB.%2BB.%26aulast%3DKatzman%26aufirst%3DS.%2BD.%26aulast%3DFowell%26aufirst%3DD.%2BJ.%26atitle%3DCutting%2520edge%253A%2520Itk-dependent%2520signals%2520required%2520for%2520CD4%252B%2520T%2520cells%2520to%2520exert%252C%2520but%2520not%2520gain%252C%2520Th2%2520effector%2520function%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D176%26spage%3D3895%26epage%3D3899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Gomez-Rodriguez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">August, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P. L.</span><span> </span><span class="NLM_article-title">Differential expression of interleukin-17A and −17F is coupled to T cell receptor signaling via inducible T cell kinase</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2009&pages=587-597&author=J.+Gomez-Rodriguezauthor=N.+Sahuauthor=R.+Handonauthor=T.+S.+Davidsonauthor=S.+M.+Andersonauthor=M.+R.+Kirbyauthor=A.+Augustauthor=P.+L.+Schwartzberg&title=Differential+expression+of+interleukin-17A+and+%E2%88%9217F+is+coupled+to+T+cell+receptor+signaling+via+inducible+T+cell+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Rodriguez%26aufirst%3DJ.%26aulast%3DSahu%26aufirst%3DN.%26aulast%3DHandon%26aufirst%3DR.%26aulast%3DDavidson%26aufirst%3DT.%2BS.%26aulast%3DAnderson%26aufirst%3DS.%2BM.%26aulast%3DKirby%26aufirst%3DM.%2BR.%26aulast%3DAugust%26aufirst%3DA.%26aulast%3DSchwartzberg%26aufirst%3DP.%2BL.%26atitle%3DDifferential%2520expression%2520of%2520interleukin-17A%2520and%2520%25E2%2588%259217F%2520is%2520coupled%2520to%2520T%2520cell%2520receptor%2520signaling%2520via%2520inducible%2520T%2520cell%2520kinase%26jtitle%3DImmunity%26date%3D2009%26volume%3D31%26spage%3D587%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Takesono, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P. L.</span><span> </span><span class="NLM_article-title">Requirement for Tec kinases in chemokine-induced migration and activation of Cdc42 and Rac</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1016%2Fj.cub.2004.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=15186750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvV2gtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=917-922&author=A.+Takesonoauthor=R.+Horaiauthor=M.+Mandaiauthor=D.+Dombroskiauthor=P.+L.+Schwartzberg&title=Requirement+for+Tec+kinases+in+chemokine-induced+migration+and+activation+of+Cdc42+and+Rac"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for Tec Kinases in Chemokine-Induced Migration and Activation of Cdc42 and Rac</span></div><div class="casAuthors">Takesono, Aya; Horai, Reiko; Mandai, Michiko; Dombroski, Derek; Schwartzberg, Pamela L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">917-922</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cell polarization and migration in response to chemokines is essential for proper development of the immune system and activation of immune responses.  Recent studies of chemokine signaling have revealed a crit. role for PI3-Kinase, which is required for polarized membrane assocn. of pleckstrin homol. (PH) domain-contg. proteins and activation of Rho family GTPases that are essential for cell polarization and actin reorganization.  Addnl. data argue that tyrosine kinases are also important for chemokine-induced Rac activation.  However, how and which kinases participate in these pathways remain unclear.  The authors demonstrate here that the Tec kinases Itk and Rlk play an important role in chemokine signaling in T lymphocytes.  Chemokine stimulation induced transient membrane assocn. of Itk and phosphorylation of both Itk and Rlk, and purified T cells from Rlk-/-Itk-/- mice exhibited defective migration to multiple chemokines in vitro and decreased homing to lymph nodes upon transfer to wt mice.  Expression of a dominant-neg. Itk impaired SDF-1α-induced migration, cell polarization, and activation of Rac and Cdc42.  Thus, Tec kinases are crit. components of signaling pathways required for actin polarization downstream from both antigen and chemokine receptors in T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofXj-tMpo3TbVg90H21EOLACvtfcHk0linwq6ijXftXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvV2gtbs%253D&md5=ec927299a684d0eb276b5236cec4c8d8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2004.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2004.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DTakesono%26aufirst%3DA.%26aulast%3DHorai%26aufirst%3DR.%26aulast%3DMandai%26aufirst%3DM.%26aulast%3DDombroski%26aufirst%3DD.%26aulast%3DSchwartzberg%26aufirst%3DP.%2BL.%26atitle%3DRequirement%2520for%2520Tec%2520kinases%2520in%2520chemokine-induced%2520migration%2520and%2520activation%2520of%2520Cdc42%2520and%2520Rac%26jtitle%3DCurr.%2520Biol.%26date%3D2004%26volume%3D14%26spage%3D917%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Fischer, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">August, A.</span><span> </span><span class="NLM_article-title">Regulation of CXC chemokine receptor 4-mediated migration by the Tec family tyrosine kinase ITK</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">29816</span><span class="NLM_x">–</span> <span class="NLM_lpage">29820</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=29816-29820&author=A.+M.+Fischerauthor=J.+C.+Mercerauthor=A.+Iyerauthor=M.+J.+Raginauthor=A.+August&title=Regulation+of+CXC+chemokine+receptor+4-mediated+migration+by+the+Tec+family+tyrosine+kinase+ITK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DA.%2BM.%26aulast%3DMercer%26aufirst%3DJ.%2BC.%26aulast%3DIyer%26aufirst%3DA.%26aulast%3DRagin%26aufirst%3DM.%2BJ.%26aulast%3DAugust%26aufirst%3DA.%26atitle%3DRegulation%2520of%2520CXC%2520chemokine%2520receptor%25204-mediated%2520migration%2520by%2520the%2520Tec%2520family%2520tyrosine%2520kinase%2520ITK%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D29816%26epage%3D29820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Readinger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiralli, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">August, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P. L.</span><span> </span><span class="NLM_article-title">Selective targeting of ITK blocks multiple steps of HIV replication</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">6684</span><span class="NLM_x">–</span> <span class="NLM_lpage">6689</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=6684-6689&author=J.+A.+Readingerauthor=G.+M.+Schiralliauthor=J.+K.+Jiangauthor=C.+J.+Thomasauthor=A.+Augustauthor=A.+J.+Hendersonauthor=P.+L.+Schwartzberg&title=Selective+targeting+of+ITK+blocks+multiple+steps+of+HIV+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReadinger%26aufirst%3DJ.%2BA.%26aulast%3DSchiralli%26aufirst%3DG.%2BM.%26aulast%3DJiang%26aufirst%3DJ.%2BK.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DAugust%26aufirst%3DA.%26aulast%3DHenderson%26aufirst%3DA.%2BJ.%26aulast%3DSchwartzberg%26aufirst%3DP.%2BL.%26atitle%3DSelective%2520targeting%2520of%2520ITK%2520blocks%2520multiple%2520steps%2520of%2520HIV%2520replication%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D6684%26epage%3D6689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lin, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Day, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penhallow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postelnek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Villar, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S. B.</span><span> </span><span class="NLM_article-title">Selective Itk inhibitors block T-cell activation and murine lung inflammation</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">11056</span><span class="NLM_x">–</span> <span class="NLM_lpage">11062</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi049428r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=11056-11062&author=T.+A.+Linauthor=K.+W.+McIntyreauthor=J.+Dasauthor=C.+Liuauthor=K.+D.+O%E2%80%99Dayauthor=B.+Penhallowauthor=C.+Y.+Hungauthor=G.+S.+Whitneyauthor=D.+J.+Shusterauthor=X.+Yangauthor=R.+Townsendauthor=J.+Postelnekauthor=S.+H.+Spergelauthor=J.+Linauthor=R.+V.+Moquinauthor=J.+A.+Furchauthor=A.+V.+Kamathauthor=H.+Zhangauthor=P.+H.+Maratheauthor=J.+J.+Perez-Villarauthor=A.+Doweykoauthor=L.+Killarauthor=J.+H.+Doddauthor=J.+C.+Barrishauthor=J.+Wityakauthor=S.+B.+Kanner&title=Selective+Itk+inhibitors+block+T-cell+activation+and+murine+lung+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fbi049428r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049428r%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.%2BA.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Day%26aufirst%3DK.%2BD.%26aulast%3DPenhallow%26aufirst%3DB.%26aulast%3DHung%26aufirst%3DC.%2BY.%26aulast%3DWhitney%26aufirst%3DG.%2BS.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DTownsend%26aufirst%3DR.%26aulast%3DPostelnek%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DFurch%26aufirst%3DJ.%2BA.%26aulast%3DKamath%26aufirst%3DA.%2BV.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DPerez-Villar%26aufirst%3DJ.%2BJ.%26aulast%3DDoweyko%26aufirst%3DA.%26aulast%3DKillar%26aufirst%3DL.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26atitle%3DSelective%2520Itk%2520inhibitors%2520block%2520T-cell%2520activation%2520and%2520murine%2520lung%2520inflammation%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D11056%26epage%3D11062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Day, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penhallow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span> </span><span class="NLM_article-title">Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3706</span><span class="NLM_x">–</span> <span class="NLM_lpage">3712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3706-3712&author=J.+Dasauthor=J.+A.+Furchauthor=C.+Liuauthor=R.+V.+Moquinauthor=J.+Linauthor=S.+H.+Spergelauthor=K.+W.+McIntyreauthor=D.+J.+Shusterauthor=K.+D.+O%E2%80%99Dayauthor=B.+Penhallowauthor=C.+Y.+Hungauthor=A.+M.+Doweykoauthor=A.+Kamathauthor=H.+Zhangauthor=P.+Maratheauthor=S.+B.+Kannerauthor=T.+A.+Linauthor=J.+H.+Doddauthor=J.+C.+Barrishauthor=J.+Wityak&title=Discovery+and+SAR+of+2-amino-5-%28thioaryl%29thiazoles+as+potent+and+selective+Itk+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DFurch%26aufirst%3DJ.%2BA.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DO%25E2%2580%2599Day%26aufirst%3DK.%2BD.%26aulast%3DPenhallow%26aufirst%3DB.%26aulast%3DHung%26aufirst%3DC.%2BY.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26aulast%3DLin%26aufirst%3DT.%2BA.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DWityak%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520SAR%2520of%25202-amino-5-%2528thioaryl%2529thiazoles%2520as%2520potent%2520and%2520selective%2520Itk%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3706%26epage%3D3712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yingling, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A. S.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelock, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homon, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span> </span><span class="NLM_article-title">Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1177%2F1087057106296047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=17166826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFGgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=70-83&author=M.+A.+Kashemauthor=R.+M.+Nelsonauthor=J.+D.+Yinglingauthor=S.+S.+Pullenauthor=A.+S.+Prokopowiczauthor=J.+W.+Jonesauthor=J.+P.+Wolakauthor=G.+R.+Rogersauthor=M.+M.+Morelockauthor=R.+J.+Snowauthor=C.+A.+Homonauthor=S.+Jakes&title=Three+mechanistically+distinct+kinase+assays+compared%3A+Measurement+of+intrinsic+ATPase+activity+identified+the+most+comprehensive+set+of+ITK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Three mechanistically distinct kinase assays compared: measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors</span></div><div class="casAuthors">Kashem, Mohammed A.; Nelson, Richard M.; Yingling, Jeffrey D.; Pullen, Steven S.; Prokopowicz, Anthony S., III; Jones, Jessi Wildeson; Wolak, John P.; Rogers, George R.; Morelock, Maurice M.; Snow, Roger J.; Homon, Carol Ann; Jakes, Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-83</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Numerous assay methods have been developed to identify small-mol. effectors of protein kinases, but no single method can be applied to all isolated kinases.  The authors developed a set of 3 high-throughput screening (HTS)-compatible biochem. assays that can measure 3 mechanistically distinct properties of a kinase active site, with the goal that at least 1 of the 3 would be applicable to any kinase selected as a target for drug discovery efforts.  Two assays measure catalytically active enzyme: A dissocn.-enhanced lanthanide fluoroimmuno assay (DELFIA) uses an antibody to quantitate the generation of phosphorylated substrate; a second assay uses luciferase to measure the consumption of ATP (ATP) during either phosphoryl-transfer to a peptide substrate or to water (intrinsic ATPase activity).  A third assay, which is not dependent on a catalytically active enzyme, measures the competition for binding to kinase between an inhibitor and a fluorescent ATP binding site probe.  To evaluate the suitability of these assays for drug discovery, the authors compared their ability to identify inhibitors of a nonreceptor protein tyrosine kinase from the Tec family, interleukin-2-inducible T cell kinase (ITK).  The 3 assays agreed on 57% of the combined confirmed hit set identified from screening a 10,208-compd. library enriched with known kinase inhibitors and mols. that were structurally similar.  Among the 3 assays, the one measuring intrinsic ATPase activity produced the largest no. of unique hits, the fewest unique misses, and the most comprehensive hit set, missing only 2.7% of the confirmed inhibitors identified by the other 2 assays combined.  Based on these data, all 3 assay formats are viable for screening and together provide greater options for assay design depending on the targeted kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMYJv4pFA79bVg90H21EOLACvtfcHk0lizf1hfTa461g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFGgs7k%253D&md5=7a9c01e2feca289a556f630277061732</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1177%2F1087057106296047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057106296047%26sid%3Dliteratum%253Aachs%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DNelson%26aufirst%3DR.%2BM.%26aulast%3DYingling%26aufirst%3DJ.%2BD.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DProkopowicz%26aufirst%3DA.%2BS.%26aulast%3DJones%26aufirst%3DJ.%2BW.%26aulast%3DWolak%26aufirst%3DJ.%2BP.%26aulast%3DRogers%26aufirst%3DG.%2BR.%26aulast%3DMorelock%26aufirst%3DM.%2BM.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DHomon%26aufirst%3DC.%2BA.%26aulast%3DJakes%26aufirst%3DS.%26atitle%3DThree%2520mechanistically%2520distinct%2520kinase%2520assays%2520compared%253A%2520Measurement%2520of%2520intrinsic%2520ATPase%2520activity%2520identified%2520the%2520most%2520comprehensive%2520set%2520of%2520ITK%2520inhibitors%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2007%26volume%3D12%26spage%3D70%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Winters, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woska, J. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplita, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DesJarlais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, K. J.</span><span> </span><span class="NLM_article-title">5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5541</span><span class="NLM_x">–</span> <span class="NLM_lpage">5544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5541-5544&author=M.+P.+Wintersauthor=D.+J.+Robinsonauthor=H.+H.+Khineauthor=S.+S.+Pullenauthor=J.+R.+Woskaauthor=E.+L.+Raymondauthor=R.+Sellatiauthor=C.+L.+Cywinauthor=R.+J.+Snowauthor=M.+A.+Kashemauthor=J.+P.+Wolakauthor=J.+Kingauthor=P.+V.+Kaplitaauthor=L.+H.+Liuauthor=T.+M.+Farrellauthor=R.+DesJarlaisauthor=G.+P.+Rothauthor=H.+Takahashiauthor=K.+J.+Moriarty&title=5-Aminomethyl-1H-benzimidazoles+as+orally+active+inhibitors+of+inducible+T-cell+kinase+%28Itk%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWinters%26aufirst%3DM.%2BP.%26aulast%3DRobinson%26aufirst%3DD.%2BJ.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DWoska%26aufirst%3DJ.%2BR.%26aulast%3DRaymond%26aufirst%3DE.%2BL.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DWolak%26aufirst%3DJ.%2BP.%26aulast%3DKing%26aufirst%3DJ.%26aulast%3DKaplita%26aufirst%3DP.%2BV.%26aulast%3DLiu%26aufirst%3DL.%2BH.%26aulast%3DFarrell%26aufirst%3DT.%2BM.%26aulast%3DDesJarlais%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DMoriarty%26aufirst%3DK.%2BJ.%26atitle%3D5-Aminomethyl-1H-benzimidazoles%2520as%2520orally%2520active%2520inhibitors%2520of%2520inducible%2520T-cell%2520kinase%2520%2528Itk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5541%26epage%3D5544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywardane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarko, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span> </span><span class="NLM_article-title">Hit-to-lead studies on benzimidazole inhibitors of ITK: discovery of a novel class of kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3660</span><span class="NLM_x">–</span> <span class="NLM_lpage">3665</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3660-3665&author=R.+J.+Snowauthor=A.+Abeywardaneauthor=S.+Campbellauthor=J.+Lordauthor=M.+A.+Kashemauthor=H.+H.+Khineauthor=J.+Kingauthor=J.+A.+Kowalskiauthor=S.+S.+Pullenauthor=T.+Romaauthor=G.+P.+Rothauthor=C.+R.+Sarkoauthor=N.+S.+Wilsonauthor=M.+P.+Wintersauthor=J.+P.+Wolakauthor=C.+L.+Cywin&title=Hit-to-lead+studies+on+benzimidazole+inhibitors+of+ITK%3A+discovery+of+a+novel+class+of+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DAbeywardane%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DLord%26aufirst%3DJ.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DKing%26aufirst%3DJ.%26aulast%3DKowalski%26aufirst%3DJ.%2BA.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DRoma%26aufirst%3DT.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DSarko%26aufirst%3DC.%2BR.%26aulast%3DWilson%26aufirst%3DN.%2BS.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26aulast%3DWolak%26aufirst%3DJ.%2BP.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26atitle%3DHit-to-lead%2520studies%2520on%2520benzimidazole%2520inhibitors%2520of%2520ITK%253A%2520discovery%2520of%2520a%2520novel%2520class%2520of%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3660%26epage%3D3665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Moriarty, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sallati, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woska, J. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DesJarlais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B.</span><span> </span><span class="NLM_article-title">Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5545</span><span class="NLM_x">–</span> <span class="NLM_lpage">5549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5545-5549&author=K.+J.+Moriartyauthor=H.+Takahashiauthor=S.+S.+Pullenauthor=H.+H.+Khineauthor=R.+H.+Sallatiauthor=E.+L.+Raymondauthor=J.+R.+Woskaauthor=D.+D.+Jeanfavreauthor=G.+P.+Rothauthor=M.+P.+Wintersauthor=L.+Qiaoauthor=D.+Ryanauthor=R.+DesJarlaisauthor=D.+Robinsonauthor=M.+Wilsonauthor=M.+Bobkoauthor=B.+N.+Cookauthor=H.+Y.+Loauthor=P.+A.+Nemotoauthor=M.+A.+Kashemauthor=J.+P.+Wolakauthor=A.+Whiteauthor=R.+L.+Magoldaauthor=B.+Tomczuk&title=Discovery%2C+SAR+and+X-ray+structure+of+1H-benzimidazole-5-carboxylic+acid+cyclohexyl-methyl-amides+as+inhibitors+of+inducible+T-cell+kinase+%28Itk%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DK.%2BJ.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DSallati%26aufirst%3DR.%2BH.%26aulast%3DRaymond%26aufirst%3DE.%2BL.%26aulast%3DWoska%26aufirst%3DJ.%2BR.%26aulast%3DJeanfavre%26aufirst%3DD.%2BD.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26aulast%3DQiao%26aufirst%3DL.%26aulast%3DRyan%26aufirst%3DD.%26aulast%3DDesJarlais%26aufirst%3DR.%26aulast%3DRobinson%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DBobko%26aufirst%3DM.%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DLo%26aufirst%3DH.%2BY.%26aulast%3DNemoto%26aufirst%3DP.%2BA.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DWolak%26aufirst%3DJ.%2BP.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DTomczuk%26aufirst%3DB.%26atitle%3DDiscovery%252C%2520SAR%2520and%2520X-ray%2520structure%2520of%25201H-benzimidazole-5-carboxylic%2520acid%2520cyclohexyl-methyl-amides%2520as%2520inhibitors%2520of%2520inducible%2520T-cell%2520kinase%2520%2528Itk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5545%26epage%3D5549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleymanzadeh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugler, S. Z.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lombaert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=773-777&author=B.+N.+Cookauthor=J.+Bentzienauthor=A.+Whiteauthor=P.+A.+Nemotoauthor=J.+Wangauthor=C.+C.+Manauthor=F.+Soleymanzadehauthor=H.+H.+Khineauthor=M.+A.+Kashemauthor=S.+Z.+Kuglerauthor=J.+P.+Wolakauthor=G.+P.+Rothauthor=S.+De+Lombaertauthor=S.+S.+Pullenauthor=H.+Takahashi&title=Discovery+of+potent+inhibitors+of+interleukin-2+inducible+T-cell+kinase+%28ITK%29+through+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DBentzien%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DNemoto%26aufirst%3DP.%2BA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMan%26aufirst%3DC.%2BC.%26aulast%3DSoleymanzadeh%26aufirst%3DF.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DKugler%26aufirst%3DS.%2BZ.%26aulast%3DWolak%26aufirst%3DJ.%2BP.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitors%2520of%2520interleukin-2%2520inducible%2520T-cell%2520kinase%2520%2528ITK%2529%2520through%2520structure-based%2520drug%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D773%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Riether, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zindell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombaert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugler, S. Z.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woska, J. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labissiere, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">5-Aminomethylbenzimidazoles as potent ITK antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1588</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1588-1591&author=D.+Rietherauthor=R.+Zindellauthor=J.+A.+Kowalskiauthor=B.+N.+Cookauthor=J.+Bentzienauthor=S.+D.+Lombaertauthor=D.+Thomsonauthor=S.+Z.+Kuglerauthor=D.+Skowauthor=L.+S.+Martinauthor=E.+L.+Raymondauthor=H.+H.+Khineauthor=K.+O%E2%80%99Sheaauthor=J.+R.+Woskaauthor=D.+Jeanfavreauthor=R.+Sellatiauthor=K.+L.+Ralphauthor=J.+Ahlbergauthor=G.+Labissiereauthor=M.+A.+Kashemauthor=S.+S.+Pullenauthor=H.+Takahashi&title=5-Aminomethylbenzimidazoles+as+potent+ITK+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiether%26aufirst%3DD.%26aulast%3DZindell%26aufirst%3DR.%26aulast%3DKowalski%26aufirst%3DJ.%2BA.%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DBentzien%26aufirst%3DJ.%26aulast%3DLombaert%26aufirst%3DS.%2BD.%26aulast%3DThomson%26aufirst%3DD.%26aulast%3DKugler%26aufirst%3DS.%2BZ.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DL.%2BS.%26aulast%3DRaymond%26aufirst%3DE.%2BL.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DK.%26aulast%3DWoska%26aufirst%3DJ.%2BR.%26aulast%3DJeanfavre%26aufirst%3DD.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DRalph%26aufirst%3DK.%2BL.%26aulast%3DAhlberg%26aufirst%3DJ.%26aulast%3DLabissiere%26aufirst%3DG.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3D5-Aminomethylbenzimidazoles%2520as%2520potent%2520ITK%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1588%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Charrier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenchley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twin, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keily, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durrant, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knegtel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curnock, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, J. M.</span><span> </span><span class="NLM_article-title">Discovery and structure-activity relationship of 3-aminopyrid-2-ones as potent and selective interleukin-2 inducible T-cell kinase (Itk) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2341</span><span class="NLM_x">–</span> <span class="NLM_lpage">2350</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101499u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2341-2350&author=J.+D.+Charrierauthor=A.+Millerauthor=D.+P.+Kayauthor=G.+Brenchleyauthor=H.+C.+Twinauthor=P.+N.+Collierauthor=S.+Ramayaauthor=S.+B.+Keilyauthor=S.+J.+Durrantauthor=R.+M.+Knegtelauthor=A.+J.+Tannerauthor=K.+Brownauthor=A.+P.+Curnockauthor=J.+M.+Jimenez&title=Discovery+and+structure-activity+relationship+of+3-aminopyrid-2-ones+as+potent+and+selective+interleukin-2+inducible+T-cell+kinase+%28Itk%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm101499u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101499u%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DJ.%2BD.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DKay%26aufirst%3DD.%2BP.%26aulast%3DBrenchley%26aufirst%3DG.%26aulast%3DTwin%26aufirst%3DH.%2BC.%26aulast%3DCollier%26aufirst%3DP.%2BN.%26aulast%3DRamaya%26aufirst%3DS.%26aulast%3DKeily%26aufirst%3DS.%2BB.%26aulast%3DDurrant%26aufirst%3DS.%2BJ.%26aulast%3DKnegtel%26aufirst%3DR.%2BM.%26aulast%3DTanner%26aufirst%3DA.%2BJ.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DCurnock%26aufirst%3DA.%2BP.%26aulast%3DJimenez%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%2520and%2520structure-activity%2520relationship%2520of%25203-aminopyrid-2-ones%2520as%2520potent%2520and%2520selective%2520interleukin-2%2520inducible%2520T-cell%2520kinase%2520%2528Itk%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2341%26epage%3D2350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Knegtel, R. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. D.</span><span> </span><span class="NLM_article-title">A Role for Hydration in interleukin-2 inducible T cell kinase (Itk) selectivity</span> <span class="citation_source-journal">Mol. Inf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">950</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1002%2Fminf.201100086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCqsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=950-959&author=R.+M.+A.+Knegtelauthor=D.+D.+Robinson&title=A+Role+for+Hydration+in+interleukin-2+inducible+T+cell+kinase+%28Itk%29+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A Role for Hydration in Interleukin-2 Inducible T Cell Kinase (Itk) Selectivity</span></div><div class="casAuthors">Knegtel, Ronald M. A.; Robinson, Daniel D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">950-959</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The selectivity profile of kinase inhibitors is commonly explained in terms of favorable or unfavorable interactions between the inhibitor and active site residues.  In practice residue sequence differences have not always been sufficient to explain obsd. selectivity profiles.  A series of interleukin-2 inducible T cell kinase (Itk, EC 2.7.10.2) inhibitors that achieve selectivity through the introduction of a single nitrogen atom in an arom. ring has recently been discovered.  Structures of these inhibitors bound to Itk showed this nitrogen to be solvent exposed and not involved in any direct interactions with the enzyme.  By analyzing active site hydration, using the mol. dynamics tool WaterMap, the obsd. selectivity profile can be explained in terms of the replacement of a thermodynamically unfavorable water mol. by the inhibitor and improved hydration of the bound ligand.  The location of this hydration site was successfully used to enrich virtual screening results in their content of selective Itk inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8WcgSAoEdzLVg90H21EOLACvtfcHk0lj8ffoYOdVwhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCqsbfJ&md5=36ab3cc60f8b794e0664c04a153ba5e1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fminf.201100086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201100086%26sid%3Dliteratum%253Aachs%26aulast%3DKnegtel%26aufirst%3DR.%2BM.%2BA.%26aulast%3DRobinson%26aufirst%3DD.%2BD.%26atitle%3DA%2520Role%2520for%2520Hydration%2520in%2520interleukin-2%2520inducible%2520T%2520cell%2520kinase%2520%2528Itk%2529%2520selectivity%26jtitle%3DMol.%2520Inf.%26date%3D2011%26volume%3D30%26spage%3D950%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Flynn, G. A.; Lee, S. A.; Faris, M.; Brandt, D. W.; Chakravarty, S.</span><span> </span><span class="NLM_article-title">Intracellular Kinase Inhibitors</span>. US 2007/0293499 A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=G.+A.+Flynn&author=S.+A.+Lee&author=M.+Faris&author=D.+W.+Brandt&author=S.+Chakravarty&title=Intracellular+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFlynn%26aufirst%3DG.%2BA.%26atitle%3DIntracellular%2520Kinase%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Alder, C. M.; Baldwin, I. R.; Barton, N. P.; Campbell, A. J.; Champigny, A. C.; Harling, J. D.; Maxwell, A. C.</span><span> </span><span class="NLM_article-title">Derivatives of 2-[2-(Benzo- or Pyrido-)thiazolylamino]-6-aminopyridine, Useful in the Treatment of Respiratoric, Allergic or Inflammatory Diseases</span>. WO 2011/110575 Al,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+M.+Alder&author=I.+R.+Baldwin&author=N.+P.+Barton&author=A.+J.+Campbell&author=A.+C.+Champigny&author=J.+D.+Harling&author=A.+C.+Maxwell&title=Derivatives+of+2-%5B2-%28Benzo-+or+Pyrido-%29thiazolylamino%5D-6-aminopyridine%2C+Useful+in+the+Treatment+of+Respiratoric%2C+Allergic+or+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlder%26aufirst%3DC.%2BM.%26atitle%3DDerivatives%2520of%25202-%255B2-%2528Benzo-%2520or%2520Pyrido-%2529thiazolylamino%255D-6-aminopyridine%252C%2520Useful%2520in%2520the%2520Treatment%2520of%2520Respiratoric%252C%2520Allergic%2520or%2520Inflammatory%2520Diseases%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Maxwell, A. C.; Alder, C.; Ambler, M.; Campbell, A.; Champigny, A.; Harling, J.; Scullion, C.; Smith, I.; Somers, D.; Tame, C.; Wilson, C.; Woolven, J.</span> In  <span class="citation_source-book">Identification of Novel and Selective ITK Inhibitors through a Template Hopping Strategy</span>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">MEDI-8</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=MEDI-8&author=A.+C.+Maxwell&author=C.+Alder&author=M.+Ambler&author=A.+Campbell&author=A.+Champigny&author=J.+Harling&author=C.+Scullion&author=I.+Smith&author=D.+Somers&author=C.+Tame&author=C.+Wilson&author=J.+Woolven&title=Identification+of+Novel+and+Selective+ITK+Inhibitors+through+a+Template+Hopping+Strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DA.%2BC.%26btitle%3DIdentification%2520of%2520Novel%2520and%2520Selective%2520ITK%2520Inhibitors%2520through%2520a%2520Template%2520Hopping%2520Strategy%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2011%26spage%3DMEDI-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28K1%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lg7G8qEIngpCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span> </span><span class="NLM_article-title">Biochemical mechanisms of drug action: what does it take for success?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=801-808&author=D.+C.+Swinney&title=Biochemical+mechanisms+of+drug+action%3A+what+does+it+take+for+success%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26atitle%3DBiochemical%2520mechanisms%2520of%2520drug%2520action%253A%2520what%2520does%2520it%2520take%2520for%2520success%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D801%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bogoyevitch, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">622</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=622-633&author=M.+A.+Bogoyevitchauthor=D.+P.+Fairlie&title=A+new+paradigm+for+protein+kinase+inhibition%3A+blocking+phosphorylation+without+directly+targeting+ATP+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBogoyevitch%26aufirst%3DM.%2BA.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DA%2520new%2520paradigm%2520for%2520protein%2520kinase%2520inhibition%253A%2520blocking%2520phosphorylation%2520without%2520directly%2520targeting%2520ATP%2520binding%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D622%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Harrison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karim, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclean, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D.</span><span> </span><span class="NLM_article-title">Non-ATP-competitive kinase inhibitors: enhancing selectivity through new inhibition strategies</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=761-774&author=S.+Harrisonauthor=K.+Dasauthor=F.+Karimauthor=D.+Macleanauthor=D.+Mendel&title=Non-ATP-competitive+kinase+inhibitors%3A+enhancing+selectivity+through+new+inhibition+strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DKarim%26aufirst%3DF.%26aulast%3DMaclean%26aufirst%3DD.%26aulast%3DMendel%26aufirst%3DD.%26atitle%3DNon-ATP-competitive%2520kinase%2520inhibitors%253A%2520enhancing%2520selectivity%2520through%2520new%2520inhibition%2520strategies%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D761%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Navratilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A.</span><span> </span><span class="NLM_article-title">Biosensor-based approach to the identification of protein kinase ligands with dual-site modes of action</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1177%2F1087057111422746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=22068706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVKltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=183-193&author=I.+Navratilovaauthor=G.+Macdonaldauthor=C.+Robinsonauthor=S.+Hughesauthor=J.+Mathiasauthor=C.+Phillipsauthor=A.+Cook&title=Biosensor-based+approach+to+the+identification+of+protein+kinase+ligands+with+dual-site+modes+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Biosensor-based approach to the identification of protein kinase ligands with dual-site modes of action</span></div><div class="casAuthors">Navratilova, Iva; MacDonald, Graeme; Robinson, Colin; Hughes, Samantha; Mathias, John; Phillips, Chris; Cook, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-193</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The authors have used a surface plasmon resonance (SPR)-based biosensor approach to identify and characterize compds. with a unique binding mode to protein kinases.  Biacore was used to characterize hits from an enzymic high-throughput screen of the Tec family tyrosine kinase, IL2-inducible T cell kinase (ITK).  Complex binding kinetics was obsd. for some compds., which led to identification of compds. that bound simultaneously at both the ATP binding site and a second, allosteric site on ITK.  The presence of the second binding site was confirmed by X-ray crystallog.  The second site is located in the N-terminal lobe of the protein kinase catalytic domain, adjacent to but distinct from the ATP site.  To enable rapid optimization of binding properties, a competition-based Biacore assay has been developed to successfully identify second site noncompetitive binders that have been confirmed by X-ray crystallog. studies.  The authors have found that SPR technol. is a key method for rapid identification of compds. with dual-site modes of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_O18si5LWPLVg90H21EOLACvtfcHk0lg7G8qEIngpCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVKltL8%253D&md5=8860bb955a27b7ba6b167725224c9e60</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1177%2F1087057111422746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057111422746%26sid%3Dliteratum%253Aachs%26aulast%3DNavratilova%26aufirst%3DI.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%26aulast%3DMathias%26aufirst%3DJ.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DA.%26atitle%3DBiosensor-based%2520approach%2520to%2520the%2520identification%2520of%2520protein%2520kinase%2520ligands%2520with%2520dual-site%2520modes%2520of%2520action%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D183%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Han, S.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Han%2C+S.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Robertson, J. G.</span><span> </span><span class="NLM_article-title">Mechanistic basis of enzyme-targeted drugs</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5561</span><span class="NLM_x">–</span> <span class="NLM_lpage">5571</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi050247e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5561-5571&author=J.+G.+Robertson&title=Mechanistic+basis+of+enzyme-targeted+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi050247e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi050247e%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26atitle%3DMechanistic%2520basis%2520of%2520enzyme-targeted%2520drugs%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D5561%26epage%3D5571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0lgLB1WNw7EaLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Schwobel, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koleva, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enoch, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madden, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, M. T.</span><span> </span><span class="NLM_article-title">Measurement and estimation of electrophilic reactivity for predictive toxicology</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">2562</span><span class="NLM_x">–</span> <span class="NLM_lpage">2596</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr100098n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=2562-2596&author=J.+A.+Schwobelauthor=Y.+K.+Kolevaauthor=S.+J.+Enochauthor=F.+Bajotauthor=M.+Hewittauthor=J.+C.+Maddenauthor=D.+W.+Robertsauthor=T.+W.+Schultzauthor=M.+T.+Cronin&title=Measurement+and+estimation+of+electrophilic+reactivity+for+predictive+toxicology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcr100098n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr100098n%26sid%3Dliteratum%253Aachs%26aulast%3DSchwobel%26aufirst%3DJ.%2BA.%26aulast%3DKoleva%26aufirst%3DY.%2BK.%26aulast%3DEnoch%26aufirst%3DS.%2BJ.%26aulast%3DBajot%26aufirst%3DF.%26aulast%3DHewitt%26aufirst%3DM.%26aulast%3DMadden%26aufirst%3DJ.%2BC.%26aulast%3DRoberts%26aufirst%3DD.%2BW.%26aulast%3DSchultz%26aufirst%3DT.%2BW.%26aulast%3DCronin%26aufirst%3DM.%2BT.%26atitle%3DMeasurement%2520and%2520estimation%2520of%2520electrophilic%2520reactivity%2520for%2520predictive%2520toxicology%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D2562%26epage%3D2596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maderna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnute, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashiro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lussier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrocklage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soutter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunussi-Joannopoulos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douhan, J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6258</span><span class="NLM_x">–</span> <span class="NLM_lpage">6263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6258-6263&author=K.+H.+Kimauthor=A.+Madernaauthor=M.+E.+Schnuteauthor=M.+Hegenauthor=S.+Mohanauthor=J.+Miyashiroauthor=L.+Linauthor=E.+Liauthor=S.+Keeganauthor=J.+Lussierauthor=C.+Wrocklageauthor=C.+L.+Nickerson-Nutterauthor=A.+J.+Wittwerauthor=H.+Soutterauthor=N.+Caspersauthor=S.+Hanauthor=R.+Kurumbailauthor=K.+Dunussi-Joannopoulosauthor=J.+Douhanauthor=A.+Wissner&title=Imidazo%5B1%2C5-a%5Dquinoxalines+as+irreversible+BTK+inhibitors+for+the+treatment+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DMaderna%26aufirst%3DA.%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DMiyashiro%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DE.%26aulast%3DKeegan%26aufirst%3DS.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DWrocklage%26aufirst%3DC.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DSoutter%26aufirst%3DH.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DDunussi-Joannopoulos%26aufirst%3DK.%26aulast%3DDouhan%26aufirst%3DJ.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DImidazo%255B1%252C5-a%255Dquinoxalines%2520as%2520irreversible%2520BTK%2520inhibitors%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6258%26epage%3D6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Pan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheerens, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprengeler, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrill, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grothaus, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoerke, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigberg, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalrymple, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span> </span><span class="NLM_article-title">Discovery of selective irreversible inhibitors for Bruton’s tyrosine kinase</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=58-61&author=Z.+Panauthor=H.+Scheerensauthor=S.+J.+Liauthor=B.+E.+Schultzauthor=P.+A.+Sprengelerauthor=L.+C.+Burrillauthor=R.+V.+Mendoncaauthor=M.+D.+Sweeneyauthor=K.+C.+Scottauthor=P.+G.+Grothausauthor=D.+A.+Jefferyauthor=J.+M.+Spoerkeauthor=L.+A.+Honigbergauthor=P.+R.+Youngauthor=S.+A.+Dalrympleauthor=J.+T.+Palmer&title=Discovery+of+selective+irreversible+inhibitors+for+Bruton%E2%80%99s+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DScheerens%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%2BJ.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DBurrill%26aufirst%3DL.%2BC.%26aulast%3DMendonca%26aufirst%3DR.%2BV.%26aulast%3DSweeney%26aufirst%3DM.%2BD.%26aulast%3DScott%26aufirst%3DK.%2BC.%26aulast%3DGrothaus%26aufirst%3DP.%2BG.%26aulast%3DJeffery%26aufirst%3DD.%2BA.%26aulast%3DSpoerke%26aufirst%3DJ.%2BM.%26aulast%3DHonigberg%26aufirst%3DL.%2BA.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DDalrymple%26aufirst%3DS.%2BA.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26atitle%3DDiscovery%2520of%2520selective%2520irreversible%2520inhibitors%2520for%2520Bruton%25E2%2580%2599s%2520tyrosine%2520kinase%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D58%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Honigberg, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisawad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loury, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thamm, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span> </span><span class="NLM_article-title">The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">13075</span><span class="NLM_x">–</span> <span class="NLM_lpage">13080</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1073%2Fpnas.1004594107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=20615965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=13075-13080&author=L.+A.+Honigbergauthor=A.+M.+Smithauthor=M.+Sirisawadauthor=E.+Vernerauthor=D.+Louryauthor=B.+Changauthor=S.+Liauthor=Z.+Panauthor=D.+H.+Thammauthor=R.+A.+Millerauthor=J.+J.+Buggy&title=The+Bruton+tyrosine+kinase+inhibitor+PCI-32765+blocks+B-cell+activation+and+is+efficacious+in+models+of+autoimmune+disease+and+B-cell+malignancy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy</span></div><div class="casAuthors">Honigberg, Lee A.; Smith, Ashley M.; Sirisawad, Mint; Verner, Erik; Loury, David; Chang, Betty; Li, Shyr; Pan, Zhengying; Thamm, Douglas H.; Miller, Richard A.; Buggy, Joseph J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">13075-13080, S13075/1-S13075/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Activation of the B-cell antigen receptor (BCR) signaling pathway contributes to the initiation and maintenance of B-cell malignancies and autoimmune diseases.  The Bruton tyrosine kinase (Btk) is specifically required for BCR signaling as demonstrated by human and mouse mutations that disrupt Btk function and prevent B-cell maturation at steps that require a functional BCR pathway.  Herein we describe a selective and irreversible Btk inhibitor, PCI-32765, that is currently under clin. development in patients with B-cell non-Hodgkin lymphoma.  We have used this inhibitor to investigate the biol. effects of Btk inhibition on mature B-cell function and the progression of B cell-assocd. diseases in vivo.  PCI-32765 blocked BCR signaling in human peripheral B cells at concns. that did not affect T cell receptor signaling.  In mice with collagen-induced arthritis, orally administered PCI-32765 reduced the level of circulating autoantibodies and completely suppressed disease.  PCI-32765 also inhibited autoantibody prodn. and the development of kidney disease in the MRL-Fas(lpr) lupus model.  Occupancy of the Btk active site by PCI-32765 was monitored in vitro and in vivo using a fluorescent affinity probe for Btk.  Active site occupancy of Btk was tightly correlated with the blockade of BCR signaling and in vivo efficacy.  Finally, PCI-32765 induced objective clin. responses in dogs with spontaneous B-cell non-Hodgkin lymphoma.  These findings support Btk inhibition as a therapeutic approach for the treatment of human diseases assocd. with activation of the BCR pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT4OQHme7oHLVg90H21EOLACvtfcHk0lhYvjYbWkpMbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCrsbk%253D&md5=196ce4a05bb9c622c49cb7e908682e63</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1004594107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1004594107%26sid%3Dliteratum%253Aachs%26aulast%3DHonigberg%26aufirst%3DL.%2BA.%26aulast%3DSmith%26aufirst%3DA.%2BM.%26aulast%3DSirisawad%26aufirst%3DM.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DLoury%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DThamm%26aufirst%3DD.%2BH.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Bruton%2520tyrosine%2520kinase%2520inhibitor%2520PCI-32765%2520blocks%2520B-cell%2520activation%2520and%2520is%2520efficacious%2520in%2520models%2520of%2520autoimmune%2520disease%2520and%2520B-cell%2520malignancy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D13075%26epage%3D13080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">The development of HKI-272 and related compounds for the treatment of cancer</span> <span class="citation_source-journal">Arch. Pharm. (Weinheim, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1002%2Fardp.200800009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=18493974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKnsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2008&pages=465-477&author=A.+Wissnerauthor=T.+S.+Mansour&title=The+development+of+HKI-272+and+related+compounds+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The development of HKI-272 and related compounds for the treatment of cancer</span></div><div class="casAuthors">Wissner, Allan; Mansour, Tarek S.</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">465-477</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The development of HKI-272 and EKB-569 for the treatment of cancer is described.  These compds. function as irreversible inhibitors of some members of the ErbB family of receptor tyrosine kinases.  In particular, they target epidermal growth factor receptor (EGFR, also known as ErbB-1) and human epidermal growth factor receptor-2 (HER2, also known as ErbB-2).  Both, HKI-272 and EKB-569 are 4-anilino-3-cyano quinoline derivs. that contain a 4-(dimethylamino)crotonamide Michael-acceptor group at the 6-position.  These compds. inhibit the function of the target enzymes by forming a covalent interaction with a conserved cysteine residue located in the kinase domains of these proteins.  The potential advantages of using irreversible inhibitors for this purpose are discussed.  We summarize the recent findings concerning some somatic mutations in EGFR and their relevance with respect to the irreversible inhibitors.  In particular, we highlight the findings that these irreversible inhibitors retain activity against tumors that have acquired a resistance to the reversible binding inhibitors gefitinib and erlotinib.  The promising interim clin. trial results for HKI-272 and EKB-569 in treating colon, lung, and breast cancers are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCSokM42ZhprVg90H21EOLACvtfcHk0lhYvjYbWkpMbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKnsb7E&md5=2e46d99ca74e297e6a7e860634bf096d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fardp.200800009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200800009%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DThe%2520development%2520of%2520HKI-272%2520and%2520related%2520compounds%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%252C%2520Ger.%2529%26date%3D2008%26volume%3D341%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Nakayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, O.</span><span> </span><span class="NLM_article-title">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1970</span><span class="NLM_x">–</span> <span class="NLM_lpage">1977</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1124%2Fdmd.109.027797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=19487250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1970-1977&author=S.+Nakayamaauthor=R.+Atsumiauthor=H.+Takakusaauthor=Y.+Kobayashiauthor=A.+Kuriharaauthor=Y.+Nagaiauthor=D.+Nakaiauthor=O.+Okazaki&title=A+zone+classification+system+for+risk+assessment+of+idiosyncratic+drug+toxicity+using+daily+dose+and+covalent+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span></div><div class="casAuthors">Nakayama, Shintaro; Atsumi, Ryo; Takakusa, Hideo; Kobayashi, Yoshimasa; Kurihara, Atsushi; Nagai, Yoko; Nakai, Daisuke; Okazaki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1970-1977</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The risk of idiosyncratic drug toxicity (IDT) is of great concern to the pharmaceutical industry.  Current hypotheses based on retrospective studies suggest that the occurrence of IDT is related to covalent binding and daily dose.  The authors detd. the covalent binding of 42 radiolabeled drugs in three test systems (human liver microsomes and hepatocytes in vitro and rat liver in vivo) to assess the risk of IDT.  On the basis of safety profiles given in official documentation, tested drugs were classified into the safety categories of safe, warning, black box warning, and withdrawn.  The covalent binding in each of the three test systems did not distinguish the safety categories clearly.  However, when the log-normalized covalent binding was plotted against the log-normalized daily dose, the distribution of the plot in the safety categories became clear.  An ordinal logistic regression anal. indicated that both covalent binding and daily dose were significantly correlated with safety category and that covalent binding in hepatocytes was the best predictor among the three systems.  When two sepn. lines were drawn on the correlation graph between covalent binding in human hepatocytes and daily dose by a regression anal. to create three zones, 30 of 37 tested drugs were located in zones corresponding to their resp. classified safety categories.  In conclusion, the authors established a zone classification system using covalent binding in human hepatocytes and daily dose for the risk assessment of IDTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtahZPkNJ3JbVg90H21EOLACvtfcHk0lhYvjYbWkpMbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO&md5=425119e0451fc50ec6ca95d5e3fe5fd3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.027797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.027797%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DAtsumi%26aufirst%3DR.%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DA.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DNakai%26aufirst%3DD.%26aulast%3DOkazaki%26aufirst%3DO.%26atitle%3DA%2520zone%2520classification%2520system%2520for%2520risk%2520assessment%2520of%2520idiosyncratic%2520drug%2520toxicity%2520using%2520daily%2520dose%2520and%2520covalent%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1970%26epage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="note"><p class="first last">Please see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for more details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Naramura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Band, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Band, H.</span><span> </span><span class="NLM_article-title">Indispensable roles of mammalian Cbl family proteins as negative regulators of protein tyrosine kinase signaling: Insights from in vivo models</span> <span class="citation_source-journal">Commun. Integr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.4161%2Fcib.4.2.14716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=21655429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVahsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=159-162&author=M.+Naramuraauthor=V.+Bandauthor=H.+Band&title=Indispensable+roles+of+mammalian+Cbl+family+proteins+as+negative+regulators+of+protein+tyrosine+kinase+signaling%3A+Insights+from+in+vivo+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Indispensable roles of mammalian Cbl family proteins as negative regulators of protein tyrosine kinase signaling - insights from in vivo models</span></div><div class="casAuthors">Naramura, Mayumi; Band, Vimla; Band, Hamid</div><div class="citationInfo"><span class="NLM_cas:title">Communicative & Integrative Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-162</span>CODEN:
                <span class="NLM_cas:coden">CIBOBQ</span>;
        ISSN:<span class="NLM_cas:issn">1942-0889</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  All higher eukaryotes utilize protein tyrosine kinases (PTKs) as mol. switches to control a variety of cellular signals.  Notably, many PTKs have been identified as proto-oncogenes whose aberrant expression, mutations or co-option by pathogens can lead to human malignancies.  Thus, it is obvious that PTK functions must be precisely regulated in order to maintain homeostasis of an organism.  Investigations over the past fifteen years have revealed that members of the Cbl family proteins can serve as neg. regulators of PTK signaling, and biochem. and cell biol. studies have unraveled the mechanistic basis of this regulation.  Yet, it is only recently that the field has begun to appreciate the real significance of this novel regulatory app. in shaping PTK-mediated signaling in organismic contexts and in human diseases.  Here, we discuss recent progress in murine models that are beginning to provide insights into the crit. roles of Cbl proteins in physiol. pathways, with important implications in understanding how aberrations of Cbl proteins contribute to oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRtiJqFyqaC7Vg90H21EOLACvtfcHk0lgn0nP2nt5tSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVahsLk%253D&md5=d9e876f139b2f1db11d15af705a46258</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.4161%2Fcib.4.2.14716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcib.4.2.14716%26sid%3Dliteratum%253Aachs%26aulast%3DNaramura%26aufirst%3DM.%26aulast%3DBand%26aufirst%3DV.%26aulast%3DBand%26aufirst%3DH.%26atitle%3DIndispensable%2520roles%2520of%2520mammalian%2520Cbl%2520family%2520proteins%2520as%2520negative%2520regulators%2520of%2520protein%2520tyrosine%2520kinase%2520signaling%253A%2520Insights%2520from%2520in%2520vivo%2520models%26jtitle%3DCommun.%2520Integr.%2520Biol.%26date%3D2011%26volume%3D4%26spage%3D159%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Katkere, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, J. R.</span><span> </span><span class="NLM_article-title">The Syk-binding ubiquitin ligase c-Cbl mediates signaling-dependent B cell receptor ubiquitination and B cell receptor-mediated antigen processing and presentation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">16636</span><span class="NLM_x">–</span> <span class="NLM_lpage">16644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=16636-16644&author=B.+Katkereauthor=S.+Rosaauthor=J.+R.+Drake&title=The+Syk-binding+ubiquitin+ligase+c-Cbl+mediates+signaling-dependent+B+cell+receptor+ubiquitination+and+B+cell+receptor-mediated+antigen+processing+and+presentation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatkere%26aufirst%3DB.%26aulast%3DRosa%26aufirst%3DS.%26aulast%3DDrake%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Syk-binding%2520ubiquitin%2520ligase%2520c-Cbl%2520mediates%2520signaling-dependent%2520B%2520cell%2520receptor%2520ubiquitination%2520and%2520B%2520cell%2520receptor-mediated%2520antigen%2520processing%2520and%2520presentation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D16636%26epage%3D16644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Paolino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thien, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterleitner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baier, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langdon, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penninger, J. M.</span><span> </span><span class="NLM_article-title">Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">2138</span><span class="NLM_x">–</span> <span class="NLM_lpage">2147</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=2138-2147&author=M.+Paolinoauthor=C.+B.+Thienauthor=T.+Gruberauthor=R.+Hinterleitnerauthor=G.+Baierauthor=W.+Y.+Langdonauthor=J.+M.+Penninger&title=Essential+role+of+E3+ubiquitin+ligase+activity+in+Cbl-b-regulated+T+cell+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaolino%26aufirst%3DM.%26aulast%3DThien%26aufirst%3DC.%2BB.%26aulast%3DGruber%26aufirst%3DT.%26aulast%3DHinterleitner%26aufirst%3DR.%26aulast%3DBaier%26aufirst%3DG.%26aulast%3DLangdon%26aufirst%3DW.%2BY.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26atitle%3DEssential%2520role%2520of%2520E3%2520ubiquitin%2520ligase%2520activity%2520in%2520Cbl-b-regulated%2520T%2520cell%2520functions%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D2138%26epage%3D2147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="note"><p class="first last">Compound <b>41</b> (PF-06465469) is now commercially available from Sigma-Aldrich Corp. (St. Louis, MO), Tocris Bioscience (Bristol, U.K.), or Toronto Research Chemicals, Inc. (North York, ON, Canada).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Kawasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freire, E.</span><span> </span><span class="NLM_article-title">Finding a better path to drug selectivity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">990</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1016%2Fj.drudis.2011.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=21839183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWktbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=985-990&author=Y.+Kawasakiauthor=E.+Freire&title=Finding+a+better+path+to+drug+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Finding a better path to drug selectivity</span></div><div class="casAuthors">Kawasaki, Yuko; Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">985-990</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Extremely high affinity and selectivity are two of the most sought-after properties of drug mols.  Selectivity has been difficult to achieve, esp. for targets that belong to large families of structurally and functionally related proteins.  There are essentially two ways by which selectivity can be improved during lead optimization: a chem. modification of the lead compd. that improves the affinity towards the target to a higher extent than to off-target mols.; and a chem. modification that lowers the affinity of the lead compd. towards off-target mols.  Maximal selectivity is achieved when both mechanisms can be combined synergistically.  As we discuss here, anal. of several protease inhibitors that vary in a single functionality indicates that nonpolar functionalities preferentially follow the first mechanism, whereas polar functionalities follow the second, and that those features are imprinted in their thermodn. signatures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGj1IsjIk4bbVg90H21EOLACvtfcHk0lgn0nP2nt5tSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWktbjF&md5=68ab56fd05adcdc61d12ee955b0fddc5</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DKawasaki%26aufirst%3DY.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DFinding%2520a%2520better%2520path%2520to%2520drug%2520selectivity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D985%26epage%3D990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boatman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMillan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finzel, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span> </span><span class="NLM_article-title">Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1804</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">–</span> <span class="NLM_lpage">1831</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=1817-1831&author=Z.+Wangauthor=W.+Wattauthor=N.+A.+Brooksauthor=M.+S.+Harrisauthor=J.+Urbanauthor=D.+Boatmanauthor=M.+McMillanauthor=M.+Kahnauthor=R.+L.+Heinriksonauthor=B.+C.+Finzelauthor=A.+J.+Wittwerauthor=J.+Blinnauthor=S.+Kamtekarauthor=A.+G.+Tomasselli&title=Kinetic+and+structural+characterization+of+caspase-3+and+caspase-8+inhibition+by+a+novel+class+of+irreversible+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWatt%26aufirst%3DW.%26aulast%3DBrooks%26aufirst%3DN.%2BA.%26aulast%3DHarris%26aufirst%3DM.%2BS.%26aulast%3DUrban%26aufirst%3DJ.%26aulast%3DBoatman%26aufirst%3DD.%26aulast%3DMcMillan%26aufirst%3DM.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DFinzel%26aufirst%3DB.%2BC.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DBlinn%26aufirst%3DJ.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26atitle%3DKinetic%2520and%2520structural%2520characterization%2520of%2520caspase-3%2520and%2520caspase-8%2520inhibition%2520by%2520a%2520novel%2520class%2520of%2520irreversible%2520inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1804%26spage%3D1817%26epage%3D1831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrusin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haske, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span> </span><span class="NLM_article-title">Structure-based design of a potent, selective, and irreversible inhibitor of the catalytic domain of the erbB receptor subfamily of protein tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1130</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960380s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADyaK2sXitFGmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1130-1135&author=J.+Singhauthor=E.+M.+Dobrusinauthor=D.+W.+Fryauthor=T.+Haskeauthor=A.+Whittyauthor=D.+J.+McNamara&title=Structure-based+design+of+a+potent%2C+selective%2C+and+irreversible+inhibitor+of+the+catalytic+domain+of+the+erbB+receptor+subfamily+of+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases</span></div><div class="casAuthors">Singh, Juswinder; Dobrusin, Ellen M.; Fry, David W.; Haske, Taraneh; Whitty, Adrian; McNamara, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1130-1135</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the use of structure-based drug design to create a selective erbB-1 (a.k.a. epidermal growth factor receptor) and erbB-2 (a.k.a. neu/her2 growth factor receptor) tyrosine kinase inhibitor.  Using the x-ray crystal structure of the ternary complex of the cAMP-dependent Ser/Thr kinase together with a sequence alignment of the catalytic domains of a representative set of Ser/Thr and Tyr protein kinases, the authors have examd. the nucleotide binding site for potential positions to attach an irreversible inhibitor.  This information, combined with homol. modeling of the erbB-1 and erbB-2 tyrosine kinase catalytic domains, has led to the identification of Cys797 of erbB1 and Cys805 of erbB2, which are structurally equiv. to Glu127 in the cAMP dependent Ser/Thr kinase as potential target residues.  The x-ray structure of the cAMP Ser/Thr kinase shows Glu127 to be involved in a hydrogen-bonding interaction with the 2'-OH of the ribose portion of ATP.  Using mol. modeling, it was predicted that the Cys side chains in erbB-1 and erbB-2 performed an analogous role, and it was postulated that the replacement of the 2'-OH of adenosine with a thiol might allow for a covalent bond to form.  Since only erbB-1 and erbB-2 have a Cys at this position, the inhibitor should be selective.  This model was subsequently tested exptl. by chem. synthesis of 2'-thioadenosine and assayed against the full length erbB-1 receptor and the catalytic domains of erbB-2, insulin receptor, β-PDGF receptor, and the FGF receptor.  The results show that thioadenosine covalently inactivates erbB-1 with a second-order rate const. of kmax/KS = 2000 M-1 s-1.  Inactivation is fully reversed by 1 mM dithiothreitol, suggesting that inactivation involves the modification of a cysteine residue at the active site, presumably Cys797.  The rate of inactivation sats. with increasing thioadenosine concns., suggesting that inactivation occurs through initial formation of a noncovalent complex with KD = 1.0 μM, followed by the slow formation of a disulfide bond with a rate const. of kmax = (2.3) × 10-3 s-1.  This approach may have application in the design of selective irreversible inhibitors against other members of the kinase family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6EaHMhyfSKbVg90H21EOLACvtfcHk0lgzGOIBkLPUPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitFGmu74%253D&md5=161daa8b5c2e8a88d8e48dd102ac1e49</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm960380s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960380s%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DDobrusin%26aufirst%3DE.%2BM.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DHaske%26aufirst%3DT.%26aulast%3DWhitty%26aufirst%3DA.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26atitle%3DStructure-based%2520design%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520irreversible%2520inhibitor%2520of%2520the%2520catalytic%2520domain%2520of%2520the%2520erbB%2520receptor%2520subfamily%2520of%2520protein%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1130%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':[],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':[],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 50 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Levente M. Mihalovits, György G. Ferenczy, <span class="NLM_string-name hlFld-ContribAuthor">György M. Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Affinity and Selectivity Assessment of Covalent Inhibitors by Free Energy Calculations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (12)
                                     , 6579-6594. <a href="https://doi.org/10.1021/acs.jcim.0c00834" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00834</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00834%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAffinity%252Band%252BSelectivity%252BAssessment%252Bof%252BCovalent%252BInhibitors%252Bby%252BFree%252BEnergy%252BCalculations%26aulast%3DMihalovits%26aufirst%3DLevente%2BM.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22072020%26date%3D09122020%26volume%3D60%26issue%3D12%26spage%3D6579%26epage%3D6594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robin A. Fairhurst, Thomas Knoepfel, Nicole Buschmann, Catherine Leblanc, Robert Mah, Milen Todorov, Pierre Nimsgern, Sebastien Ripoche, Michel Niklaus, Nicolas Warin, Van Huy Luu, Mario Madoerin, Jasmin Wirth, Diana Graus-Porta, Andreas Weiss, Michael Kiffe, Markus Wartmann, Jacqueline Kinyamu-Akunda, Dario Sterker, Christelle Stamm, Flavia Adler, Alexandra Buhles, Heiko Schadt, Philippe Couttet, Jutta Blank, Inga Galuba, Jörg Trappe, Johannes Voshol, Nils Ostermann, Chao Zou, Jörg Berghausen, Alberto Del Rio Espinola, Wolfgang Jahnke, <span class="NLM_string-name hlFld-ContribAuthor">Pascal Furet</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12542-12573. <a href="https://doi.org/10.1021/acs.jmedchem.0c01019" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BRoblitinib%252B%252528FGF401%252529%252Bas%252Ba%252BReversible-Covalent%252BInhibitor%252Bof%252Bthe%252BKinase%252BActivity%252Bof%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252B4%26aulast%3DFairhurst%26aufirst%3DRobin%2BA.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15062020%26date%3D01102020%26date%3D15092020%26volume%3D63%26issue%3D21%26spage%3D12542%26epage%3D12573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthias Gehringer, <span class="NLM_string-name hlFld-ContribAuthor">Stefan A. Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (12)
                                     , 5673-5724. <a href="https://doi.org/10.1021/acs.jmedchem.8b01153" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01153%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEmerging%252Band%252BRe-Emerging%252BWarheads%252Bfor%252BTargeted%252BCovalent%252BInhibitors%25253A%252BApplications%252Bin%252BMedicinal%252BChemistry%252Band%252BChemical%252BBiology%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D23072018%26date%3D25012019%26date%3D19122018%26volume%3D62%26issue%3D12%26spage%3D5673%26epage%3D5724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hua Xu, Michael I. Jesson, Uthpala I. Seneviratne, Tsung H. Lin, M. Nusrat Sharif, Liang Xue, Chuong Nguyen, Robert A. Everley, John I. Trujillo, Douglas S. Johnson, Gary R. Point, Atli Thorarensen, Iain Kilty, <span class="NLM_string-name hlFld-ContribAuthor">Jean-Baptiste Telliez</span>. </span><span class="cited-content_cbyCitation_article-title">PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2019,</strong> <em>14 </em>
                                    (6)
                                     , 1235-1242. <a href="https://doi.org/10.1021/acschembio.9b00188" title="DOI URL">https://doi.org/10.1021/acschembio.9b00188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00188%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DPF-06651600%25252C%252Ba%252BDual%252BJAK3%25252FTEC%252BFamily%252BKinase%252BInhibitor%26aulast%3DXu%26aufirst%3DHua%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08032019%26date%3D13052019%26date%3D22052019%26date%3D13052019%26volume%3D14%26issue%3D6%26spage%3D1235%26epage%3D1242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mark E. Schnute, Stephen E. Benoit, Ingrid P. Buchler, Nicole Caspers, Margaret L. Grapperhaus, Seungil Han, Rajeev Hotchandani, Nelson Huang, Robert O. Hughes, Brian M. Juba, Kyung-Hee Kim, Erica Liu, Erin McCarthy, Dean Messing, Joy S. Miyashiro, Shashi Mohan, Thomas N. O’Connell, Jeffrey F. Ohren, Mihir D. Parikh, Michelle Schmidt, Shaun R. Selness, John R. Springer, Venkataraman Thanabal, John I. Trujillo, Daniel P. Walker, Zhao-Kui Wan, Jane M. Withka, Arthur J. Wittwer, Nancy L. Wood, Li Xing, Christoph W. Zapf, <span class="NLM_string-name hlFld-ContribAuthor">John Douhan, III</span>. </span><span class="cited-content_cbyCitation_article-title">Aminopyrazole Carboxamide Bruton’s Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group Tuning. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 80-85. <a href="https://doi.org/10.1021/acsmedchemlett.8b00461" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00461%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAminopyrazole%252BCarboxamide%252BBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%252BInhibitors.%252BIrreversible%252Bto%252BReversible%252BCovalent%252BReactive%252BGroup%252BTuning%26aulast%3DSchnute%26aufirst%3DMark%2BE.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03102018%26date%3D03122018%26date%3D05122018%26date%3D03122018%26volume%3D10%26issue%3D1%26spage%3D80%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marian C. Bryan, <span class="NLM_string-name hlFld-ContribAuthor">Naomi S. Rajapaksa</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9030-9058. <a href="https://doi.org/10.1021/acs.jmedchem.8b00667" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00667%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BImmunological%252BDisorders%25253A%252BRecent%252BAdvances%26aulast%3DBryan%26aufirst%3DMarian%2BC.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26042018%26date%3D15062018%26date%3D05062018%26volume%3D61%26issue%3D20%26spage%3D9030%26epage%3D9058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julian  Engel</span>, <span class="hlFld-ContribAuthor ">Steven  Smith</span>, <span class="hlFld-ContribAuthor ">Jonas  Lategahn</span>, <span class="hlFld-ContribAuthor ">Hannah L.  Tumbrink</span>, <span class="hlFld-ContribAuthor ">Lisa  Goebel</span>, <span class="hlFld-ContribAuthor ">Christian  Becker</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Hennes</span>, <span class="hlFld-ContribAuthor ">Marina  Keul</span>, <span class="hlFld-ContribAuthor ">Anke  Unger</span>, <span class="hlFld-ContribAuthor ">Heiko  Müller</span>, <span class="hlFld-ContribAuthor ">Matthias  Baumann</span>, <span class="hlFld-ContribAuthor ">Carsten  Schultz-Fademrecht</span>, <span class="hlFld-ContribAuthor ">Georgia  Günther</span>, <span class="hlFld-ContribAuthor ">Jan G.  Hengstler</span>, and <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Development of Covalent and Mutant-Selective Pyrazolopyrimidines to Target T790M Drug Resistance in Epidermal Growth Factor Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (18)
                                     , 7725-7744. <a href="https://doi.org/10.1021/acs.jmedchem.7b00515" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00515%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDevelopment%252Bof%252BCovalent%252Band%252BMutant-Selective%252BPyrazolopyrimidines%252Bto%252BTarget%252BT790M%252BDrug%252BResistance%252Bin%252BEpidermal%252BGrowth%252BFactor%252BReceptor%26aulast%3DEngel%26aufirst%3DJulian%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D03042017%26date%3D18092017%26date%3D28092017%26date%3D30082017%26volume%3D60%26issue%3D18%26spage%3D7725%26epage%3D7744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason D.  Burch</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Yuan  Chen</span>, <span class="hlFld-ContribAuthor ">Jason  DeVoss</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Richard  Goldsmith</span>, <span class="hlFld-ContribAuthor ">M. Hicham A.  Ismaili</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Lin</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Ali A.  Zarrin</span>, <span class="hlFld-ContribAuthor ">Paul A.  McEwan</span>, <span class="hlFld-ContribAuthor ">John J.  Barker</span>, <span class="hlFld-ContribAuthor ">Claire  Ellebrandt</span>, <span class="hlFld-ContribAuthor ">Daniel  Kordt</span>, <span class="hlFld-ContribAuthor ">Daniel B.  Stein</span>, <span class="hlFld-ContribAuthor ">Xiaolu  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Chen</span>, <span class="hlFld-ContribAuthor ">Baihua  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Xu</span>, <span class="hlFld-ContribAuthor ">Po-Wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Yamin  Zhang</span>, and <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>  . </span><span class="cited-content_cbyCitation_article-title">Tetrahydroindazoles as Interleukin-2 Inducible T-Cell Kinase Inhibitors. Part II. Second-Generation Analogues with Enhanced Potency, Selectivity, and Pharmacodynamic Modulation in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (9)
                                     , 3806-3816. <a href="https://doi.org/10.1021/jm501998m" title="DOI URL">https://doi.org/10.1021/jm501998m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501998m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501998m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTetrahydroindazoles%252Bas%252BInterleukin-2%252BInducible%252BT-Cell%252BKinase%252BInhibitors.%252BPart%252BII.%252BSecond-Generation%252BAnalogues%252Bwith%252BEnhanced%252BPotency%25252C%252BSelectivity%25252C%252Band%252BPharmacodynamic%252BModulation%252Bin%252BVivo%26aulast%3DBurch%26aufirst%3DJason%2BD.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D23122014%26date%3D16042015%26date%3D14052015%26date%3D06042015%26volume%3D58%26issue%3D9%26spage%3D3806%26epage%3D3816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen E.  Leonard</span>, <span class="hlFld-ContribAuthor ">A. C.  Register</span>, <span class="hlFld-ContribAuthor ">Ratika  Krishnamurty</span>, <span class="hlFld-ContribAuthor ">Gabriel J.  Brighty</span>, and <span class="hlFld-ContribAuthor ">Dustin J.  Maly</span>  . </span><span class="cited-content_cbyCitation_article-title">Divergent Modulation of Src-Family Kinase Regulatory Interactions with ATP-Competitive Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2014,</strong> <em>9 </em>
                                    (8)
                                     , 1894-1905. <a href="https://doi.org/10.1021/cb500371g" title="DOI URL">https://doi.org/10.1021/cb500371g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb500371g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb500371g%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DDivergent%252BModulation%252Bof%252BSrc-Family%252BKinase%252BRegulatory%252BInteractions%252Bwith%252BATP-Competitive%252BInhibitors%26aulast%3DLeonard%26aufirst%3DStephen%2BE.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D24012014%26date%3D19062014%26date%3D02072014%26date%3D15082014%26date%3D19062014%26volume%3D9%26issue%3D8%26spage%3D1894%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atli  Thorarensen</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Banker</span>, <span class="hlFld-ContribAuthor ">Andrew  Fensome</span>, <span class="hlFld-ContribAuthor ">Jean-Baptiste  Telliez</span>, <span class="hlFld-ContribAuthor ">Brian  Juba</span>, <span class="hlFld-ContribAuthor ">Fabien  Vincent</span>, <span class="hlFld-ContribAuthor ">Robert M.  Czerwinski</span>, and <span class="hlFld-ContribAuthor ">Agustin  Casimiro-Garcia</span>  . </span><span class="cited-content_cbyCitation_article-title">ATP-Mediated Kinome Selectivity: The Missing Link in Understanding the Contribution of Individual JAK Kinase Isoforms to Cellular Signaling. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2014,</strong> <em>9 </em>
                                    (7)
                                     , 1552-1558. <a href="https://doi.org/10.1021/cb5002125" title="DOI URL">https://doi.org/10.1021/cb5002125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb5002125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb5002125%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DATP-Mediated%252BKinome%252BSelectivity%25253A%252BThe%252BMissing%252BLink%252Bin%252BUnderstanding%252Bthe%252BContribution%252Bof%252BIndividual%252BJAK%252BKinase%252BIsoforms%252Bto%252BCellular%252BSignaling%26aulast%3DThorarensen%26aufirst%3DAtli%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D19032014%26date%3D12052014%26date%3D28052014%26date%3D18072014%26date%3D12052014%26volume%3D9%26issue%3D7%26spage%3D1552%26epage%3D1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason D.  Burch</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">John J.  Barker</span>, <span class="hlFld-ContribAuthor ">Fred  Brookfield</span>, <span class="hlFld-ContribAuthor ">Yong  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan  Chen</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Claire  Ellebrandt</span>, <span class="hlFld-ContribAuthor ">M. Hicham A.  Ismaili</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Daniel  Kordt</span>, <span class="hlFld-ContribAuthor ">Colin H.  MacKinnon</span>, <span class="hlFld-ContribAuthor ">Paul A.  McEwan</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Daniel B.  Stein</span>, <span class="hlFld-ContribAuthor ">Xiaolu  Wang</span>, <span class="hlFld-ContribAuthor ">Dirk  Winkler</span>, <span class="hlFld-ContribAuthor ">Po-Wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Yamin  Zhang</span>, <span class="hlFld-ContribAuthor ">Ali A.  Zarrin</span>, and <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>  . </span><span class="cited-content_cbyCitation_article-title">Property- and Structure-Guided Discovery of a Tetrahydroindazole Series of Interleukin-2 Inducible T-Cell Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (13)
                                     , 5714-5727. <a href="https://doi.org/10.1021/jm500550e" title="DOI URL">https://doi.org/10.1021/jm500550e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500550e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500550e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProperty-%252Band%252BStructure-Guided%252BDiscovery%252Bof%252Ba%252BTetrahydroindazole%252BSeries%252Bof%252BInterleukin-2%252BInducible%252BT-Cell%252BKinase%252BInhibitors%26aulast%3DBurch%26aufirst%3DJason%2BD.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D08042014%26date%3D27062014%26date%3D10072014%26date%3D11062014%26volume%3D57%26issue%3D13%26spage%3D5714%26epage%3D5727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xitao  Li</span>, <span class="hlFld-ContribAuthor ">Yingying  Zuo</span>, <span class="hlFld-ContribAuthor ">Guanghui  Tang</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Xueying  Wang</span>, <span class="hlFld-ContribAuthor ">Tianlin  Guo</span>, <span class="hlFld-ContribAuthor ">Mengying  Xia</span>, <span class="hlFld-ContribAuthor ">Ning  Ding</span>, and <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of 2,5-Diaminopyrimidine Covalent Irreversible Inhibitors of Bruton’s Tyrosine Kinase with in Vivo Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5112-5128. <a href="https://doi.org/10.1021/jm4017762" title="DOI URL">https://doi.org/10.1021/jm4017762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4017762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4017762%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252B2%25252C5-Diaminopyrimidine%252BCovalent%252BIrreversible%252BInhibitors%252Bof%252BBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%252Bwith%252Bin%252BVivo%252BAntitumor%252BActivity%26aulast%3DLi%26aufirst%3DXitao%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D16112013%26date%3D10062014%26date%3D26062014%26volume%3D57%26issue%3D12%26spage%3D5112%26epage%3D5128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar P. J.  van Linden</span>, <span class="hlFld-ContribAuthor ">Albert J.  Kooistra</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Iwan J. P.  de Esch</span>, and <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>  . </span><span class="cited-content_cbyCitation_article-title">KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (2)
                                     , 249-277. <a href="https://doi.org/10.1021/jm400378w" title="DOI URL">https://doi.org/10.1021/jm400378w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400378w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400378w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKLIFS%25253A%252BA%252BKnowledge-Based%252BStructural%252BDatabase%252BTo%252BNavigate%252BKinase%2525E2%252580%252593Ligand%252BInteraction%252BSpace%26aulast%3Dvan%2BLinden%26aufirst%3DOscar%2BP.%2BJ.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D14032013%26date%3D20092013%26date%3D23012014%26date%3D13082013%26volume%3D57%26issue%3D2%26spage%3D249%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catherine M.  Alder</span>, <span class="hlFld-ContribAuthor ">Martin  Ambler</span>, <span class="hlFld-ContribAuthor ">Amanda J.  Campbell</span>, <span class="hlFld-ContribAuthor ">Aurelie C.  Champigny</span>, <span class="hlFld-ContribAuthor ">Angela M.  Deakin</span>, <span class="hlFld-ContribAuthor ">John D.  Harling</span>, <span class="hlFld-ContribAuthor ">Carol A.  Harris</span>, <span class="hlFld-ContribAuthor ">Tim  Longstaff</span>, <span class="hlFld-ContribAuthor ">Sean  Lynn</span>, <span class="hlFld-ContribAuthor ">Aoife C.  Maxwell</span>, <span class="hlFld-ContribAuthor ">Chris J.  Mooney</span>, <span class="hlFld-ContribAuthor ">Callum  Scullion</span>, <span class="hlFld-ContribAuthor ">Onkar M. P.  Singh</span>, <span class="hlFld-ContribAuthor ">Ian E. D.  Smith</span>, <span class="hlFld-ContribAuthor ">Donald O.  Somers</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Tame</span>, <span class="hlFld-ContribAuthor ">Gareth  Wayne</span>, <span class="hlFld-ContribAuthor ">Caroline  Wilson</span>, and <span class="hlFld-ContribAuthor ">James M.  Woolven</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping Strategy. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (10)
                                     , 948-952. <a href="https://doi.org/10.1021/ml400206q" title="DOI URL">https://doi.org/10.1021/ml400206q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml400206q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml400206q%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Ba%252BNovel%252Band%252BSelective%252BSeries%252Bof%252BItk%252BInhibitors%252Bvia%252Ba%252BTemplate-Hopping%252BStrategy%26aulast%3DAlder%26aufirst%3DCatherine%2BM.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D28052013%26date%3D12082013%26date%3D13082013%26date%3D10102013%26date%3D12082013%26volume%3D4%26issue%3D10%26spage%3D948%26epage%3D952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Hui  Peng</span>, <span class="hlFld-ContribAuthor ">Hui-Yi  Shiao</span>, <span class="hlFld-ContribAuthor ">Chih-Hsiang  Tu</span>, <span class="hlFld-ContribAuthor ">Pang-Min  Liu</span>, <span class="hlFld-ContribAuthor ">John Tsu-An  Hsu</span>, <span class="hlFld-ContribAuthor ">Prashanth Kumar  Amancha</span>, <span class="hlFld-ContribAuthor ">Jian-Sung  Wu</span>, <span class="hlFld-ContribAuthor ">Mohane Selvaraj  Coumar</span>, <span class="hlFld-ContribAuthor ">Chun-Hwa  Chen</span>, <span class="hlFld-ContribAuthor ">Sing-Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-Hsing  Lin</span>, <span class="hlFld-ContribAuthor ">Hsu-Yi  Sun</span>, <span class="hlFld-ContribAuthor ">Yu-Sheng  Chao</span>, <span class="hlFld-ContribAuthor ">Ping-Chiang  Lyu</span>, <span class="hlFld-ContribAuthor ">Hsing-Pang  Hsieh</span>, and <span class="hlFld-ContribAuthor ">Su-Ying  Wu</span>  . </span><span class="cited-content_cbyCitation_article-title">Protein Kinase Inhibitor Design by Targeting the Asp-Phe-Gly (DFG) Motif: The Role of the DFG Motif in the Design of Epidermal Growth Factor Receptor Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (10)
                                     , 3889-3903. <a href="https://doi.org/10.1021/jm400072p" title="DOI URL">https://doi.org/10.1021/jm400072p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400072p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400072p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProtein%252BKinase%252BInhibitor%252BDesign%252Bby%252BTargeting%252Bthe%252BAsp-Phe-Gly%252B%252528DFG%252529%252BMotif%25253A%252BThe%252BRole%252Bof%252Bthe%252BDFG%252BMotif%252Bin%252Bthe%252BDesign%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BInhibitors%26aulast%3DPeng%26aufirst%3DYi-Hui%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D15012013%26date%3D10052013%26date%3D23052013%26date%3D23042013%26volume%3D56%26issue%3D10%26spage%3D3889%26epage%3D3903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angus T.  Voice</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Rebecca M.  Twidale</span>, <span class="hlFld-ContribAuthor ">Herman  van Vlijmen</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Mulholland</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanism of covalent binding of ibrutinib to Bruton's tyrosine kinase revealed by QM/MM calculations. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>12 </em>
                                    (15)
                                     , 5511-5516. <a href="https://doi.org/10.1039/D0SC06122K" title="DOI URL">https://doi.org/10.1039/D0SC06122K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC06122K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC06122K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DMechanism%252Bof%252Bcovalent%252Bbinding%252Bof%252Bibrutinib%252Bto%252BBruton%252527s%252Btyrosine%252Bkinase%252Brevealed%252Bby%252BQM%25252FMM%252Bcalculations%26aulast%3DVoice%26aufirst%3DAngus%2BT.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D15%26spage%3D5511%26epage%3D5516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Approaches to mitigate the risk of serious adverse reactions in covalent drug design. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>16 </em>
                                    (3)
                                     , 275-287. <a href="https://doi.org/10.1080/17460441.2021.1832079" title="DOI URL">https://doi.org/10.1080/17460441.2021.1832079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1832079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1832079%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DApproaches%252Bto%252Bmitigate%252Bthe%252Brisk%252Bof%252Bserious%252Badverse%252Breactions%252Bin%252Bcovalent%252Bdrug%252Bdesign%26aulast%3DBaillie%26aufirst%3DThomas%2BA.%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D275%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eddie L  Myers</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5–6 Systems: Other Four Heteroatoms 2:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00056-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00056-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00056-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00056-1%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5%2525E2%252580%2525936%252BSystems%25253A%252BOther%252BFour%252BHeteroatoms%252B2%25253A2%26aulast%3DMyers%26aufirst%3DEddie%2BL%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Forster</span>, <span class="hlFld-ContribAuthor ">Xiaojun Julia  Liang</span>, <span class="hlFld-ContribAuthor ">Martin  Schröder</span>, <span class="hlFld-ContribAuthor ">Stefan  Gerstenecker</span>, <span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Stefan  Laufer</span>, <span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (23)
                                     , 9269. <a href="https://doi.org/10.3390/ijms21239269" title="DOI URL">https://doi.org/10.3390/ijms21239269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21239269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21239269%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BClass%252Bof%252BCovalent%252BDual%252BInhibitors%252BTargeting%252Bthe%252BProtein%252BKinases%252BBMX%252Band%252BBTK%26aulast%3DForster%26aufirst%3DMichael%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D23%26spage%3D9269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ekaterina V.  Vinogradova</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhang</span>, <span class="hlFld-ContribAuthor ">David  Remillard</span>, <span class="hlFld-ContribAuthor ">Daniel C.  Lazar</span>, <span class="hlFld-ContribAuthor ">Radu M.  Suciu</span>, <span class="hlFld-ContribAuthor ">Yujia  Wang</span>, <span class="hlFld-ContribAuthor ">Giulia  Bianco</span>, <span class="hlFld-ContribAuthor ">Yu  Yamashita</span>, <span class="hlFld-ContribAuthor ">Vincent M.  Crowley</span>, <span class="hlFld-ContribAuthor ">Michael A.  Schafroth</span>, <span class="hlFld-ContribAuthor ">Minoru  Yokoyama</span>, <span class="hlFld-ContribAuthor ">David B.  Konrad</span>, <span class="hlFld-ContribAuthor ">Kenneth M.  Lum</span>, <span class="hlFld-ContribAuthor ">Gabriel M.  Simon</span>, <span class="hlFld-ContribAuthor ">Esther K.  Kemper</span>, <span class="hlFld-ContribAuthor ">Michael R.  Lazear</span>, <span class="hlFld-ContribAuthor ">Sifei  Yin</span>, <span class="hlFld-ContribAuthor ">Megan M.  Blewett</span>, <span class="hlFld-ContribAuthor ">Melissa M.  Dix</span>, <span class="hlFld-ContribAuthor ">Nhan  Nguyen</span>, <span class="hlFld-ContribAuthor ">Maxim N.  Shokhirev</span>, <span class="hlFld-ContribAuthor ">Emily N.  Chin</span>, <span class="hlFld-ContribAuthor ">Luke L.  Lairson</span>, <span class="hlFld-ContribAuthor ">Bruno  Melillo</span>, <span class="hlFld-ContribAuthor ">Stuart L.  Schreiber</span>, <span class="hlFld-ContribAuthor ">Stefano  Forli</span>, <span class="hlFld-ContribAuthor ">John R.  Teijaro</span>, <span class="hlFld-ContribAuthor ">Benjamin F.  Cravatt</span>. </span><span class="cited-content_cbyCitation_article-title">An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells. </span><span class="cited-content_cbyCitation_journal-name">Cell</span><span> <strong>2020,</strong> <em>182 </em>
                                    (4)
                                     , 1009-1026.e29. <a href="https://doi.org/10.1016/j.cell.2020.07.001" title="DOI URL">https://doi.org/10.1016/j.cell.2020.07.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cell.2020.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cell.2020.07.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%26atitle%3DAn%252BActivity-Guided%252BMap%252Bof%252BElectrophile-Cysteine%252BInteractions%252Bin%252BPrimary%252BHuman%252BT%252BCells%26aulast%3DVinogradova%26aufirst%3DEkaterina%2BV.%26date%3D2020%26volume%3D182%26issue%3D4%26spage%3D1009%26epage%3D1026.e29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayah  Abdeldayem</span>, <span class="hlFld-ContribAuthor ">Yasir S.  Raouf</span>, <span class="hlFld-ContribAuthor ">Stefan N.  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in covalent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2020,</strong> <em>49 </em>
                                    (9)
                                     , 2617-2687. <a href="https://doi.org/10.1039/C9CS00720B" title="DOI URL">https://doi.org/10.1039/C9CS00720B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CS00720B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CS00720B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DAdvances%252Bin%252Bcovalent%252Bkinase%252Binhibitors%26aulast%3DAbdeldayem%26aufirst%3DAyah%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D9%26spage%3D2617%26epage%3D2687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueying  Wang</span>, <span class="hlFld-ContribAuthor ">Gang  Xue</span>, <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and structure–activity relationship of indolylindazoles as potent and selective covalent inhibitors of interleukin-2 inducible T-cell kinase (ITK). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111918. <a href="https://doi.org/10.1016/j.ejmech.2019.111918" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111918</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111918%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bof%252Bindolylindazoles%252Bas%252Bpotent%252Band%252Bselective%252Bcovalent%252Binhibitors%252Bof%252Binterleukin-2%252Binducible%252BT-cell%252Bkinase%252B%252528ITK%252529%26aulast%3DWang%26aufirst%3DXueying%26date%3D2020%26volume%3D187%26spage%3D111918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Kinase Inhibitors: An Overview. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 43-94. <a href="https://doi.org/10.1007/7355_2020_103" title="DOI URL">https://doi.org/10.1007/7355_2020_103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2020_103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2020_103%26sid%3Dliteratum%253Aachs%26atitle%3DCovalent%252BKinase%252BInhibitors%25253A%252BAn%252BOverview%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2020%26date%3D2020%26spage%3D43%26epage%3D94%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DProteinkinase%252BInhibitors%26aulast%3DLaufer%26aufirst%3DStefan%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rie  Hantani</span>, <span class="hlFld-ContribAuthor ">Saya  Hanawa</span>, <span class="hlFld-ContribAuthor ">Shohei  Oie</span>, <span class="hlFld-ContribAuthor ">Kayo  Umetani</span>, <span class="hlFld-ContribAuthor ">Toshihiro  Sato</span>, <span class="hlFld-ContribAuthor ">Yoshiji  Hantani</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a New Inhibitor That Stabilizes Interleukin-2-Inducible T-Cell Kinase in Its Inactive Conformation. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2019,</strong> <em>24 </em>
                                    (8)
                                     , 854-862. <a href="https://doi.org/10.1177/2472555219857542" title="DOI URL">https://doi.org/10.1177/2472555219857542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555219857542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555219857542%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DIdentification%252Bof%252Ba%252BNew%252BInhibitor%252BThat%252BStabilizes%252BInterleukin-2-Inducible%252BT-Cell%252BKinase%252Bin%252BIts%252BInactive%252BConformation%26aulast%3DHantani%26aufirst%3DRie%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D8%26spage%3D854%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanghui  Tang</span>, <span class="hlFld-ContribAuthor ">Lihong  Liu</span>, <span class="hlFld-ContribAuthor ">Xueying  Wang</span>, <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 7H-pyrrolo[2,3-d]pyrimidine derivatives as selective covalent irreversible inhibitors of interleukin-2-inducible T-cell kinase (Itk). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>173 </em>, 167-183. <a href="https://doi.org/10.1016/j.ejmech.2019.03.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bas%252Bselective%252Bcovalent%252Birreversible%252Binhibitors%252Bof%252Binterleukin-2-inducible%252BT-cell%252Bkinase%252B%252528Itk%252529%26aulast%3DTang%26aufirst%3DGuanghui%26date%3D2019%26volume%3D173%26spage%3D167%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.  Muthuraja</span>, <span class="hlFld-ContribAuthor ">V.  Veeramani</span>, <span class="hlFld-ContribAuthor ">S.  Prakash</span>, <span class="hlFld-ContribAuthor ">M.  Himesh</span>, <span class="hlFld-ContribAuthor ">U.  Venkatasubramanian</span>, <span class="hlFld-ContribAuthor ">P.  Manisankar</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship of pyrazolo pyrimidine derivatives as inhibitors of mitotic kinesin Eg5 and anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>, 493-504. <a href="https://doi.org/10.1016/j.bioorg.2018.12.014" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.12.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.12.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Bof%252Bpyrazolo%252Bpyrimidine%252Bderivatives%252Bas%252Binhibitors%252Bof%252Bmitotic%252Bkinesin%252BEg5%252Band%252Banticancer%252Bagents%26aulast%3DMuthuraja%26aufirst%3DP.%26date%3D2019%26volume%3D84%26spage%3D493%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher M.  Harris</span>, <span class="hlFld-ContribAuthor ">Sage E.  Foley</span>, <span class="hlFld-ContribAuthor ">Eric R.  Goedken</span>, <span class="hlFld-ContribAuthor ">Mark  Michalak</span>, <span class="hlFld-ContribAuthor ">Sara  Murdock</span>, <span class="hlFld-ContribAuthor ">Noel S.  Wilson</span>. </span><span class="cited-content_cbyCitation_article-title">Merits and Pitfalls in the Characterization of Covalent Inhibitors of Bruton’s Tyrosine Kinase. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2018,</strong> <em>23 </em>
                                    (10)
                                     , 1040-1050. <a href="https://doi.org/10.1177/2472555218787445" title="DOI URL">https://doi.org/10.1177/2472555218787445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555218787445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555218787445%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DMerits%252Band%252BPitfalls%252Bin%252Bthe%252BCharacterization%252Bof%252BCovalent%252BInhibitors%252Bof%252BBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%26aulast%3DHarris%26aufirst%3DChristopher%2BM.%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D10%26spage%3D1040%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshiji  Hantani</span>, <span class="hlFld-ContribAuthor ">Kiyosei  Iio</span>, <span class="hlFld-ContribAuthor ">Rie  Hantani</span>, <span class="hlFld-ContribAuthor ">Kayo  Umetani</span>, <span class="hlFld-ContribAuthor ">Toshihiro  Sato</span>, <span class="hlFld-ContribAuthor ">Tracy  Young</span>, <span class="hlFld-ContribAuthor ">Katelyn  Connell</span>, <span class="hlFld-ContribAuthor ">Sam  Kintz</span>, <span class="hlFld-ContribAuthor ">Joshua  Salafsky</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of inactive conformation‐selective interleukin‐2‐inducible T‐cell kinase (
              ITK
              ) inhibitors based on second‐harmonic generation. </span><span class="cited-content_cbyCitation_journal-name">FEBS Open Bio</span><span> <strong>2018,</strong> <em>8 </em>
                                    (9)
                                     , 1412-1423. <a href="https://doi.org/10.1002/2211-5463.12489" title="DOI URL">https://doi.org/10.1002/2211-5463.12489</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/2211-5463.12489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F2211-5463.12489%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Open%2520Bio%26atitle%3DIdentification%252Bof%252Binactive%252Bconformation%2525E2%252580%252590selective%252Binterleukin%2525E2%252580%2525902%2525E2%252580%252590inducible%252BT%2525E2%252580%252590cell%252Bkinase%252B%252528%252BITK%252B%252529%252Binhibitors%252Bbased%252Bon%252Bsecond%2525E2%252580%252590harmonic%252Bgeneration%26aulast%3DHantani%26aufirst%3DYoshiji%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D9%26spage%3D1412%26epage%3D1423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Jon  Cuccui</span>, <span class="hlFld-ContribAuthor ">Carmen  Denman</span>, <span class="hlFld-ContribAuthor ">Tripty  Maharjan</span>, <span class="hlFld-ContribAuthor ">Brendan W.  Wren</span>, <span class="hlFld-ContribAuthor ">Gerd K.  Wagner</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationships in a new class of non-substrate-like covalent inhibitors of the bacterial glycosyltransferase LgtC. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (11)
                                     , 2973-2983. <a href="https://doi.org/10.1016/j.bmc.2018.03.006" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationships%252Bin%252Ba%252Bnew%252Bclass%252Bof%252Bnon-substrate-like%252Bcovalent%252Binhibitors%252Bof%252Bthe%252Bbacterial%252Bglycosyltransferase%252BLgtC%26aulast%3DXu%26aufirst%3DYong%26date%3D2018%26volume%3D26%26issue%3D11%26spage%3D2973%26epage%3D2983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nan  Zheng</span>, <span class="hlFld-ContribAuthor ">Jing  Pan</span>, <span class="hlFld-ContribAuthor ">Qun  Hao</span>, <span class="hlFld-ContribAuthor ">Yingxia  Li</span>, <span class="hlFld-ContribAuthor ">Weicheng  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 3-substituted pyrazolopyrimidine derivatives as potent Bruton’s tyrosine kinase (BTK) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (8)
                                     , 2165-2172. <a href="https://doi.org/10.1016/j.bmc.2018.03.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.03.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.03.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B3-substituted%252Bpyrazolopyrimidine%252Bderivatives%252Bas%252Bpotent%252BBruton%2525E2%252580%252599s%252Btyrosine%252Bkinase%252B%252528BTK%252529%252Binhibitors%26aulast%3DZheng%26aufirst%3DNan%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D2165%26epage%3D2172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga  Gorelenkova Miller</span>, <span class="hlFld-ContribAuthor ">Kyle S.  Cole</span>, <span class="hlFld-ContribAuthor ">Corey C.  Emerson</span>, <span class="hlFld-ContribAuthor ">Dharmaraja  Allimuthu</span>, <span class="hlFld-ContribAuthor ">Marcin  Golczak</span>, <span class="hlFld-ContribAuthor ">Phoebe L.  Stewart</span>, <span class="hlFld-ContribAuthor ">Eranthie  Weerapana</span>, <span class="hlFld-ContribAuthor ">Drew J.  Adams</span>, <span class="hlFld-ContribAuthor ">John J.  Mieyal</span>, . </span><span class="cited-content_cbyCitation_article-title">Novel chloroacetamido compound CWR-J02 is an anti-inflammatory glutaredoxin-1 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2017,</strong> <em>12 </em>
                                    (11)
                                     , e0187991. <a href="https://doi.org/10.1371/journal.pone.0187991" title="DOI URL">https://doi.org/10.1371/journal.pone.0187991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0187991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0187991%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DNovel%252Bchloroacetamido%252Bcompound%252BCWR-J02%252Bis%252Ban%252Banti-inflammatory%252Bglutaredoxin-1%252Binhibitor%26aulast%3DGorelenkova%2BMiller%26aufirst%3DOlga%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D11%26spage%3De0187991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tjeerd  Barf</span>, <span class="hlFld-ContribAuthor ">Todd  Covey</span>, <span class="hlFld-ContribAuthor ">Raquel  Izumi</span>, <span class="hlFld-ContribAuthor ">Bas  van de Kar</span>, <span class="hlFld-ContribAuthor ">Michael  Gulrajani</span>, <span class="hlFld-ContribAuthor ">Bart  van Lith</span>, <span class="hlFld-ContribAuthor ">Maaike  van Hoek</span>, <span class="hlFld-ContribAuthor ">Edwin  de Zwart</span>, <span class="hlFld-ContribAuthor ">Diana  Mittag</span>, <span class="hlFld-ContribAuthor ">Dennis  Demont</span>, <span class="hlFld-ContribAuthor ">Saskia  Verkaik</span>, <span class="hlFld-ContribAuthor ">Fanny  Krantz</span>, <span class="hlFld-ContribAuthor ">Paul G.  Pearson</span>, <span class="hlFld-ContribAuthor ">Roger  Ulrich</span>, <span class="hlFld-ContribAuthor ">Allard  Kaptein</span>. </span><span class="cited-content_cbyCitation_article-title">Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2017,</strong> <em>363 </em>
                                    (2)
                                     , 240-252. <a href="https://doi.org/10.1124/jpet.117.242909" title="DOI URL">https://doi.org/10.1124/jpet.117.242909</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.117.242909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.117.242909%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DAcalabrutinib%252B%252528ACP-196%252529%25253A%252BA%252BCovalent%252BBruton%252BTyrosine%252BKinase%252BInhibitor%252Bwith%252Ba%252BDifferentiated%252BSelectivity%252Band%252BIn%252BVivo%252BPotency%252BProfile%26aulast%3DBarf%26aufirst%3DTjeerd%26date%3D2017%26date%3D2017%26volume%3D363%26issue%3D2%26spage%3D240%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zaheer  Ul-Haq</span>, <span class="hlFld-ContribAuthor ">Juweria Shahrukh  Effendi</span>, <span class="hlFld-ContribAuthor ">Sajda  Ashraf</span>, <span class="hlFld-ContribAuthor ">Majdi M.  Bkhaitan</span>. </span><span class="cited-content_cbyCitation_article-title">Atom and receptor based 3D QSAR models for generating new conformations from pyrazolopyrimidine as IL-2 inducible tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2017,</strong> <em>74 </em>, 379-395. <a href="https://doi.org/10.1016/j.jmgm.2017.03.016" title="DOI URL">https://doi.org/10.1016/j.jmgm.2017.03.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2017.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2017.03.016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DAtom%252Band%252Breceptor%252Bbased%252B3D%252BQSAR%252Bmodels%252Bfor%252Bgenerating%252Bnew%252Bconformations%252Bfrom%252Bpyrazolopyrimidine%252Bas%252BIL-2%252Binducible%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DUl-Haq%26aufirst%3DZaheer%26date%3D2017%26volume%3D74%26spage%3D379%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy D.  Owens</span>, <span class="hlFld-ContribAuthor ">Yan  Lou</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Kinase Inhibitors for Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 76-103. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12399-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12399-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12399-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12399-6%26sid%3Dliteratum%253Aachs%26atitle%3DCovalent%252BKinase%252BInhibitors%252Bfor%252BCancer%26aulast%3DOwens%26aufirst%3DTimothy%2BD.%26date%3D2017%26spage%3D76%26epage%3D103%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John M.  Strelow</span>. </span><span class="cited-content_cbyCitation_article-title">A Perspective on the Kinetics of Covalent and Irreversible Inhibition. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2017,</strong> <em>22 </em>
                                    (1)
                                     , 3-20. <a href="https://doi.org/10.1177/1087057116671509" title="DOI URL">https://doi.org/10.1177/1087057116671509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1087057116671509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1087057116671509%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DA%252BPerspective%252Bon%252Bthe%252BKinetics%252Bof%252BCovalent%252Band%252BIrreversible%252BInhibition%26aulast%3DStrelow%26aufirst%3DJohn%2BM.%26date%3D2017%26date%3D2016%26volume%3D22%26issue%3D1%26spage%3D3%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Zielgerichtete kovalente Inhibitoren für das Wirkstoffdesign. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2016,</strong> <em>128 </em>
                                    (43)
                                     , 13606-13619. <a href="https://doi.org/10.1002/ange.201601091" title="DOI URL">https://doi.org/10.1002/ange.201601091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201601091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201601091%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DZielgerichtete%252Bkovalente%252BInhibitoren%252Bf%2525C3%2525BCr%252Bdas%252BWirkstoffdesign%26aulast%3DBaillie%26aufirst%3DThomas%2BA.%26date%3D2016%26date%3D2016%26volume%3D128%26issue%3D43%26spage%3D13606%26epage%3D13619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Covalent Inhibitors for Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2016,</strong> <em>55 </em>
                                    (43)
                                     , 13408-13421. <a href="https://doi.org/10.1002/anie.201601091" title="DOI URL">https://doi.org/10.1002/anie.201601091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201601091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201601091%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DTargeted%252BCovalent%252BInhibitors%252Bfor%252BDrug%252BDesign%26aulast%3DBaillie%26aufirst%3DThomas%2BA.%26date%3D2016%26date%3D2016%26volume%3D55%26issue%3D43%26spage%3D13408%26epage%3D13421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander M.  Haydl</span>, <span class="hlFld-ContribAuthor ">Lukas J.  Hilpert</span>, <span class="hlFld-ContribAuthor ">Bernhard  Breit</span>. </span><span class="cited-content_cbyCitation_article-title">Regioconvergent and Enantioselective Rhodium-Catalyzed Hydroamination of Internal and Terminal Alkynes: A Highly Flexible Access to Chiral Pyrazoles. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2016,</strong> <em>22 </em>
                                    (19)
                                     , 6547-6551. <a href="https://doi.org/10.1002/chem.201601198" title="DOI URL">https://doi.org/10.1002/chem.201601198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201601198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201601198%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DRegioconvergent%252Band%252BEnantioselective%252BRhodium-Catalyzed%252BHydroamination%252Bof%252BInternal%252Band%252BTerminal%252BAlkynes%25253A%252BA%252BHighly%252BFlexible%252BAccess%252Bto%252BChiral%252BPyrazoles%26aulast%3DHaydl%26aufirst%3DAlexander%2BM.%26date%3D2016%26date%3D2016%26volume%3D22%26issue%3D19%26spage%3D6547%26epage%3D6551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catalin V.  Maftei</span>, <span class="hlFld-ContribAuthor ">Elena  Fodor</span>, <span class="hlFld-ContribAuthor ">Peter G.  Jones</span>, <span class="hlFld-ContribAuthor ">Constantin G.  Daniliuc</span>, <span class="hlFld-ContribAuthor ">M. Heiko  Franz</span>, <span class="hlFld-ContribAuthor ">Gerhard  Kelter</span>, <span class="hlFld-ContribAuthor ">Heinz-Herbert  Fiebig</span>, <span class="hlFld-ContribAuthor ">Matthias  Tamm</span>, <span class="hlFld-ContribAuthor ">Ion  Neda</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 1,2,4-oxadiazoles and trifluoromethylpyridines related to natural products: synthesis, structural analysis and investigation of their antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (9)
                                     , 1185-1199. <a href="https://doi.org/10.1016/j.tet.2016.01.011" title="DOI URL">https://doi.org/10.1016/j.tet.2016.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DNovel%252B1%25252C2%25252C4-oxadiazoles%252Band%252Btrifluoromethylpyridines%252Brelated%252Bto%252Bnatural%252Bproducts%25253A%252Bsynthesis%25252C%252Bstructural%252Banalysis%252Band%252Binvestigation%252Bof%252Btheir%252Bantitumor%252Bactivity%26aulast%3DMaftei%26aufirst%3DCatalin%2BV.%26date%3D2016%26volume%3D72%26issue%3D9%26spage%3D1185%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander M.  Haydl</span>, <span class="hlFld-ContribAuthor ">Kun  Xu</span>, <span class="hlFld-ContribAuthor ">Bernhard  Breit</span>. </span><span class="cited-content_cbyCitation_article-title">Regio- and Enantioselective Synthesis of N-Substituted Pyrazoles by Rhodium-Catalyzed Asymmetric Addition to Allenes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (24)
                                     , 7255-7259. <a href="https://doi.org/10.1002/ange.201501758" title="DOI URL">https://doi.org/10.1002/ange.201501758</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201501758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201501758%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DRegio-%252Band%252BEnantioselective%252BSynthesis%252Bof%252BN-Substituted%252BPyrazoles%252Bby%252BRhodium-Catalyzed%252BAsymmetric%252BAddition%252Bto%252BAllenes%26aulast%3DHaydl%26aufirst%3DAlexander%2BM.%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D24%26spage%3D7255%26epage%3D7259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander M.  Haydl</span>, <span class="hlFld-ContribAuthor ">Kun  Xu</span>, <span class="hlFld-ContribAuthor ">Bernhard  Breit</span>. </span><span class="cited-content_cbyCitation_article-title">Regio- and Enantioselective Synthesis of N-Substituted Pyrazoles by Rhodium-Catalyzed Asymmetric Addition to Allenes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (24)
                                     , 7149-7153. <a href="https://doi.org/10.1002/anie.201501758" title="DOI URL">https://doi.org/10.1002/anie.201501758</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201501758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201501758%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DRegio-%252Band%252BEnantioselective%252BSynthesis%252Bof%252BN-Substituted%252BPyrazoles%252Bby%252BRhodium-Catalyzed%252BAsymmetric%252BAddition%252Bto%252BAllenes%26aulast%3DHaydl%26aufirst%3DAlexander%2BM.%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D24%26spage%3D7149%26epage%3D7153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joel  Morris</span>, <span class="hlFld-ContribAuthor ">Lajos  Kovács</span>, <span class="hlFld-ContribAuthor ">Kouichi  Ohe</span>. </span><span class="cited-content_cbyCitation_article-title">Cyanogen Bromide. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 1-8. <a href="https://doi.org/10.1002/047084289X.rc269.pub3" title="DOI URL">https://doi.org/10.1002/047084289X.rc269.pub3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/047084289X.rc269.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F047084289X.rc269.pub3%26sid%3Dliteratum%253Aachs%26atitle%3DCyanogen%252BBromide%26aulast%3DMorris%26aufirst%3DJoel%26date%3D2015%26date%3D2015%26spage%3D1%26epage%3D8%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DEncyclopedia%252Bof%252BReagents%252Bfor%252BOrganic%252BSynthesis%26date%3D2001%26date%3D2001%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chong Long  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-tert-butylaniline by Using Hydrodechlorination Technology. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials Research</span><span> <strong>2014,</strong> <em>1051 </em>, 125-129. <a href="https://doi.org/10.4028/www.scientific.net/AMR.1051.125" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMR.1051.125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMR.1051.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMR.1051.125%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%2520Research%26atitle%3DSynthesis%252Bof%252B3-tert-butylaniline%252Bby%252BUsing%252BHydrodechlorination%252BTechnology%26aulast%3DLi%26aufirst%3DChong%2BLong%26date%3D2014%26date%3D2014%26volume%3D1051%26spage%3D125%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Inducible tyrosine kinase inhibitors: a review of the patent literature (2010 – 2013). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (9)
                                     , 979-991. <a href="https://doi.org/10.1517/13543776.2014.936381" title="DOI URL">https://doi.org/10.1517/13543776.2014.936381</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.936381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.936381%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DInducible%252Btyrosine%252Bkinase%252Binhibitors%25253A%252Ba%252Breview%252Bof%252Bthe%252Bpatent%252Bliterature%252B%2525282010%252B%2525E2%252580%252593%252B2013%252529%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D9%26spage%3D979%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard M.  Pastor</span>, <span class="hlFld-ContribAuthor ">Jason D.  Burch</span>, <span class="hlFld-ContribAuthor ">Steven  Magnuson</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Yuan  Chen</span>, <span class="hlFld-ContribAuthor ">Kelly  De La Torre</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Yichin  Liu</span>, <span class="hlFld-ContribAuthor ">Steven  Shia</span>, <span class="hlFld-ContribAuthor ">Xiaolu  Wang</span>, <span class="hlFld-ContribAuthor ">Lawren C.  Wu</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (11)
                                     , 2448-2452. <a href="https://doi.org/10.1016/j.bmcl.2014.04.023" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.04.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.04.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Bindazoles%252Bas%252Bpotent%252Band%252Bselective%252Binterleukin-2%252Binducible%252BT%252Bcell%252Bkinase%252B%252528ITK%252529%252Binhibitors%26aulast%3DPastor%26aufirst%3DRichard%2BM.%26date%3D2014%26volume%3D24%26issue%3D11%26spage%3D2448%26epage%3D2452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Mah</span>, <span class="hlFld-ContribAuthor ">Jason R.  Thomas</span>, <span class="hlFld-ContribAuthor ">Cynthia M.  Shafer</span>. </span><span class="cited-content_cbyCitation_article-title">Drug discovery considerations in the development of covalent inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (1)
                                     , 33-39. <a href="https://doi.org/10.1016/j.bmcl.2013.10.003" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDrug%252Bdiscovery%252Bconsiderations%252Bin%252Bthe%252Bdevelopment%252Bof%252Bcovalent%252Binhibitors%26aulast%3DMah%26aufirst%3DRobert%26date%3D2014%26volume%3D24%26issue%3D1%26spage%3D33%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Colin H.  MacKinnon</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">Jason D.  Burch</span>, <span class="hlFld-ContribAuthor ">Yuan  Chen</span>, <span class="hlFld-ContribAuthor ">Jonathon  Dines</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Alexander  Heifetz</span>, <span class="hlFld-ContribAuthor ">Allan  Jaochico</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Joachim  Kraemer</span>, <span class="hlFld-ContribAuthor ">Susanne  Kruger</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Krülle</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Rosemary  Maghames</span>, <span class="hlFld-ContribAuthor ">Christian A.G.N.  Montalbetti</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Yolanda  Pérez-Fuertes</span>, <span class="hlFld-ContribAuthor ">Steven  Shia</span>, <span class="hlFld-ContribAuthor ">Daniel B.  Stein</span>, <span class="hlFld-ContribAuthor ">Giancarlo  Trani</span>, <span class="hlFld-ContribAuthor ">Darshan G.  Vaidya</span>, <span class="hlFld-ContribAuthor ">Xiaolu  Wang</span>, <span class="hlFld-ContribAuthor ">Steven M.  Bromidge</span>, <span class="hlFld-ContribAuthor ">Lawren C.  Wu</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (23)
                                     , 6331-6335. <a href="https://doi.org/10.1016/j.bmcl.2013.09.069" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.069%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdesign%252Band%252Bsynthesis%252Bof%252Bpotent%252Bbenzothiazole%252Binhibitors%252Bof%252Binterleukin-2%252Binducible%252BT%252Bcell%252Bkinase%252B%252528ITK%252529%26aulast%3DMacKinnon%26aufirst%3DColin%2BH.%26date%3D2013%26volume%3D23%26issue%3D23%26spage%3D6331%26epage%3D6335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John D.  Harling</span>, <span class="hlFld-ContribAuthor ">Angela M.  Deakin</span>, <span class="hlFld-ContribAuthor ">Sébastien  Campos</span>, <span class="hlFld-ContribAuthor ">Rachel  Grimley</span>, <span class="hlFld-ContribAuthor ">Laiq  Chaudry</span>, <span class="hlFld-ContribAuthor ">Catherine  Nye</span>, <span class="hlFld-ContribAuthor ">Oxana  Polyakova</span>, <span class="hlFld-ContribAuthor ">Christina M.  Bessant</span>, <span class="hlFld-ContribAuthor ">Nick  Barton</span>, <span class="hlFld-ContribAuthor ">Don  Somers</span>, <span class="hlFld-ContribAuthor ">John  Barrett</span>, <span class="hlFld-ContribAuthor ">Rebecca H.  Graves</span>, <span class="hlFld-ContribAuthor ">Laura  Hanns</span>, <span class="hlFld-ContribAuthor ">William J.  Kerr</span>, <span class="hlFld-ContribAuthor ">Roberto  Solari</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Irreversible Inhibitors of Interleukin (IL)-2-inducible Tyrosine Kinase (Itk) by Targeting Cysteine 442 in the ATP Pocket. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2013,</strong> <em>288 </em>
                                    (39)
                                     , 28195-28206. <a href="https://doi.org/10.1074/jbc.M113.474114" title="DOI URL">https://doi.org/10.1074/jbc.M113.474114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M113.474114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M113.474114%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BIrreversible%252BInhibitors%252Bof%252BInterleukin%252B%252528IL%252529-2-inducible%252BTyrosine%252BKinase%252B%252528Itk%252529%252Bby%252BTargeting%252BCysteine%252B442%252Bin%252Bthe%252BATP%252BPocket%26aulast%3DHarling%26aufirst%3DJohn%2BD.%26date%3D2013%26volume%3D288%26issue%3D39%26spage%3D28195%26epage%3D28206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Yogesh  Sabnis</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Tinghu  Zhang</span>, <span class="hlFld-ContribAuthor ">Sara J.  Buhrlage</span>, <span class="hlFld-ContribAuthor ">Lyn H.  Jones</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Developing Irreversible Inhibitors of the Protein Kinase Cysteinome. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biology</span><span> <strong>2013,</strong> <em>20 </em>
                                    (2)
                                     , 146-159. <a href="https://doi.org/10.1016/j.chembiol.2012.12.006" title="DOI URL">https://doi.org/10.1016/j.chembiol.2012.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2012.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2012.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biology%26atitle%3DDeveloping%252BIrreversible%252BInhibitors%252Bof%252Bthe%252BProtein%252BKinase%252BCysteinome%26aulast%3DLiu%26aufirst%3DQingsong%26date%3D2013%26volume%3D20%26issue%3D2%26spage%3D146%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Known Itk inhibitors from the literature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pulse-chase experiment in the presence and absence of a covalent Itk inhibitor to determine the functional half-life of Itk in primary cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Determination of the inhibition of phospho-PLCγ1 over time in the presence of 10 μM covalent Itk inhibitors. The measured phospho-PLCγ1 inhibition in the presence of an inhibitor was normalized to the control (absence of inhibitor).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Aryl and Heteroaryl-Substituted Pyrazolopyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIAD, PPh<sub>3</sub>, THF; (b) boronic acid, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 120 °C; (c) 4 N HCl, 1,4-dioxane; (d) EDCI, HOBT, TEA, acrylic acid, THF or acryloyl chloride, TEA, DCM.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Amide Substituted Pyrazolopyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-(methoxycarbonyl)phenylboronic acid, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 1,4 dioxane, 120 °C; (b) NaOH, MeOH, H<sub>2</sub>O; (c) HATU, TEA, HNR<sub>1</sub>R<sub>2</sub>, THF; (d) 4 N HCl, 1,4-dioxane; (e) HATU, TEA, R<sub>3</sub>CO<sub>2</sub>H, THF or R<sub>3</sub>C(O)Cl, TEA, DCM or BrCN, Cs<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Itk potency of amide <b>52</b>. (B) X-ray crystal structures of <b>52</b> in the ATP binding site of Itk (a portion of the P-loop was omitted for clarity purposes).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Comparison of the potencies of the enantiomeric pair <b>40</b> and <b>53</b> highlights the critical influence of the stereogenic center. (B) Overlay of the two enantiomers bound to the ATP-binding site of Itk.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Reasonable correlation is observed (within approximately 20-fold) for potency data obtained from the cell-based IP1 and 1 mM ATP enzyme assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/medium/jm-2012-01190s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. A pIC<sub>50</sub> vs clogP plot reveals that among the acrylamides (cyan) several of them are potent and show LipE values in the 4–5 range; the noncovalent acetamides (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) are included as well (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301190s/production/images/large/jm-2012-01190s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301190s&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11030" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11030" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Iyer, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">August, A.</span><span> </span><span class="NLM_article-title">The Tec family kinase, IL-2-inducible T cell kinase, differentially controls mast cell responses</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">7869</span><span class="NLM_x">–</span> <span class="NLM_lpage">7877</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=7869-7877&author=A.+S.+Iyerauthor=A.+August&title=The+Tec+family+kinase%2C+IL-2-inducible+T+cell+kinase%2C+differentially+controls+mast+cell+responses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIyer%26aufirst%3DA.%2BS.%26aulast%3DAugust%26aufirst%3DA.%26atitle%3DThe%2520Tec%2520family%2520kinase%252C%2520IL-2-inducible%2520T%2520cell%2520kinase%252C%2520differentially%2520controls%2520mast%2520cell%2520responses%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D7869%26epage%3D7877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Andreotti, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, L. J.</span><span> </span><span class="NLM_article-title">T-cell signaling regulated by the Tec family kinase, Itk</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a002287</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=a002287&author=A.+H.+Andreottiauthor=P.+L.+Schwartzbergauthor=R.+E.+Josephauthor=L.+J.+Berg&title=T-cell+signaling+regulated+by+the+Tec+family+kinase%2C+Itk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndreotti%26aufirst%3DA.%2BH.%26aulast%3DSchwartzberg%26aufirst%3DP.%2BL.%26aulast%3DJoseph%26aufirst%3DR.%2BE.%26aulast%3DBerg%26aufirst%3DL.%2BJ.%26atitle%3DT-cell%2520signaling%2520regulated%2520by%2520the%2520Tec%2520family%2520kinase%252C%2520Itk%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2010%26volume%3D2%26spage%3Da002287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Berg, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P. L.</span><span> </span><span class="NLM_article-title">Tec family kinases in T lymphocyte development and function</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1146%2Fannurev.immunol.22.012703.104743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=15771581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFOjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=549-600&author=L.+J.+Bergauthor=L.+D.+Finkelsteinauthor=J.+A.+Lucasauthor=P.+L.+Schwartzberg&title=Tec+family+kinases+in+T+lymphocyte+development+and+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tec family kinases in T lymphocyte development and function</span></div><div class="casAuthors">Berg, Leslie J.; Finkelstein, Lisa D.; Lucas, Julie A.; Schwartzberg, Pamela L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">549-600</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The Tec family tyrosine kinases are now recognized as important mediators of antigen receptor signaling in lymphocytes.  Three members of this family, Itk, Rlk, and Tec, are expressed in T cells and activated in response to T cell receptor (TCR) engagement.  Although initial studies demonstrated a role for these proteins in TCR-mediated activation of phospholipase C-γ, recent data indicate that Tec family kinases also regulate actin cytoskeletal reorganization and cellular adhesion following TCR stimulation.  In addn., Tec family kinases are activated downstream of G protein-coupled chemokine receptors, where they play parallel roles in the regulation of Rho GTPases, cell polarization, adhesion, and migration.  In all these systems, however, Tec family kinases are not essential signaling components, but instead function to modulate or amplify signaling pathways.  Although they quant. reduce proximal signaling, mutations that eliminate Tec family kinases in T cells nonetheless qual. alter T cell development and differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq80olBDulky7Vg90H21EOLACvtfcHk0ljJsajgZSJl9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFOjurc%253D&md5=bf2a0bd00c2bbea96c2683c5afbd56fa</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.22.012703.104743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.22.012703.104743%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DL.%2BJ.%26aulast%3DFinkelstein%26aufirst%3DL.%2BD.%26aulast%3DLucas%26aufirst%3DJ.%2BA.%26aulast%3DSchwartzberg%26aufirst%3DP.%2BL.%26atitle%3DTec%2520family%2520kinases%2520in%2520T%2520lymphocyte%2520development%2520and%2520function%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D23%26spage%3D549%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Burbach, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medeiros, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, Y.</span><span> </span><span class="NLM_article-title">T-cell receptor signaling to integrins</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">218</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1111%2Fj.1600-065X.2007.00527.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=17624944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSiu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=2007&pages=65-81&author=B.+J.+Burbachauthor=R.+B.+Medeirosauthor=K.+L.+Muellerauthor=Y.+Shimizu&title=T-cell+receptor+signaling+to+integrins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">T-cell receptor signaling to integrins</span></div><div class="casAuthors">Burbach, Brandon J.; Medeiros, Ricardo B.; Mueller, Kristen L.; Shimizu, Yoji</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65-81</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Integrin adhesion receptors are crit. for antigen recognition by T cells and for regulated recirculation and trafficking into and through various tissues in the body.  T-cell receptor (TCR) signaling induces rapid increases in integrin function that facilitate T-cell activation by promoting stable contact with antigen-presenting cells and extracellular proteins in the environment.  In this review, we outline the mol. mechanisms by which the TCR signals to integrins and present a model that highlights four key events:.  (i) initiation of proximal TCR signals nucleated by the linker for activated T cells (LAT) adapter protein and involving Itk, phospholipase C-γ1, Vav1, and Src homol. 2 domain-contg. leukocyte-specific phosphoprotein of 76 kDa;.  (ii) transmission of integrin activation signals from the LAT signalosome to integrins by protein kinase (PK) C and the adapter protein, adhesion and degranulation-promoting adapter protein;.  (iii) assembly of integrin-assocd. signaling complexes that include PKD, the guanosine triphosphatase Rap1 and its effectors, and talin; and.  (iv) reorganization of the actin cytoskeleton by WAVE2 and other actin-remodeling proteins.  These events coordinate changes in integrin conformation and clustering that result in enhanced integrin functional activity following TCR stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP7lwoCheD2bVg90H21EOLACvtfcHk0ljJsajgZSJl9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSiu7%252FK&md5=850a4b10b4c1ef6704a7df4cf3c044cc</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2007.00527.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2007.00527.x%26sid%3Dliteratum%253Aachs%26aulast%3DBurbach%26aufirst%3DB.%2BJ.%26aulast%3DMedeiros%26aufirst%3DR.%2BB.%26aulast%3DMueller%26aufirst%3DK.%2BL.%26aulast%3DShimizu%26aufirst%3DY.%26atitle%3DT-cell%2520receptor%2520signaling%2520to%2520integrins%26jtitle%3DImmunol.%2520Rev.%26date%3D2007%26volume%3D218%26spage%3D65%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sahu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">August, A.</span><span> </span><span class="NLM_article-title">Differential sensitivity to Itk kinase signals for T helper 2 cytokine production and chemokine-mediated migration</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">3833</span><span class="NLM_x">–</span> <span class="NLM_lpage">3838</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=3833-3838&author=N.+Sahuauthor=C.+Muellerauthor=A.+Fischerauthor=A.+August&title=Differential+sensitivity+to+Itk+kinase+signals+for+T+helper+2+cytokine+production+and+chemokine-mediated+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSahu%26aufirst%3DN.%26aulast%3DMueller%26aufirst%3DC.%26aulast%3DFischer%26aufirst%3DA.%26aulast%3DAugust%26aufirst%3DA.%26atitle%3DDifferential%2520sensitivity%2520to%2520Itk%2520kinase%2520signals%2520for%2520T%2520helper%25202%2520cytokine%2520production%2520and%2520chemokine-mediated%2520migration%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D3833%26epage%3D3838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kosaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felices, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, L. J.</span><span> </span><span class="NLM_article-title">Itk and Th2 responses: action but no reaction</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1016%2Fj.it.2006.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=16931156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Cntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=453-460&author=Y.+Kosakaauthor=M.+Felicesauthor=L.+J.+Berg&title=Itk+and+Th2+responses%3A+action+but+no+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Itk and Th2 responses: action but no reaction</span></div><div class="casAuthors">Kosaka, Yoko; Felices, Martin; Berg, Leslie J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Tec family tyrosine kinase, Itk, was initially characterized as a crucial component of T-cell receptor signaling pathways resulting in phospholipase C-γ1 activation and actin polymn.  In 1999, a seminal report by Fowell, Locksley and colleagues demonstrated that, in CD4+ T cells, Itk-dependent signals are differentially required for T-helper (Th)2 vs. Th1 differentiation and effector function.  These findings launched a series of in vitro and in vivo studies addressing the mol. defects of Itk-/- CD4+ T cells, and the impaired immune responses of intact Itk-deficient mice.  While demonstrating a bias against Th2 differentiation, overall these expts. have indicated that the most significant failing is an inability of Itk-/- CD4+ T cells to produce Th2 cytokines in a recall response, rather than an abs. defect in Th2 differentiation by T cells lacking Itk.  In this review, the authors discuss the pathways by which Itk might impact the differentiation of Th cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt4jE6pciDZLVg90H21EOLACvtfcHk0ljJsajgZSJl9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Cntro%253D&md5=12211f8e47c4ff4e1f0ddad9dbae76f7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2006.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2006.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DKosaka%26aufirst%3DY.%26aulast%3DFelices%26aufirst%3DM.%26aulast%3DBerg%26aufirst%3DL.%2BJ.%26atitle%3DItk%2520and%2520Th2%2520responses%253A%2520action%2520but%2520no%2520reaction%26jtitle%3DTrends%2520Immunol.%26date%3D2006%26volume%3D27%26spage%3D453%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Au-Yeung, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowell, D. J.</span><span> </span><span class="NLM_article-title">Cutting edge: Itk-dependent signals required for CD4+ T cells to exert, but not gain, Th2 effector function</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">3895</span><span class="NLM_x">–</span> <span class="NLM_lpage">3899</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=3895-3899&author=B.+B.+Au-Yeungauthor=S.+D.+Katzmanauthor=D.+J.+Fowell&title=Cutting+edge%3A+Itk-dependent+signals+required+for+CD4%2B+T+cells+to+exert%2C+but+not+gain%2C+Th2+effector+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAu-Yeung%26aufirst%3DB.%2BB.%26aulast%3DKatzman%26aufirst%3DS.%2BD.%26aulast%3DFowell%26aufirst%3DD.%2BJ.%26atitle%3DCutting%2520edge%253A%2520Itk-dependent%2520signals%2520required%2520for%2520CD4%252B%2520T%2520cells%2520to%2520exert%252C%2520but%2520not%2520gain%252C%2520Th2%2520effector%2520function%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D176%26spage%3D3895%26epage%3D3899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Gomez-Rodriguez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">August, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P. L.</span><span> </span><span class="NLM_article-title">Differential expression of interleukin-17A and −17F is coupled to T cell receptor signaling via inducible T cell kinase</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2009&pages=587-597&author=J.+Gomez-Rodriguezauthor=N.+Sahuauthor=R.+Handonauthor=T.+S.+Davidsonauthor=S.+M.+Andersonauthor=M.+R.+Kirbyauthor=A.+Augustauthor=P.+L.+Schwartzberg&title=Differential+expression+of+interleukin-17A+and+%E2%88%9217F+is+coupled+to+T+cell+receptor+signaling+via+inducible+T+cell+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Rodriguez%26aufirst%3DJ.%26aulast%3DSahu%26aufirst%3DN.%26aulast%3DHandon%26aufirst%3DR.%26aulast%3DDavidson%26aufirst%3DT.%2BS.%26aulast%3DAnderson%26aufirst%3DS.%2BM.%26aulast%3DKirby%26aufirst%3DM.%2BR.%26aulast%3DAugust%26aufirst%3DA.%26aulast%3DSchwartzberg%26aufirst%3DP.%2BL.%26atitle%3DDifferential%2520expression%2520of%2520interleukin-17A%2520and%2520%25E2%2588%259217F%2520is%2520coupled%2520to%2520T%2520cell%2520receptor%2520signaling%2520via%2520inducible%2520T%2520cell%2520kinase%26jtitle%3DImmunity%26date%3D2009%26volume%3D31%26spage%3D587%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Takesono, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P. L.</span><span> </span><span class="NLM_article-title">Requirement for Tec kinases in chemokine-induced migration and activation of Cdc42 and Rac</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1016%2Fj.cub.2004.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=15186750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvV2gtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=917-922&author=A.+Takesonoauthor=R.+Horaiauthor=M.+Mandaiauthor=D.+Dombroskiauthor=P.+L.+Schwartzberg&title=Requirement+for+Tec+kinases+in+chemokine-induced+migration+and+activation+of+Cdc42+and+Rac"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for Tec Kinases in Chemokine-Induced Migration and Activation of Cdc42 and Rac</span></div><div class="casAuthors">Takesono, Aya; Horai, Reiko; Mandai, Michiko; Dombroski, Derek; Schwartzberg, Pamela L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">917-922</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cell polarization and migration in response to chemokines is essential for proper development of the immune system and activation of immune responses.  Recent studies of chemokine signaling have revealed a crit. role for PI3-Kinase, which is required for polarized membrane assocn. of pleckstrin homol. (PH) domain-contg. proteins and activation of Rho family GTPases that are essential for cell polarization and actin reorganization.  Addnl. data argue that tyrosine kinases are also important for chemokine-induced Rac activation.  However, how and which kinases participate in these pathways remain unclear.  The authors demonstrate here that the Tec kinases Itk and Rlk play an important role in chemokine signaling in T lymphocytes.  Chemokine stimulation induced transient membrane assocn. of Itk and phosphorylation of both Itk and Rlk, and purified T cells from Rlk-/-Itk-/- mice exhibited defective migration to multiple chemokines in vitro and decreased homing to lymph nodes upon transfer to wt mice.  Expression of a dominant-neg. Itk impaired SDF-1α-induced migration, cell polarization, and activation of Rac and Cdc42.  Thus, Tec kinases are crit. components of signaling pathways required for actin polarization downstream from both antigen and chemokine receptors in T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofXj-tMpo3TbVg90H21EOLACvtfcHk0lgDSqrETYhsLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvV2gtbs%253D&md5=ec927299a684d0eb276b5236cec4c8d8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2004.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2004.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DTakesono%26aufirst%3DA.%26aulast%3DHorai%26aufirst%3DR.%26aulast%3DMandai%26aufirst%3DM.%26aulast%3DDombroski%26aufirst%3DD.%26aulast%3DSchwartzberg%26aufirst%3DP.%2BL.%26atitle%3DRequirement%2520for%2520Tec%2520kinases%2520in%2520chemokine-induced%2520migration%2520and%2520activation%2520of%2520Cdc42%2520and%2520Rac%26jtitle%3DCurr.%2520Biol.%26date%3D2004%26volume%3D14%26spage%3D917%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Fischer, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">August, A.</span><span> </span><span class="NLM_article-title">Regulation of CXC chemokine receptor 4-mediated migration by the Tec family tyrosine kinase ITK</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">29816</span><span class="NLM_x">–</span> <span class="NLM_lpage">29820</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=29816-29820&author=A.+M.+Fischerauthor=J.+C.+Mercerauthor=A.+Iyerauthor=M.+J.+Raginauthor=A.+August&title=Regulation+of+CXC+chemokine+receptor+4-mediated+migration+by+the+Tec+family+tyrosine+kinase+ITK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DA.%2BM.%26aulast%3DMercer%26aufirst%3DJ.%2BC.%26aulast%3DIyer%26aufirst%3DA.%26aulast%3DRagin%26aufirst%3DM.%2BJ.%26aulast%3DAugust%26aufirst%3DA.%26atitle%3DRegulation%2520of%2520CXC%2520chemokine%2520receptor%25204-mediated%2520migration%2520by%2520the%2520Tec%2520family%2520tyrosine%2520kinase%2520ITK%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D29816%26epage%3D29820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Readinger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiralli, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">August, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P. L.</span><span> </span><span class="NLM_article-title">Selective targeting of ITK blocks multiple steps of HIV replication</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">6684</span><span class="NLM_x">–</span> <span class="NLM_lpage">6689</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=6684-6689&author=J.+A.+Readingerauthor=G.+M.+Schiralliauthor=J.+K.+Jiangauthor=C.+J.+Thomasauthor=A.+Augustauthor=A.+J.+Hendersonauthor=P.+L.+Schwartzberg&title=Selective+targeting+of+ITK+blocks+multiple+steps+of+HIV+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReadinger%26aufirst%3DJ.%2BA.%26aulast%3DSchiralli%26aufirst%3DG.%2BM.%26aulast%3DJiang%26aufirst%3DJ.%2BK.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DAugust%26aufirst%3DA.%26aulast%3DHenderson%26aufirst%3DA.%2BJ.%26aulast%3DSchwartzberg%26aufirst%3DP.%2BL.%26atitle%3DSelective%2520targeting%2520of%2520ITK%2520blocks%2520multiple%2520steps%2520of%2520HIV%2520replication%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D6684%26epage%3D6689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lin, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Day, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penhallow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postelnek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Villar, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S. B.</span><span> </span><span class="NLM_article-title">Selective Itk inhibitors block T-cell activation and murine lung inflammation</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">11056</span><span class="NLM_x">–</span> <span class="NLM_lpage">11062</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi049428r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=11056-11062&author=T.+A.+Linauthor=K.+W.+McIntyreauthor=J.+Dasauthor=C.+Liuauthor=K.+D.+O%E2%80%99Dayauthor=B.+Penhallowauthor=C.+Y.+Hungauthor=G.+S.+Whitneyauthor=D.+J.+Shusterauthor=X.+Yangauthor=R.+Townsendauthor=J.+Postelnekauthor=S.+H.+Spergelauthor=J.+Linauthor=R.+V.+Moquinauthor=J.+A.+Furchauthor=A.+V.+Kamathauthor=H.+Zhangauthor=P.+H.+Maratheauthor=J.+J.+Perez-Villarauthor=A.+Doweykoauthor=L.+Killarauthor=J.+H.+Doddauthor=J.+C.+Barrishauthor=J.+Wityakauthor=S.+B.+Kanner&title=Selective+Itk+inhibitors+block+T-cell+activation+and+murine+lung+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fbi049428r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049428r%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.%2BA.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Day%26aufirst%3DK.%2BD.%26aulast%3DPenhallow%26aufirst%3DB.%26aulast%3DHung%26aufirst%3DC.%2BY.%26aulast%3DWhitney%26aufirst%3DG.%2BS.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DTownsend%26aufirst%3DR.%26aulast%3DPostelnek%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DFurch%26aufirst%3DJ.%2BA.%26aulast%3DKamath%26aufirst%3DA.%2BV.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DPerez-Villar%26aufirst%3DJ.%2BJ.%26aulast%3DDoweyko%26aufirst%3DA.%26aulast%3DKillar%26aufirst%3DL.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26atitle%3DSelective%2520Itk%2520inhibitors%2520block%2520T-cell%2520activation%2520and%2520murine%2520lung%2520inflammation%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D11056%26epage%3D11062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Day, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penhallow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span> </span><span class="NLM_article-title">Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3706</span><span class="NLM_x">–</span> <span class="NLM_lpage">3712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3706-3712&author=J.+Dasauthor=J.+A.+Furchauthor=C.+Liuauthor=R.+V.+Moquinauthor=J.+Linauthor=S.+H.+Spergelauthor=K.+W.+McIntyreauthor=D.+J.+Shusterauthor=K.+D.+O%E2%80%99Dayauthor=B.+Penhallowauthor=C.+Y.+Hungauthor=A.+M.+Doweykoauthor=A.+Kamathauthor=H.+Zhangauthor=P.+Maratheauthor=S.+B.+Kannerauthor=T.+A.+Linauthor=J.+H.+Doddauthor=J.+C.+Barrishauthor=J.+Wityak&title=Discovery+and+SAR+of+2-amino-5-%28thioaryl%29thiazoles+as+potent+and+selective+Itk+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DFurch%26aufirst%3DJ.%2BA.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DO%25E2%2580%2599Day%26aufirst%3DK.%2BD.%26aulast%3DPenhallow%26aufirst%3DB.%26aulast%3DHung%26aufirst%3DC.%2BY.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26aulast%3DLin%26aufirst%3DT.%2BA.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DWityak%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520SAR%2520of%25202-amino-5-%2528thioaryl%2529thiazoles%2520as%2520potent%2520and%2520selective%2520Itk%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3706%26epage%3D3712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yingling, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A. S.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelock, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homon, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span> </span><span class="NLM_article-title">Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1177%2F1087057106296047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=17166826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFGgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=70-83&author=M.+A.+Kashemauthor=R.+M.+Nelsonauthor=J.+D.+Yinglingauthor=S.+S.+Pullenauthor=A.+S.+Prokopowiczauthor=J.+W.+Jonesauthor=J.+P.+Wolakauthor=G.+R.+Rogersauthor=M.+M.+Morelockauthor=R.+J.+Snowauthor=C.+A.+Homonauthor=S.+Jakes&title=Three+mechanistically+distinct+kinase+assays+compared%3A+Measurement+of+intrinsic+ATPase+activity+identified+the+most+comprehensive+set+of+ITK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Three mechanistically distinct kinase assays compared: measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors</span></div><div class="casAuthors">Kashem, Mohammed A.; Nelson, Richard M.; Yingling, Jeffrey D.; Pullen, Steven S.; Prokopowicz, Anthony S., III; Jones, Jessi Wildeson; Wolak, John P.; Rogers, George R.; Morelock, Maurice M.; Snow, Roger J.; Homon, Carol Ann; Jakes, Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-83</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Numerous assay methods have been developed to identify small-mol. effectors of protein kinases, but no single method can be applied to all isolated kinases.  The authors developed a set of 3 high-throughput screening (HTS)-compatible biochem. assays that can measure 3 mechanistically distinct properties of a kinase active site, with the goal that at least 1 of the 3 would be applicable to any kinase selected as a target for drug discovery efforts.  Two assays measure catalytically active enzyme: A dissocn.-enhanced lanthanide fluoroimmuno assay (DELFIA) uses an antibody to quantitate the generation of phosphorylated substrate; a second assay uses luciferase to measure the consumption of ATP (ATP) during either phosphoryl-transfer to a peptide substrate or to water (intrinsic ATPase activity).  A third assay, which is not dependent on a catalytically active enzyme, measures the competition for binding to kinase between an inhibitor and a fluorescent ATP binding site probe.  To evaluate the suitability of these assays for drug discovery, the authors compared their ability to identify inhibitors of a nonreceptor protein tyrosine kinase from the Tec family, interleukin-2-inducible T cell kinase (ITK).  The 3 assays agreed on 57% of the combined confirmed hit set identified from screening a 10,208-compd. library enriched with known kinase inhibitors and mols. that were structurally similar.  Among the 3 assays, the one measuring intrinsic ATPase activity produced the largest no. of unique hits, the fewest unique misses, and the most comprehensive hit set, missing only 2.7% of the confirmed inhibitors identified by the other 2 assays combined.  Based on these data, all 3 assay formats are viable for screening and together provide greater options for assay design depending on the targeted kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMYJv4pFA79bVg90H21EOLACvtfcHk0lgIsbQmFzp5JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFGgs7k%253D&md5=7a9c01e2feca289a556f630277061732</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1177%2F1087057106296047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057106296047%26sid%3Dliteratum%253Aachs%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DNelson%26aufirst%3DR.%2BM.%26aulast%3DYingling%26aufirst%3DJ.%2BD.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DProkopowicz%26aufirst%3DA.%2BS.%26aulast%3DJones%26aufirst%3DJ.%2BW.%26aulast%3DWolak%26aufirst%3DJ.%2BP.%26aulast%3DRogers%26aufirst%3DG.%2BR.%26aulast%3DMorelock%26aufirst%3DM.%2BM.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DHomon%26aufirst%3DC.%2BA.%26aulast%3DJakes%26aufirst%3DS.%26atitle%3DThree%2520mechanistically%2520distinct%2520kinase%2520assays%2520compared%253A%2520Measurement%2520of%2520intrinsic%2520ATPase%2520activity%2520identified%2520the%2520most%2520comprehensive%2520set%2520of%2520ITK%2520inhibitors%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2007%26volume%3D12%26spage%3D70%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Winters, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woska, J. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplita, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DesJarlais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, K. J.</span><span> </span><span class="NLM_article-title">5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5541</span><span class="NLM_x">–</span> <span class="NLM_lpage">5544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5541-5544&author=M.+P.+Wintersauthor=D.+J.+Robinsonauthor=H.+H.+Khineauthor=S.+S.+Pullenauthor=J.+R.+Woskaauthor=E.+L.+Raymondauthor=R.+Sellatiauthor=C.+L.+Cywinauthor=R.+J.+Snowauthor=M.+A.+Kashemauthor=J.+P.+Wolakauthor=J.+Kingauthor=P.+V.+Kaplitaauthor=L.+H.+Liuauthor=T.+M.+Farrellauthor=R.+DesJarlaisauthor=G.+P.+Rothauthor=H.+Takahashiauthor=K.+J.+Moriarty&title=5-Aminomethyl-1H-benzimidazoles+as+orally+active+inhibitors+of+inducible+T-cell+kinase+%28Itk%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWinters%26aufirst%3DM.%2BP.%26aulast%3DRobinson%26aufirst%3DD.%2BJ.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DWoska%26aufirst%3DJ.%2BR.%26aulast%3DRaymond%26aufirst%3DE.%2BL.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DWolak%26aufirst%3DJ.%2BP.%26aulast%3DKing%26aufirst%3DJ.%26aulast%3DKaplita%26aufirst%3DP.%2BV.%26aulast%3DLiu%26aufirst%3DL.%2BH.%26aulast%3DFarrell%26aufirst%3DT.%2BM.%26aulast%3DDesJarlais%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DMoriarty%26aufirst%3DK.%2BJ.%26atitle%3D5-Aminomethyl-1H-benzimidazoles%2520as%2520orally%2520active%2520inhibitors%2520of%2520inducible%2520T-cell%2520kinase%2520%2528Itk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5541%26epage%3D5544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywardane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarko, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span> </span><span class="NLM_article-title">Hit-to-lead studies on benzimidazole inhibitors of ITK: discovery of a novel class of kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3660</span><span class="NLM_x">–</span> <span class="NLM_lpage">3665</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3660-3665&author=R.+J.+Snowauthor=A.+Abeywardaneauthor=S.+Campbellauthor=J.+Lordauthor=M.+A.+Kashemauthor=H.+H.+Khineauthor=J.+Kingauthor=J.+A.+Kowalskiauthor=S.+S.+Pullenauthor=T.+Romaauthor=G.+P.+Rothauthor=C.+R.+Sarkoauthor=N.+S.+Wilsonauthor=M.+P.+Wintersauthor=J.+P.+Wolakauthor=C.+L.+Cywin&title=Hit-to-lead+studies+on+benzimidazole+inhibitors+of+ITK%3A+discovery+of+a+novel+class+of+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DAbeywardane%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DLord%26aufirst%3DJ.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DKing%26aufirst%3DJ.%26aulast%3DKowalski%26aufirst%3DJ.%2BA.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DRoma%26aufirst%3DT.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DSarko%26aufirst%3DC.%2BR.%26aulast%3DWilson%26aufirst%3DN.%2BS.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26aulast%3DWolak%26aufirst%3DJ.%2BP.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26atitle%3DHit-to-lead%2520studies%2520on%2520benzimidazole%2520inhibitors%2520of%2520ITK%253A%2520discovery%2520of%2520a%2520novel%2520class%2520of%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3660%26epage%3D3665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Moriarty, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sallati, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woska, J. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DesJarlais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B.</span><span> </span><span class="NLM_article-title">Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5545</span><span class="NLM_x">–</span> <span class="NLM_lpage">5549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5545-5549&author=K.+J.+Moriartyauthor=H.+Takahashiauthor=S.+S.+Pullenauthor=H.+H.+Khineauthor=R.+H.+Sallatiauthor=E.+L.+Raymondauthor=J.+R.+Woskaauthor=D.+D.+Jeanfavreauthor=G.+P.+Rothauthor=M.+P.+Wintersauthor=L.+Qiaoauthor=D.+Ryanauthor=R.+DesJarlaisauthor=D.+Robinsonauthor=M.+Wilsonauthor=M.+Bobkoauthor=B.+N.+Cookauthor=H.+Y.+Loauthor=P.+A.+Nemotoauthor=M.+A.+Kashemauthor=J.+P.+Wolakauthor=A.+Whiteauthor=R.+L.+Magoldaauthor=B.+Tomczuk&title=Discovery%2C+SAR+and+X-ray+structure+of+1H-benzimidazole-5-carboxylic+acid+cyclohexyl-methyl-amides+as+inhibitors+of+inducible+T-cell+kinase+%28Itk%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DK.%2BJ.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DSallati%26aufirst%3DR.%2BH.%26aulast%3DRaymond%26aufirst%3DE.%2BL.%26aulast%3DWoska%26aufirst%3DJ.%2BR.%26aulast%3DJeanfavre%26aufirst%3DD.%2BD.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26aulast%3DQiao%26aufirst%3DL.%26aulast%3DRyan%26aufirst%3DD.%26aulast%3DDesJarlais%26aufirst%3DR.%26aulast%3DRobinson%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DBobko%26aufirst%3DM.%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DLo%26aufirst%3DH.%2BY.%26aulast%3DNemoto%26aufirst%3DP.%2BA.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DWolak%26aufirst%3DJ.%2BP.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DTomczuk%26aufirst%3DB.%26atitle%3DDiscovery%252C%2520SAR%2520and%2520X-ray%2520structure%2520of%25201H-benzimidazole-5-carboxylic%2520acid%2520cyclohexyl-methyl-amides%2520as%2520inhibitors%2520of%2520inducible%2520T-cell%2520kinase%2520%2528Itk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5545%26epage%3D5549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleymanzadeh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugler, S. Z.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lombaert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=773-777&author=B.+N.+Cookauthor=J.+Bentzienauthor=A.+Whiteauthor=P.+A.+Nemotoauthor=J.+Wangauthor=C.+C.+Manauthor=F.+Soleymanzadehauthor=H.+H.+Khineauthor=M.+A.+Kashemauthor=S.+Z.+Kuglerauthor=J.+P.+Wolakauthor=G.+P.+Rothauthor=S.+De+Lombaertauthor=S.+S.+Pullenauthor=H.+Takahashi&title=Discovery+of+potent+inhibitors+of+interleukin-2+inducible+T-cell+kinase+%28ITK%29+through+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DBentzien%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DNemoto%26aufirst%3DP.%2BA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMan%26aufirst%3DC.%2BC.%26aulast%3DSoleymanzadeh%26aufirst%3DF.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DKugler%26aufirst%3DS.%2BZ.%26aulast%3DWolak%26aufirst%3DJ.%2BP.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitors%2520of%2520interleukin-2%2520inducible%2520T-cell%2520kinase%2520%2528ITK%2529%2520through%2520structure-based%2520drug%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D773%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Riether, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zindell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombaert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugler, S. Z.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woska, J. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labissiere, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">5-Aminomethylbenzimidazoles as potent ITK antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1588</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1588-1591&author=D.+Rietherauthor=R.+Zindellauthor=J.+A.+Kowalskiauthor=B.+N.+Cookauthor=J.+Bentzienauthor=S.+D.+Lombaertauthor=D.+Thomsonauthor=S.+Z.+Kuglerauthor=D.+Skowauthor=L.+S.+Martinauthor=E.+L.+Raymondauthor=H.+H.+Khineauthor=K.+O%E2%80%99Sheaauthor=J.+R.+Woskaauthor=D.+Jeanfavreauthor=R.+Sellatiauthor=K.+L.+Ralphauthor=J.+Ahlbergauthor=G.+Labissiereauthor=M.+A.+Kashemauthor=S.+S.+Pullenauthor=H.+Takahashi&title=5-Aminomethylbenzimidazoles+as+potent+ITK+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiether%26aufirst%3DD.%26aulast%3DZindell%26aufirst%3DR.%26aulast%3DKowalski%26aufirst%3DJ.%2BA.%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DBentzien%26aufirst%3DJ.%26aulast%3DLombaert%26aufirst%3DS.%2BD.%26aulast%3DThomson%26aufirst%3DD.%26aulast%3DKugler%26aufirst%3DS.%2BZ.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DL.%2BS.%26aulast%3DRaymond%26aufirst%3DE.%2BL.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DK.%26aulast%3DWoska%26aufirst%3DJ.%2BR.%26aulast%3DJeanfavre%26aufirst%3DD.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DRalph%26aufirst%3DK.%2BL.%26aulast%3DAhlberg%26aufirst%3DJ.%26aulast%3DLabissiere%26aufirst%3DG.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3D5-Aminomethylbenzimidazoles%2520as%2520potent%2520ITK%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1588%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Charrier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenchley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twin, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keily, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durrant, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knegtel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curnock, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, J. M.</span><span> </span><span class="NLM_article-title">Discovery and structure-activity relationship of 3-aminopyrid-2-ones as potent and selective interleukin-2 inducible T-cell kinase (Itk) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2341</span><span class="NLM_x">–</span> <span class="NLM_lpage">2350</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101499u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2341-2350&author=J.+D.+Charrierauthor=A.+Millerauthor=D.+P.+Kayauthor=G.+Brenchleyauthor=H.+C.+Twinauthor=P.+N.+Collierauthor=S.+Ramayaauthor=S.+B.+Keilyauthor=S.+J.+Durrantauthor=R.+M.+Knegtelauthor=A.+J.+Tannerauthor=K.+Brownauthor=A.+P.+Curnockauthor=J.+M.+Jimenez&title=Discovery+and+structure-activity+relationship+of+3-aminopyrid-2-ones+as+potent+and+selective+interleukin-2+inducible+T-cell+kinase+%28Itk%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm101499u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101499u%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DJ.%2BD.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DKay%26aufirst%3DD.%2BP.%26aulast%3DBrenchley%26aufirst%3DG.%26aulast%3DTwin%26aufirst%3DH.%2BC.%26aulast%3DCollier%26aufirst%3DP.%2BN.%26aulast%3DRamaya%26aufirst%3DS.%26aulast%3DKeily%26aufirst%3DS.%2BB.%26aulast%3DDurrant%26aufirst%3DS.%2BJ.%26aulast%3DKnegtel%26aufirst%3DR.%2BM.%26aulast%3DTanner%26aufirst%3DA.%2BJ.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DCurnock%26aufirst%3DA.%2BP.%26aulast%3DJimenez%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%2520and%2520structure-activity%2520relationship%2520of%25203-aminopyrid-2-ones%2520as%2520potent%2520and%2520selective%2520interleukin-2%2520inducible%2520T-cell%2520kinase%2520%2528Itk%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2341%26epage%3D2350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Knegtel, R. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. D.</span><span> </span><span class="NLM_article-title">A Role for Hydration in interleukin-2 inducible T cell kinase (Itk) selectivity</span> <span class="citation_source-journal">Mol. Inf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">950</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1002%2Fminf.201100086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCqsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=950-959&author=R.+M.+A.+Knegtelauthor=D.+D.+Robinson&title=A+Role+for+Hydration+in+interleukin-2+inducible+T+cell+kinase+%28Itk%29+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A Role for Hydration in Interleukin-2 Inducible T Cell Kinase (Itk) Selectivity</span></div><div class="casAuthors">Knegtel, Ronald M. A.; Robinson, Daniel D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">950-959</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The selectivity profile of kinase inhibitors is commonly explained in terms of favorable or unfavorable interactions between the inhibitor and active site residues.  In practice residue sequence differences have not always been sufficient to explain obsd. selectivity profiles.  A series of interleukin-2 inducible T cell kinase (Itk, EC 2.7.10.2) inhibitors that achieve selectivity through the introduction of a single nitrogen atom in an arom. ring has recently been discovered.  Structures of these inhibitors bound to Itk showed this nitrogen to be solvent exposed and not involved in any direct interactions with the enzyme.  By analyzing active site hydration, using the mol. dynamics tool WaterMap, the obsd. selectivity profile can be explained in terms of the replacement of a thermodynamically unfavorable water mol. by the inhibitor and improved hydration of the bound ligand.  The location of this hydration site was successfully used to enrich virtual screening results in their content of selective Itk inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8WcgSAoEdzLVg90H21EOLACvtfcHk0lir0Hd-baThww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCqsbfJ&md5=36ab3cc60f8b794e0664c04a153ba5e1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fminf.201100086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201100086%26sid%3Dliteratum%253Aachs%26aulast%3DKnegtel%26aufirst%3DR.%2BM.%2BA.%26aulast%3DRobinson%26aufirst%3DD.%2BD.%26atitle%3DA%2520Role%2520for%2520Hydration%2520in%2520interleukin-2%2520inducible%2520T%2520cell%2520kinase%2520%2528Itk%2529%2520selectivity%26jtitle%3DMol.%2520Inf.%26date%3D2011%26volume%3D30%26spage%3D950%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Flynn, G. A.; Lee, S. A.; Faris, M.; Brandt, D. W.; Chakravarty, S.</span><span> </span><span class="NLM_article-title">Intracellular Kinase Inhibitors</span>. US 2007/0293499 A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=G.+A.+Flynn&author=S.+A.+Lee&author=M.+Faris&author=D.+W.+Brandt&author=S.+Chakravarty&title=Intracellular+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFlynn%26aufirst%3DG.%2BA.%26atitle%3DIntracellular%2520Kinase%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Alder, C. M.; Baldwin, I. R.; Barton, N. P.; Campbell, A. J.; Champigny, A. C.; Harling, J. D.; Maxwell, A. C.</span><span> </span><span class="NLM_article-title">Derivatives of 2-[2-(Benzo- or Pyrido-)thiazolylamino]-6-aminopyridine, Useful in the Treatment of Respiratoric, Allergic or Inflammatory Diseases</span>. WO 2011/110575 Al,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+M.+Alder&author=I.+R.+Baldwin&author=N.+P.+Barton&author=A.+J.+Campbell&author=A.+C.+Champigny&author=J.+D.+Harling&author=A.+C.+Maxwell&title=Derivatives+of+2-%5B2-%28Benzo-+or+Pyrido-%29thiazolylamino%5D-6-aminopyridine%2C+Useful+in+the+Treatment+of+Respiratoric%2C+Allergic+or+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlder%26aufirst%3DC.%2BM.%26atitle%3DDerivatives%2520of%25202-%255B2-%2528Benzo-%2520or%2520Pyrido-%2529thiazolylamino%255D-6-aminopyridine%252C%2520Useful%2520in%2520the%2520Treatment%2520of%2520Respiratoric%252C%2520Allergic%2520or%2520Inflammatory%2520Diseases%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Maxwell, A. C.; Alder, C.; Ambler, M.; Campbell, A.; Champigny, A.; Harling, J.; Scullion, C.; Smith, I.; Somers, D.; Tame, C.; Wilson, C.; Woolven, J.</span> In  <span class="citation_source-book">Identification of Novel and Selective ITK Inhibitors through a Template Hopping Strategy</span>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">MEDI-8</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=MEDI-8&author=A.+C.+Maxwell&author=C.+Alder&author=M.+Ambler&author=A.+Campbell&author=A.+Champigny&author=J.+Harling&author=C.+Scullion&author=I.+Smith&author=D.+Somers&author=C.+Tame&author=C.+Wilson&author=J.+Woolven&title=Identification+of+Novel+and+Selective+ITK+Inhibitors+through+a+Template+Hopping+Strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DA.%2BC.%26btitle%3DIdentification%2520of%2520Novel%2520and%2520Selective%2520ITK%2520Inhibitors%2520through%2520a%2520Template%2520Hopping%2520Strategy%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2011%26spage%3DMEDI-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28K1%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lir0Hd-baThww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span> </span><span class="NLM_article-title">Biochemical mechanisms of drug action: what does it take for success?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=801-808&author=D.+C.+Swinney&title=Biochemical+mechanisms+of+drug+action%3A+what+does+it+take+for+success%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26atitle%3DBiochemical%2520mechanisms%2520of%2520drug%2520action%253A%2520what%2520does%2520it%2520take%2520for%2520success%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D801%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bogoyevitch, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">622</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=622-633&author=M.+A.+Bogoyevitchauthor=D.+P.+Fairlie&title=A+new+paradigm+for+protein+kinase+inhibition%3A+blocking+phosphorylation+without+directly+targeting+ATP+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBogoyevitch%26aufirst%3DM.%2BA.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DA%2520new%2520paradigm%2520for%2520protein%2520kinase%2520inhibition%253A%2520blocking%2520phosphorylation%2520without%2520directly%2520targeting%2520ATP%2520binding%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D622%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Harrison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karim, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclean, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D.</span><span> </span><span class="NLM_article-title">Non-ATP-competitive kinase inhibitors: enhancing selectivity through new inhibition strategies</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=761-774&author=S.+Harrisonauthor=K.+Dasauthor=F.+Karimauthor=D.+Macleanauthor=D.+Mendel&title=Non-ATP-competitive+kinase+inhibitors%3A+enhancing+selectivity+through+new+inhibition+strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DKarim%26aufirst%3DF.%26aulast%3DMaclean%26aufirst%3DD.%26aulast%3DMendel%26aufirst%3DD.%26atitle%3DNon-ATP-competitive%2520kinase%2520inhibitors%253A%2520enhancing%2520selectivity%2520through%2520new%2520inhibition%2520strategies%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D761%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Navratilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A.</span><span> </span><span class="NLM_article-title">Biosensor-based approach to the identification of protein kinase ligands with dual-site modes of action</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1177%2F1087057111422746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=22068706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVKltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=183-193&author=I.+Navratilovaauthor=G.+Macdonaldauthor=C.+Robinsonauthor=S.+Hughesauthor=J.+Mathiasauthor=C.+Phillipsauthor=A.+Cook&title=Biosensor-based+approach+to+the+identification+of+protein+kinase+ligands+with+dual-site+modes+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Biosensor-based approach to the identification of protein kinase ligands with dual-site modes of action</span></div><div class="casAuthors">Navratilova, Iva; MacDonald, Graeme; Robinson, Colin; Hughes, Samantha; Mathias, John; Phillips, Chris; Cook, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-193</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The authors have used a surface plasmon resonance (SPR)-based biosensor approach to identify and characterize compds. with a unique binding mode to protein kinases.  Biacore was used to characterize hits from an enzymic high-throughput screen of the Tec family tyrosine kinase, IL2-inducible T cell kinase (ITK).  Complex binding kinetics was obsd. for some compds., which led to identification of compds. that bound simultaneously at both the ATP binding site and a second, allosteric site on ITK.  The presence of the second binding site was confirmed by X-ray crystallog.  The second site is located in the N-terminal lobe of the protein kinase catalytic domain, adjacent to but distinct from the ATP site.  To enable rapid optimization of binding properties, a competition-based Biacore assay has been developed to successfully identify second site noncompetitive binders that have been confirmed by X-ray crystallog. studies.  The authors have found that SPR technol. is a key method for rapid identification of compds. with dual-site modes of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_O18si5LWPLVg90H21EOLACvtfcHk0ljiJCBdUKO5ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVKltL8%253D&md5=8860bb955a27b7ba6b167725224c9e60</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1177%2F1087057111422746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057111422746%26sid%3Dliteratum%253Aachs%26aulast%3DNavratilova%26aufirst%3DI.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%26aulast%3DMathias%26aufirst%3DJ.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DA.%26atitle%3DBiosensor-based%2520approach%2520to%2520the%2520identification%2520of%2520protein%2520kinase%2520ligands%2520with%2520dual-site%2520modes%2520of%2520action%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D183%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Han, S.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Han%2C+S.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Robertson, J. G.</span><span> </span><span class="NLM_article-title">Mechanistic basis of enzyme-targeted drugs</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5561</span><span class="NLM_x">–</span> <span class="NLM_lpage">5571</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi050247e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5561-5571&author=J.+G.+Robertson&title=Mechanistic+basis+of+enzyme-targeted+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi050247e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi050247e%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26atitle%3DMechanistic%2520basis%2520of%2520enzyme-targeted%2520drugs%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D5561%26epage%3D5571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0lgMQfCSxwDtWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Schwobel, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koleva, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enoch, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madden, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, M. T.</span><span> </span><span class="NLM_article-title">Measurement and estimation of electrophilic reactivity for predictive toxicology</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">2562</span><span class="NLM_x">–</span> <span class="NLM_lpage">2596</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr100098n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=2562-2596&author=J.+A.+Schwobelauthor=Y.+K.+Kolevaauthor=S.+J.+Enochauthor=F.+Bajotauthor=M.+Hewittauthor=J.+C.+Maddenauthor=D.+W.+Robertsauthor=T.+W.+Schultzauthor=M.+T.+Cronin&title=Measurement+and+estimation+of+electrophilic+reactivity+for+predictive+toxicology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcr100098n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr100098n%26sid%3Dliteratum%253Aachs%26aulast%3DSchwobel%26aufirst%3DJ.%2BA.%26aulast%3DKoleva%26aufirst%3DY.%2BK.%26aulast%3DEnoch%26aufirst%3DS.%2BJ.%26aulast%3DBajot%26aufirst%3DF.%26aulast%3DHewitt%26aufirst%3DM.%26aulast%3DMadden%26aufirst%3DJ.%2BC.%26aulast%3DRoberts%26aufirst%3DD.%2BW.%26aulast%3DSchultz%26aufirst%3DT.%2BW.%26aulast%3DCronin%26aufirst%3DM.%2BT.%26atitle%3DMeasurement%2520and%2520estimation%2520of%2520electrophilic%2520reactivity%2520for%2520predictive%2520toxicology%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D2562%26epage%3D2596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maderna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnute, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashiro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lussier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrocklage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soutter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunussi-Joannopoulos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douhan, J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6258</span><span class="NLM_x">–</span> <span class="NLM_lpage">6263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6258-6263&author=K.+H.+Kimauthor=A.+Madernaauthor=M.+E.+Schnuteauthor=M.+Hegenauthor=S.+Mohanauthor=J.+Miyashiroauthor=L.+Linauthor=E.+Liauthor=S.+Keeganauthor=J.+Lussierauthor=C.+Wrocklageauthor=C.+L.+Nickerson-Nutterauthor=A.+J.+Wittwerauthor=H.+Soutterauthor=N.+Caspersauthor=S.+Hanauthor=R.+Kurumbailauthor=K.+Dunussi-Joannopoulosauthor=J.+Douhanauthor=A.+Wissner&title=Imidazo%5B1%2C5-a%5Dquinoxalines+as+irreversible+BTK+inhibitors+for+the+treatment+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DMaderna%26aufirst%3DA.%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DMiyashiro%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DE.%26aulast%3DKeegan%26aufirst%3DS.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DWrocklage%26aufirst%3DC.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DSoutter%26aufirst%3DH.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DDunussi-Joannopoulos%26aufirst%3DK.%26aulast%3DDouhan%26aufirst%3DJ.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DImidazo%255B1%252C5-a%255Dquinoxalines%2520as%2520irreversible%2520BTK%2520inhibitors%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6258%26epage%3D6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Pan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheerens, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprengeler, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrill, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grothaus, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoerke, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigberg, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalrymple, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span> </span><span class="NLM_article-title">Discovery of selective irreversible inhibitors for Bruton’s tyrosine kinase</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=58-61&author=Z.+Panauthor=H.+Scheerensauthor=S.+J.+Liauthor=B.+E.+Schultzauthor=P.+A.+Sprengelerauthor=L.+C.+Burrillauthor=R.+V.+Mendoncaauthor=M.+D.+Sweeneyauthor=K.+C.+Scottauthor=P.+G.+Grothausauthor=D.+A.+Jefferyauthor=J.+M.+Spoerkeauthor=L.+A.+Honigbergauthor=P.+R.+Youngauthor=S.+A.+Dalrympleauthor=J.+T.+Palmer&title=Discovery+of+selective+irreversible+inhibitors+for+Bruton%E2%80%99s+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DScheerens%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%2BJ.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DBurrill%26aufirst%3DL.%2BC.%26aulast%3DMendonca%26aufirst%3DR.%2BV.%26aulast%3DSweeney%26aufirst%3DM.%2BD.%26aulast%3DScott%26aufirst%3DK.%2BC.%26aulast%3DGrothaus%26aufirst%3DP.%2BG.%26aulast%3DJeffery%26aufirst%3DD.%2BA.%26aulast%3DSpoerke%26aufirst%3DJ.%2BM.%26aulast%3DHonigberg%26aufirst%3DL.%2BA.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DDalrymple%26aufirst%3DS.%2BA.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26atitle%3DDiscovery%2520of%2520selective%2520irreversible%2520inhibitors%2520for%2520Bruton%25E2%2580%2599s%2520tyrosine%2520kinase%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D58%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Honigberg, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisawad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loury, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thamm, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span> </span><span class="NLM_article-title">The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">13075</span><span class="NLM_x">–</span> <span class="NLM_lpage">13080</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1073%2Fpnas.1004594107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=20615965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=13075-13080&author=L.+A.+Honigbergauthor=A.+M.+Smithauthor=M.+Sirisawadauthor=E.+Vernerauthor=D.+Louryauthor=B.+Changauthor=S.+Liauthor=Z.+Panauthor=D.+H.+Thammauthor=R.+A.+Millerauthor=J.+J.+Buggy&title=The+Bruton+tyrosine+kinase+inhibitor+PCI-32765+blocks+B-cell+activation+and+is+efficacious+in+models+of+autoimmune+disease+and+B-cell+malignancy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy</span></div><div class="casAuthors">Honigberg, Lee A.; Smith, Ashley M.; Sirisawad, Mint; Verner, Erik; Loury, David; Chang, Betty; Li, Shyr; Pan, Zhengying; Thamm, Douglas H.; Miller, Richard A.; Buggy, Joseph J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">13075-13080, S13075/1-S13075/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Activation of the B-cell antigen receptor (BCR) signaling pathway contributes to the initiation and maintenance of B-cell malignancies and autoimmune diseases.  The Bruton tyrosine kinase (Btk) is specifically required for BCR signaling as demonstrated by human and mouse mutations that disrupt Btk function and prevent B-cell maturation at steps that require a functional BCR pathway.  Herein we describe a selective and irreversible Btk inhibitor, PCI-32765, that is currently under clin. development in patients with B-cell non-Hodgkin lymphoma.  We have used this inhibitor to investigate the biol. effects of Btk inhibition on mature B-cell function and the progression of B cell-assocd. diseases in vivo.  PCI-32765 blocked BCR signaling in human peripheral B cells at concns. that did not affect T cell receptor signaling.  In mice with collagen-induced arthritis, orally administered PCI-32765 reduced the level of circulating autoantibodies and completely suppressed disease.  PCI-32765 also inhibited autoantibody prodn. and the development of kidney disease in the MRL-Fas(lpr) lupus model.  Occupancy of the Btk active site by PCI-32765 was monitored in vitro and in vivo using a fluorescent affinity probe for Btk.  Active site occupancy of Btk was tightly correlated with the blockade of BCR signaling and in vivo efficacy.  Finally, PCI-32765 induced objective clin. responses in dogs with spontaneous B-cell non-Hodgkin lymphoma.  These findings support Btk inhibition as a therapeutic approach for the treatment of human diseases assocd. with activation of the BCR pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT4OQHme7oHLVg90H21EOLACvtfcHk0lgMQfCSxwDtWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCrsbk%253D&md5=196ce4a05bb9c622c49cb7e908682e63</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1004594107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1004594107%26sid%3Dliteratum%253Aachs%26aulast%3DHonigberg%26aufirst%3DL.%2BA.%26aulast%3DSmith%26aufirst%3DA.%2BM.%26aulast%3DSirisawad%26aufirst%3DM.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DLoury%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DThamm%26aufirst%3DD.%2BH.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Bruton%2520tyrosine%2520kinase%2520inhibitor%2520PCI-32765%2520blocks%2520B-cell%2520activation%2520and%2520is%2520efficacious%2520in%2520models%2520of%2520autoimmune%2520disease%2520and%2520B-cell%2520malignancy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D13075%26epage%3D13080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">The development of HKI-272 and related compounds for the treatment of cancer</span> <span class="citation_source-journal">Arch. Pharm. (Weinheim, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1002%2Fardp.200800009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=18493974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKnsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2008&pages=465-477&author=A.+Wissnerauthor=T.+S.+Mansour&title=The+development+of+HKI-272+and+related+compounds+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The development of HKI-272 and related compounds for the treatment of cancer</span></div><div class="casAuthors">Wissner, Allan; Mansour, Tarek S.</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">465-477</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The development of HKI-272 and EKB-569 for the treatment of cancer is described.  These compds. function as irreversible inhibitors of some members of the ErbB family of receptor tyrosine kinases.  In particular, they target epidermal growth factor receptor (EGFR, also known as ErbB-1) and human epidermal growth factor receptor-2 (HER2, also known as ErbB-2).  Both, HKI-272 and EKB-569 are 4-anilino-3-cyano quinoline derivs. that contain a 4-(dimethylamino)crotonamide Michael-acceptor group at the 6-position.  These compds. inhibit the function of the target enzymes by forming a covalent interaction with a conserved cysteine residue located in the kinase domains of these proteins.  The potential advantages of using irreversible inhibitors for this purpose are discussed.  We summarize the recent findings concerning some somatic mutations in EGFR and their relevance with respect to the irreversible inhibitors.  In particular, we highlight the findings that these irreversible inhibitors retain activity against tumors that have acquired a resistance to the reversible binding inhibitors gefitinib and erlotinib.  The promising interim clin. trial results for HKI-272 and EKB-569 in treating colon, lung, and breast cancers are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCSokM42ZhprVg90H21EOLACvtfcHk0lgROk3QKNsb2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKnsb7E&md5=2e46d99ca74e297e6a7e860634bf096d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fardp.200800009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200800009%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DThe%2520development%2520of%2520HKI-272%2520and%2520related%2520compounds%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%252C%2520Ger.%2529%26date%3D2008%26volume%3D341%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Nakayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, O.</span><span> </span><span class="NLM_article-title">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1970</span><span class="NLM_x">–</span> <span class="NLM_lpage">1977</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1124%2Fdmd.109.027797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=19487250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1970-1977&author=S.+Nakayamaauthor=R.+Atsumiauthor=H.+Takakusaauthor=Y.+Kobayashiauthor=A.+Kuriharaauthor=Y.+Nagaiauthor=D.+Nakaiauthor=O.+Okazaki&title=A+zone+classification+system+for+risk+assessment+of+idiosyncratic+drug+toxicity+using+daily+dose+and+covalent+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span></div><div class="casAuthors">Nakayama, Shintaro; Atsumi, Ryo; Takakusa, Hideo; Kobayashi, Yoshimasa; Kurihara, Atsushi; Nagai, Yoko; Nakai, Daisuke; Okazaki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1970-1977</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The risk of idiosyncratic drug toxicity (IDT) is of great concern to the pharmaceutical industry.  Current hypotheses based on retrospective studies suggest that the occurrence of IDT is related to covalent binding and daily dose.  The authors detd. the covalent binding of 42 radiolabeled drugs in three test systems (human liver microsomes and hepatocytes in vitro and rat liver in vivo) to assess the risk of IDT.  On the basis of safety profiles given in official documentation, tested drugs were classified into the safety categories of safe, warning, black box warning, and withdrawn.  The covalent binding in each of the three test systems did not distinguish the safety categories clearly.  However, when the log-normalized covalent binding was plotted against the log-normalized daily dose, the distribution of the plot in the safety categories became clear.  An ordinal logistic regression anal. indicated that both covalent binding and daily dose were significantly correlated with safety category and that covalent binding in hepatocytes was the best predictor among the three systems.  When two sepn. lines were drawn on the correlation graph between covalent binding in human hepatocytes and daily dose by a regression anal. to create three zones, 30 of 37 tested drugs were located in zones corresponding to their resp. classified safety categories.  In conclusion, the authors established a zone classification system using covalent binding in human hepatocytes and daily dose for the risk assessment of IDTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtahZPkNJ3JbVg90H21EOLACvtfcHk0lgROk3QKNsb2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO&md5=425119e0451fc50ec6ca95d5e3fe5fd3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.027797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.027797%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DAtsumi%26aufirst%3DR.%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DA.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DNakai%26aufirst%3DD.%26aulast%3DOkazaki%26aufirst%3DO.%26atitle%3DA%2520zone%2520classification%2520system%2520for%2520risk%2520assessment%2520of%2520idiosyncratic%2520drug%2520toxicity%2520using%2520daily%2520dose%2520and%2520covalent%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1970%26epage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="note"><p class="first last">Please see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for more details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Naramura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Band, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Band, H.</span><span> </span><span class="NLM_article-title">Indispensable roles of mammalian Cbl family proteins as negative regulators of protein tyrosine kinase signaling: Insights from in vivo models</span> <span class="citation_source-journal">Commun. Integr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.4161%2Fcib.4.2.14716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=21655429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVahsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=159-162&author=M.+Naramuraauthor=V.+Bandauthor=H.+Band&title=Indispensable+roles+of+mammalian+Cbl+family+proteins+as+negative+regulators+of+protein+tyrosine+kinase+signaling%3A+Insights+from+in+vivo+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Indispensable roles of mammalian Cbl family proteins as negative regulators of protein tyrosine kinase signaling - insights from in vivo models</span></div><div class="casAuthors">Naramura, Mayumi; Band, Vimla; Band, Hamid</div><div class="citationInfo"><span class="NLM_cas:title">Communicative & Integrative Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-162</span>CODEN:
                <span class="NLM_cas:coden">CIBOBQ</span>;
        ISSN:<span class="NLM_cas:issn">1942-0889</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  All higher eukaryotes utilize protein tyrosine kinases (PTKs) as mol. switches to control a variety of cellular signals.  Notably, many PTKs have been identified as proto-oncogenes whose aberrant expression, mutations or co-option by pathogens can lead to human malignancies.  Thus, it is obvious that PTK functions must be precisely regulated in order to maintain homeostasis of an organism.  Investigations over the past fifteen years have revealed that members of the Cbl family proteins can serve as neg. regulators of PTK signaling, and biochem. and cell biol. studies have unraveled the mechanistic basis of this regulation.  Yet, it is only recently that the field has begun to appreciate the real significance of this novel regulatory app. in shaping PTK-mediated signaling in organismic contexts and in human diseases.  Here, we discuss recent progress in murine models that are beginning to provide insights into the crit. roles of Cbl proteins in physiol. pathways, with important implications in understanding how aberrations of Cbl proteins contribute to oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRtiJqFyqaC7Vg90H21EOLACvtfcHk0lgROk3QKNsb2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVahsLk%253D&md5=d9e876f139b2f1db11d15af705a46258</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.4161%2Fcib.4.2.14716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcib.4.2.14716%26sid%3Dliteratum%253Aachs%26aulast%3DNaramura%26aufirst%3DM.%26aulast%3DBand%26aufirst%3DV.%26aulast%3DBand%26aufirst%3DH.%26atitle%3DIndispensable%2520roles%2520of%2520mammalian%2520Cbl%2520family%2520proteins%2520as%2520negative%2520regulators%2520of%2520protein%2520tyrosine%2520kinase%2520signaling%253A%2520Insights%2520from%2520in%2520vivo%2520models%26jtitle%3DCommun.%2520Integr.%2520Biol.%26date%3D2011%26volume%3D4%26spage%3D159%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Katkere, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, J. R.</span><span> </span><span class="NLM_article-title">The Syk-binding ubiquitin ligase c-Cbl mediates signaling-dependent B cell receptor ubiquitination and B cell receptor-mediated antigen processing and presentation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">16636</span><span class="NLM_x">–</span> <span class="NLM_lpage">16644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=16636-16644&author=B.+Katkereauthor=S.+Rosaauthor=J.+R.+Drake&title=The+Syk-binding+ubiquitin+ligase+c-Cbl+mediates+signaling-dependent+B+cell+receptor+ubiquitination+and+B+cell+receptor-mediated+antigen+processing+and+presentation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatkere%26aufirst%3DB.%26aulast%3DRosa%26aufirst%3DS.%26aulast%3DDrake%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Syk-binding%2520ubiquitin%2520ligase%2520c-Cbl%2520mediates%2520signaling-dependent%2520B%2520cell%2520receptor%2520ubiquitination%2520and%2520B%2520cell%2520receptor-mediated%2520antigen%2520processing%2520and%2520presentation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D16636%26epage%3D16644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Paolino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thien, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterleitner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baier, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langdon, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penninger, J. M.</span><span> </span><span class="NLM_article-title">Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">2138</span><span class="NLM_x">–</span> <span class="NLM_lpage">2147</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=2138-2147&author=M.+Paolinoauthor=C.+B.+Thienauthor=T.+Gruberauthor=R.+Hinterleitnerauthor=G.+Baierauthor=W.+Y.+Langdonauthor=J.+M.+Penninger&title=Essential+role+of+E3+ubiquitin+ligase+activity+in+Cbl-b-regulated+T+cell+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaolino%26aufirst%3DM.%26aulast%3DThien%26aufirst%3DC.%2BB.%26aulast%3DGruber%26aufirst%3DT.%26aulast%3DHinterleitner%26aufirst%3DR.%26aulast%3DBaier%26aufirst%3DG.%26aulast%3DLangdon%26aufirst%3DW.%2BY.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26atitle%3DEssential%2520role%2520of%2520E3%2520ubiquitin%2520ligase%2520activity%2520in%2520Cbl-b-regulated%2520T%2520cell%2520functions%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D2138%26epage%3D2147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="note"><p class="first last">Compound <b>41</b> (PF-06465469) is now commercially available from Sigma-Aldrich Corp. (St. Louis, MO), Tocris Bioscience (Bristol, U.K.), or Toronto Research Chemicals, Inc. (North York, ON, Canada).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Kawasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freire, E.</span><span> </span><span class="NLM_article-title">Finding a better path to drug selectivity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">990</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm301190s&amp;key=10.1016%2Fj.drudis.2011.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm301190s&amp;key=21839183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWktbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=985-990&author=Y.+Kawasakiauthor=E.+Freire&title=Finding+a+better+path+to+drug+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Finding a better path to drug selectivity</span></div><div class="casAuthors">Kawasaki, Yuko; Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">985-990</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Extremely high affinity and selectivity are two of the most sought-after properties of drug mols.  Selectivity has been difficult to achieve, esp. for targets that belong to large families of structurally and functionally related proteins.  There are essentially two ways by which selectivity can be improved during lead optimization: a chem. modification of the lead compd. that improves the affinity towards the target to a higher extent than to off-target mols.; and a chem. modification that lowers the affinity of the lead compd. towards off-target mols.  Maximal selectivity is achieved when both mechanisms can be combined synergistically.  As we discuss here, anal. of several protease inhibitors that vary in a single functionality indicates that nonpolar functionalities preferentially follow the first mechanism, whereas polar functionalities follow the second, and that those features are imprinted in their thermodn. signatures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGj1IsjIk4bbVg90H21EOLACvtfcHk0lg6CMw_7DCzRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWktbjF&md5=68ab56fd05adcdc61d12ee955b0fddc5</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DKawasaki%26aufirst%3DY.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DFinding%2520a%2520better%2520path%2520to%2520drug%2520selectivity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D985%26epage%3D990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boatman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMillan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finzel, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span> </span><span class="NLM_article-title">Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1804</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">–</span> <span class="NLM_lpage">1831</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=1817-1831&author=Z.+Wangauthor=W.+Wattauthor=N.+A.+Brooksauthor=M.+S.+Harrisauthor=J.+Urbanauthor=D.+Boatmanauthor=M.+McMillanauthor=M.+Kahnauthor=R.+L.+Heinriksonauthor=B.+C.+Finzelauthor=A.+J.+Wittwerauthor=J.+Blinnauthor=S.+Kamtekarauthor=A.+G.+Tomasselli&title=Kinetic+and+structural+characterization+of+caspase-3+and+caspase-8+inhibition+by+a+novel+class+of+irreversible+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWatt%26aufirst%3DW.%26aulast%3DBrooks%26aufirst%3DN.%2BA.%26aulast%3DHarris%26aufirst%3DM.%2BS.%26aulast%3DUrban%26aufirst%3DJ.%26aulast%3DBoatman%26aufirst%3DD.%26aulast%3DMcMillan%26aufirst%3DM.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DFinzel%26aufirst%3DB.%2BC.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DBlinn%26aufirst%3DJ.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26atitle%3DKinetic%2520and%2520structural%2520characterization%2520of%2520caspase-3%2520and%2520caspase-8%2520inhibition%2520by%2520a%2520novel%2520class%2520of%2520irreversible%2520inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1804%26spage%3D1817%26epage%3D1831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrusin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haske, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span> </span><span class="NLM_article-title">Structure-based design of a potent, selective, and irreversible inhibitor of the catalytic domain of the erbB receptor subfamily of protein tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1130</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960380s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm301190s&amp;key=1%3ACAS%3A528%3ADyaK2sXitFGmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1130-1135&author=J.+Singhauthor=E.+M.+Dobrusinauthor=D.+W.+Fryauthor=T.+Haskeauthor=A.+Whittyauthor=D.+J.+McNamara&title=Structure-based+design+of+a+potent%2C+selective%2C+and+irreversible+inhibitor+of+the+catalytic+domain+of+the+erbB+receptor+subfamily+of+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases</span></div><div class="casAuthors">Singh, Juswinder; Dobrusin, Ellen M.; Fry, David W.; Haske, Taraneh; Whitty, Adrian; McNamara, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1130-1135</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the use of structure-based drug design to create a selective erbB-1 (a.k.a. epidermal growth factor receptor) and erbB-2 (a.k.a. neu/her2 growth factor receptor) tyrosine kinase inhibitor.  Using the x-ray crystal structure of the ternary complex of the cAMP-dependent Ser/Thr kinase together with a sequence alignment of the catalytic domains of a representative set of Ser/Thr and Tyr protein kinases, the authors have examd. the nucleotide binding site for potential positions to attach an irreversible inhibitor.  This information, combined with homol. modeling of the erbB-1 and erbB-2 tyrosine kinase catalytic domains, has led to the identification of Cys797 of erbB1 and Cys805 of erbB2, which are structurally equiv. to Glu127 in the cAMP dependent Ser/Thr kinase as potential target residues.  The x-ray structure of the cAMP Ser/Thr kinase shows Glu127 to be involved in a hydrogen-bonding interaction with the 2'-OH of the ribose portion of ATP.  Using mol. modeling, it was predicted that the Cys side chains in erbB-1 and erbB-2 performed an analogous role, and it was postulated that the replacement of the 2'-OH of adenosine with a thiol might allow for a covalent bond to form.  Since only erbB-1 and erbB-2 have a Cys at this position, the inhibitor should be selective.  This model was subsequently tested exptl. by chem. synthesis of 2'-thioadenosine and assayed against the full length erbB-1 receptor and the catalytic domains of erbB-2, insulin receptor, β-PDGF receptor, and the FGF receptor.  The results show that thioadenosine covalently inactivates erbB-1 with a second-order rate const. of kmax/KS = 2000 M-1 s-1.  Inactivation is fully reversed by 1 mM dithiothreitol, suggesting that inactivation involves the modification of a cysteine residue at the active site, presumably Cys797.  The rate of inactivation sats. with increasing thioadenosine concns., suggesting that inactivation occurs through initial formation of a noncovalent complex with KD = 1.0 μM, followed by the slow formation of a disulfide bond with a rate const. of kmax = (2.3) × 10-3 s-1.  This approach may have application in the design of selective irreversible inhibitors against other members of the kinase family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6EaHMhyfSKbVg90H21EOLACvtfcHk0lg6CMw_7DCzRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitFGmu74%253D&md5=161daa8b5c2e8a88d8e48dd102ac1e49</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm960380s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960380s%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DDobrusin%26aufirst%3DE.%2BM.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DHaske%26aufirst%3DT.%26aulast%3DWhitty%26aufirst%3DA.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26atitle%3DStructure-based%2520design%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520irreversible%2520inhibitor%2520of%2520the%2520catalytic%2520domain%2520of%2520the%2520erbB%2520receptor%2520subfamily%2520of%2520protein%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1130%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i43"><a href="/doi/suppl/10.1021/jm301190s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_34872"></div></div></div></div></div><hr /></hr><p class="last">Assay details, electrophilicity calculations, and <sup>1</sup>H NMR spectra. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301190s/suppl_file/jm301190s_si_001.pdf">jm301190s_si_001.pdf (4.98 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates of the Itk crystal structures have been deposited in the Protein Data Bank for compound <b>40</b> (4HCU), compound <b>52</b> (4HCT), and compound <b>53</b> (4HCV).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm301190s&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm301190s%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm301190s" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991ae0ae4324f5","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
